TTM Technologies combined its commercial circuit-board business and its defense business into one group run by Doug Soder, who has led each of them. The defense head, Cathie Gridley, becomes an adviser to the chief executive until mid-2027. The company gave no figures and did not say whether it will still report the two businesses separately.
What it did to the thesisNothing moved. Our case rests on demand for AI circuit boards and the defense base, not on how the managers are arranged. If the company stops reporting the two businesses apart, the next annual report will show it. The view stays Attractive.
Tesla said it will spend about €3 billion (about $3.3 billion) on its German factory, for a building that could make up to a million driverless Cybercabs a year from 2029. It also began selling Cybercabs to invited buyers for $29,990, plus $299 a month to make it drive, only in its robotaxi areas. Musk had already said the Cybertruck ends in mid-2027.
What it did to the thesisNothing in our view moved. The German spending makes nothing until 2029, and Tesla gave no order numbers or revenue for the Cybercab. The price still sits far above even our best case, so we stay Unattractive with high conviction.
It sells five consumer vehicles - Model 3, Model Y, Model S, Model X and Cybertruck - plus the Semi, and two energy products, Powerwall for homes and…
Tempus shares closed at $64.76 on 16 November, down from $76.05 ten days earlier. The company announced nothing that explains it: the week's news was a research partnership with a military cancer charity and six study summaries for a conference. At the new price, investors are still paying for profits Tempus has never come close to making.
What it did to the thesisNothing moved. Even after the fall, the price is far above our estimate of what the business is worth and above our most hopeful case, so the view stays Unattractive with high confidence.
At $10.99 of enterprise value for each dollar of sales, the price needs roughly a 25% operating margin on about $3.1B of revenue in 2029 - a margin T…
TE Connectivity said it will spend more than $60 million on a factory and research site near Rochester, New York, to make parts that attach optical fibre to AI chips, a product line it bought. The site opens in spring 2027, ramps up through 2031 and should employ more than 800 people. Separately, the shares fell to $213.45.
What it did to the thesisNothing moved. The plant fits what management already told us: optical parts add real sales only from 2028, and copper stays the main business in AI racks. At about 88% of our value the price is not cheap enough, so our view stays Neutral with medium conviction.
Turtle Beach shares closed at $15.99 on 16 November, down from $17.04 on 9 November, with no news from the company. We think the business is worth about $13.61 a share, so the price is now about 117% of that value, just under the line where we call it too dear.
What it did to the thesisWe now rate Turtle Beach Neutral, with medium conviction. The business has not changed and the cushion is thin, but the price is back inside our margin. Grand Theft Auto VI comes out on 19 November; the holiday report in March is the test.
On a three-stage fair value at an 8% required return Turtle Beach is worth about $13.61 a share against $17.04 at the 9 November close, about 125% of…
Seagate shares closed at $499.00 on 16 November, down from $551.72 on 11 November. We found no company news, report or filing in that time. We value the business at about $434 a share on the cash it should earn over many years.
What it did to the thesisThe price is now about 115% of our value, inside the margin we allow above it, so it no longer looks too dear. We moved Seagate from Unattractive to Neutral. Conviction stays Medium.
At $551.72, the 11 November close, the shares cost about 13.7 times analysts' FY27 EPS and 8.4 times FY28's. FY28's consensus keeps about 53% of reve…
On a three-stage fair value at an 8% required return Seagate Technology is worth about $434 a share against $551.72 at the 11 November close, about 1…
Sterling Infrastructure shares closed at $275.13 on 16 November, down from $290.67 on 9 November. We found no company news or filings in that week. We value the business at about $359 a share on the cash it should earn over many years.
What it did to the thesisThe price is now 77% of our value, just past our cushion. We keep Sterling at Neutral because its signed work fell last quarter and the cushion is thin; a wider cushion or recovered signings would change that.
On a three-stage fair value at an 8% required return Sterling is worth about $359 a share against $290.67 at the 9 November close. Base case: trailin…
SpaceX's giant Starship rocket reached orbit on 13 November, released 26 of its new, larger Starlink internet satellites, and the next day its upper stage flew back and was caught by the arms of its launch tower, a first. The lower stage failed to return and exploded over the Gulf of Mexico.
What it did to the thesisNothing moved. Catching the rocket brings cheaper, reusable launches closer and adds satellites, which helps the business. But the shares already cost far more than even our hopeful estimate of what SpaceX is worth, so the view stays Unattractive.
SoFi closed at $14.85 on 16 November, down from $16.27 on 11 November, with no new results, filings or company news. We value the shares at about $20.36, so the price is about 73% of that value.
What it did to the thesisThe view moves to Attractive. Last week we asked for a price a quarter below our value, because our value assumes SoFi earns a higher return than forecasts show. The price is now past that line. Confidence stays medium: the gloomy case is far lower.
On an excess-return value at an 8% required return SoFi is worth about $20.36 a share against $16.27 at the 11 November close, about 80% of it. Base…
Sandisk's shares closed at $809.11 on 16 November, down from $835 when we last valued them. That is about 121% of what we think a share is worth, just above the line where we would call the price fair. Separately, each shareholder gets seven new shares for every one held, and the shares trade on that basis from 20 November.
What it did to the thesisNothing about the business changed, and the price is still a little above our fair line, so the view stays Unattractive with low confidence. The split changes only the number of shares, not the value of the company.
Plug began selling GenEco Scale, a hydrogen-making plant built from standard 20 MW blocks so customers need less custom engineering. It named Arcadia eFuels, a maker of jet fuel from hydrogen, as the first customer, for a 280 MW plant in Texas. It gave no price, no firm order terms and no start date, and filed nothing with regulators.
What it did to the thesisNothing moved. Plug had already listed this Texas project among its possible deals, and without a firm order or a value it adds no sales we can count. Our case turns on cash and new shares, and this changes neither.
Onto Innovation's board approved buying back up to $400 million of its own shares, replacing an older plan from February 2024. It is permission to buy, not money already spent. Onto held $1.25 billion of cash and investments at September, against $1.5 billion of convertible bonds due 2031.
What it did to the thesisNothing moved. A buyback only matters once shares are bought, and at about 132% of what we think a share is worth, buying would spend cash dearly. The view stays Unattractive with medium conviction.
The US now needs licences for advanced chips sent to five more countries, and Nvidia's board set up an export oversight committee. Later the SEC was reported to be investigating whether Nvidia misled investors. Former chief Jensen Huang said he would return if the board asked, and Congress will question him on 1 December and Nvidia's top lawyer on 2 December.
What it did to the thesisNo sales or profit figure moved, and the shares sit well below our value, so we keep Attractive with medium confidence. The investigations raise the legal risk around the founder's exit; a finding against Nvidia or a forced change to its figures would be what moves us.
NVIDIA's independent directors opened an investigation on November 8, 2026 into the former chief executive's relationship with a Megaspeed executive…
Q2 FY2027 revenue was $96,221M, up 106% from $46,743M. Data Center was $89,023M (+117%): Hyperscale $48,710M (+102%) and AI Clouds, Industrial and En…
Gross margin was 75.0% in Q2 FY2027 and operating income $63,734M, a 66.2% margin. For FY2026 gross margin was 71.1%, down from 75.0%, after a $4.5B…
Q2 FY2027 net income of $59,688M included $7,771M of gains on equity investments, $23,707M in the half-year. GAAP diluted EPS was $2.46 and non-GAAP…
Operating income over the four quarters to July 26, 2026 was $197,579M: $36,010M in Q3 FY2026, $44,299M in Q4 FY2026, $53,536M in Q1 FY2027 and $63,7…
Operating cash flow fell to $24,077M in Q2 FY2027 from $50,344M in Q1, 40% of net income, as receivables rose to $63,059M from $38,466M in January. D…
One direct customer was 16% of Q2 FY2027 revenue; in the half-year three were 16%, 15% and 13%. Five direct customers held 22%, 14%, 13%, 11% and 10%…
At July 26, 2026 NVIDIA had $366B of commitments, $279B of them for supply and capacity, up from $119B, plus $56B of AI cloud agreements and leases,…
The Q3 FY2027 outlook is revenue of $108.0B plus or minus 2%, with no China data-centre computing, and gross margin of 74.0% plus or minus 0.5 points.
Shares outstanding fell to 24,147M at July 26, 2026 from 24,304M in January; NVIDIA bought 203M shares for $39.8B in the half-year, and on September…
NVIDIA issued $25.0B of notes in Q2 FY2027; debt was $33.4B against $56.6B of cash and marketable debt securities, with $1.0B due within a year and $…
Enterprise value is about 22.7 times trailing operating profit of $197,579M, and about 17.6 times Q2 FY2027's operating profit of $63,734M run for a…
At $186.64 the shares are about 20 times FY2027's expected earnings per share, 12 times FY2028's and 9 times FY2029's, and enterprise value is about…
The Q3 FY2027 outlook assumes no China data-centre computing; H20 shipments to China were under 1% of Data Center revenue in Q2, and customers headqu…
Part of today's profit is being lent back or held as paper: Q2 FY2027 turned only 40% of net income into cash, $7.8B of profit was gains on shares in…
Jen-Hsun Huang co-founded NVIDIA in 1993 and ran it as president and chief executive until November 11, 2026, when the board accepted his resignation…
On a three-stage fair value at an 8% required return NVIDIA is worth about $295 a share against $186.64 at the 6 November close. Base case: FY2026 sa…
NVIDIA's independent directors opened an investigation on November 8, 2026 into the former chief executive's relationship with a Megaspeed executive…
On 16 November Insight sold $650 million of five-year notes paying 0.875% a year that lenders can later swap for shares. The shares fell 8% that day to $155.29. We think the business is worth about $140 a share, so the price is now about 111% of that value.
What it did to the thesisWe now rate Insight Neutral, with medium conviction. The business did not change, but the price is back inside our cushion above its value. What the borrowed money is for is not yet clear; the next test is the February report.
On a three-stage fair value at an 8% required return Insight is worth about $140 a share against $168.75 at the 10 November close, about 121% of it.…
Netflix shares closed at $60.75 on 16 November, down about 4% in a week with no company news beyond a concert tour licensing its K-pop film. That is about 78% of the roughly $78 a share we think the business is worth, just past the line where our 20% cushion begins.
What it did to the thesisNetflix stays Neutral, with medium conviction. Whether its spending on shows slows as promised is answered by the January report, and a large studio purchase is still possible, so a two-point cushion is too thin. We now want the price near $58.55, 75% of our value.
On a three-stage fair value at an 8% required return Netflix is worth about $78.06 a share against $63.41 at the 6 November close. Base case: trailin…
Merck ended all testing of nemtabrutinib, a pill for blood cancers, after an independent panel watching a large trial said its benefits may not outweigh its risks. Two other large trials of the pill stop too. Merck did not say what the programme cost or whether it will write anything off.
What it did to the thesisWe still rate Merck Unattractive, with medium conviction. Merck needs new drugs to replace Keytruda, and this is the second late-stage one to fall away since September. The pill had no sales, so our value of the company does not change.
KLA shares closed at $143.96 on 16 November, down from $152.32 on 13 November, as chip-equipment stocks fell after a rival's report. There was no news from KLA. We think the business is worth about $120 a share, so the price is about 120% of that value.
What it did to the thesisWe still rate KLA Unattractive, with medium conviction. Our value already counts the analysts' boom year, and at the line the price still asks for more in a cyclical business. A fall to about $132, a tenth above our value, would make it Neutral.
On a three-stage fair value at an 8% required return KLA is worth about $120 a share against $151 at the 9 November close. Base case: trailing sales…
Ichor shares closed at $33.65 on 16 November, down about 10% from 11 November with no company news, filing or report. That gives back about half of the jump that took them to about 25% above the roughly $30 a share we think the business is worth.
What it did to the thesisIchor moves from Unattractive back to Neutral, with medium conviction. At about 12% above our value the price pays for the chip-equipment recovery but not for more. It would turn Unattractive again near $36 and Attractive near $24.
On a three-stage fair value at an 8% required return Ichor is worth about $30.07 a share against $37.45 at the 11 November close, about 125% of it, w…
IBM shares closed at $242.51 on 16 November, down from $247.13 on 13 November. IBM also announced plans to work with NVIDIA and the Fermilab physics laboratory on quantum computers, with no money attached. We think the business is worth about $204 a share, so the price is about 119% of that value.
What it did to the thesisWe still rate IBM Unattractive, with medium conviction. Our value already assumes IBM keeps paying a low tax rate, and growth is slow with high debt. A fall to about $225, a tenth above our value, would make it Neutral.
The shares closed at $247.13 on 13 November 2026.
At $247.13 IBM's company value is about $289B: 953.5M diluted shares, plus $63.8B of debt and $0.7B of minority interest, less $11.1B of cash and sec…
Valued in three stages at an 8% required return, IBM is worth about $204 a share in the base case, $104 in the bear and $264 in the bull, so $247.13…
Helios shares fell to $45.70 on 16 November, down from $48.00 on 10 November, as other industrial and AI-hardware shares fell. The company published nothing new. We think the business is worth about $61.80 a share, so the price is now about 74% of that.
What it did to the thesisLast week we said Helios needed a bigger discount than usual, because its customers are cyclical and its first AI order has no size: a price below $46.35. It is now there, so we moved our view from Neutral to Attractive, with medium conviction.
First Solar closed at $162.45 on 16 November, down from $201.14 on 6 November, with no new results or filings; a news headline linked the fall to fading election hopes for clean-energy policy. We value the business, counting the tax credit still to come, at about $139 a share, so the price is now about 117% of that value, back under the 120% line we had marked as too dear.
What it did to the thesisOur view moves from Unattractive to Neutral, with medium conviction. Nothing about the business changed; the price now pays only a little more than our value. What new orders fetch once the import floor starts on 4 December decides the next move.
Enterprise value is 7.4 to 8.0 times guided 2026 adjusted earnings before interest, tax and depreciation, and the shares cost $12.69 for each $1 of t…
The price pays roughly $8B for the credit still to come and about $12B for a manufacturer guided to lose money before it.
On a three-stage fair value at an 8% required return First Solar is worth about $139 a share against $201.14 at the 6 November close, where enterpris…
Forgent shares closed at $20.57 on 16 November, down from $22.12 on 13 November, with no news from the company since a quarterly report that beat its forecast and raised the year. We think the business is worth about $27.66 a share, so the price is about 74% of that value.
What it did to the thesisWe now rate Forgent Attractive, with medium conviction. The power-gear shortage will ease and orders are now reported only once a year, but the price sits about a quarter under our value, a big enough cushion. A rise back to about $22.13 would make it Neutral.
At $22.15 the company value is about $7.14B, about 11.7 times the $612M midpoint of the raised FY27 adjusted EBITDA guidance and the shares about 16.…
On a three-stage fair value at an 8% required return Forgent is worth about $27.66 a share against $22.15 at the 12 November close (about 80% of it).…
Comfort Systems said it spent $1.89B buying back its own shares this year, about $1.54B of it since the end of September, roughly 4% of all its shares at around $1,150 each. That used about seven-tenths of the $2.16B of cash it held in September. Its board approved buying up to 1 million more shares.
What it did to the thesisWe still rate Comfort Systems Attractive, with medium conviction. Buying shares well below what we think they are worth helps owners, and it shows management treats customers' prepaid cash as its own. The cost is a thinner cash cushion if those prepayments shrink.
Comfort Systems stopped buying its own shares for the first half of 2026, then restarted in the third quarter. Share repurchases were $8,232 thousand…
Element Solutions shares closed at $31.75 on 16 November, down from $32.96 a week earlier. That is about 120% of our estimate of what a share is worth, about $26.54, which is the line between a price we call too high and one we call fair. The company published nothing new.
What it did to the thesisNothing about the business changed, but the price is no longer clearly above our value, so we moved the view from Unattractive to Neutral. Confidence is low, because the price sits right on the line and a small rise would take it back.
On a three-stage fair value at an 8% required return Element Solutions is worth about $26.54 a share against $32.96 at the 9 November close ($31.35 o…
EnerSys shares fell to $138.68 on 16 November from $147.80 on 12 November, as other power and industrial shares fell. The company published nothing new. We think the business is worth about $116 a share without its tax credit, so the price is about a fifth above that.
What it did to the thesisThe price is now just inside the level where we said we would turn neutral, but only by a hair. Its forklift batteries, nearly half of sales, keep shrinking, so we hold our view at Unattractive and would turn neutral near $127.30.
Everus's board approved buying back up to $100 million of its own shares by December 2029, about 2% of the company's value. Management said buying contractors and investing in its own business still come first. The shares closed at $82.92 on 16 November.
What it did to the thesisThe buyback is a small plus. But the shares now sit only about a fifth below what we think Everus is worth, the cushion we ask for when customers are unnamed and profit runs above normal. We move from Attractive to Neutral.
Diluted shares were about 51.2M in the June 2026 quarter, roughly where they were at the spin-off; stock pay was $8.7M over twelve months; Everus pay…
On a three-stage fair value at an 8% required return Everus is worth about $103 a share against $76.60 at the 6 November close. Base case: trailing s…
Dave asked federal banking regulators for permission to open its own national bank, Dave Bank. If approved, it could hold customer deposits and make its small cash advances itself, instead of through a partner bank. Dave says it will not raise new money for this and nothing changes for customers yet. It hired a former bank president to run it.
What it did to the thesisNothing moved. Approval is not assured and could take a long time, especially while the government's lawsuit against Dave is open. Until then Dave still depends on its partner bank. Dave stays Unattractive, with medium conviction: the price is above our value.
Cisco shares closed at $94.52 on 16 November, down from $100.76 before its results last week. That is about 115% of our estimate of what a share is worth, about $81.85. No new facts about the company came out; the news was commentary on the same results.
What it did to the thesisThe business case did not change, but the price is no longer more than a fifth above our value, so we moved the view from Unattractive back to Neutral, with medium confidence. Orders after the price rises pass are still the test.
On a three-stage fair value at an 8% required return Cisco is worth about $81.85 a share against $100.76 at the 11 November close. Base case: trailin…
Chart, which Baker Hughes bought in July, agreed to sell its designs for liquefying natural gas in small and mid-sized plants, with over 90 patents and the engineers, to Italy's MAIRE for $220 million in cash. Chart will keep supplying a key piece of equipment for ten years. The buyer expects the business to earn about $25 million a year.
What it did to the thesisNothing moved. The sale trims Baker Hughes' debt slightly, but next to roughly $14 billion of net debt it barely changes the path we track, and Chart keeps making the equipment. The view stays Neutral until the February report shows Chart's margin and the debt coming down.
Arista shares closed at $187.02 on 16 November, down from $196.68 on 11 November, as other AI hardware shares fell, with no news from the company. We think the business is worth about $157 a share, so the price is now about 119% of that value, just inside the line where we stop calling it too dear.
What it did to the thesisWe now rate Arista Neutral again, with medium conviction. Nothing about the business changed, so the rating follows the price back. The premium over our value is still thin: a rise above about $188 would make it Unattractive again; the February report is the next test.
On a three-stage fair value at an 8% required return Arista is worth about $157 a share against $196.68 at the 11 November close, about 125% of it. B…
Blackstone's listed data-centre trust agreed to buy 75% of 13 newly built Amazon data-centre buildings in a deal valued at about $5 billion. Amazon keeps 25% and rents all of them back for at least 12 years. Separately, a rocket failure destroyed 40 Amazon internet satellites, and Amazon plans $7 billion of renewable power in India.
What it did to the thesisNothing moved. Selling buildings and renting them back is one more way to pay for the huge data-centre build, but it is small next to about $220 billion of spending this year. The shares sit near what we think Amazon is worth, so the view stays Neutral.
AMD closed at $504.28 on 16 November, down from $552.90 on 11 November, with no new results or filings. We value the business at about $460 a share, so the price is now about 110% of that value, back under the 120% line it had just crossed. Company releases that week, a supercomputer launch and a completed purchase of World Labs, carried no figures the case rests on.
What it did to the thesisOur view moves from Unattractive back to Neutral, with medium conviction: the price now pays only a little more than our value. Sales of the new AI racks in the fourth-quarter results decide the next move either way.
At $552.90, the 11 November close, AMD trades at about 83 times the last four quarters' adjusted EPS of $6.65, 34 times the analysts' 2027 EPS of $16…
On a three-stage fair value at an 8% required return AMD is worth about $460 a share against $552.90 at the 11 November close, about 120% of it. Base…
Adeia said Rogers Communications, Canada's largest cable and wireless company, signed a multi-year licence to use Adeia's TV and streaming patents, covering its Shaw businesses too. The deal ends all the lawsuits between the two. Adeia did not say how much Rogers will pay or for how long.
What it did to the thesisNothing in our view moved. It adds a paying customer and is another fight that ended in a licence, but with no amount we cannot size it, and our case turns on two US TV companies, DIRECTV and DISH, that still have not signed.
Three refusals have ended in licences: Disney litigated from November 2024 and signed a long-term licence in December 2025 with all cases and patent-…
ACM Research shares fell to $44.00 on 16 November, 12% below where we last valued them, alongside other chipmaking-equipment makers. Checking our value, we found it had counted all of the profit of ACM Shanghai, its Chinese operating arm, although outside investors own 27.2% of that arm. Counting their share, we put the business at about $50.85 a share, not $58.62.
What it did to the thesisAt $44.00 the shares are about 87% of our corrected value, not far enough below it to call them cheap given the China and cash risks. So our view stays Neutral with medium conviction; it would turn Attractive near $40.68.
On a three-stage fair value at an 8% required return ACM Research is worth about $58.62 a share against $49.75 at the 9 November close. Base case: tr…
Xylem said its board approved a new plan to buy back up to $1.5 billion of its own shares, starting now, on the market or in private deals, and that it may stop at any time. An earlier $1.5 billion plan from February was nearly used up. The same day it kept its quarterly dividend at 43 cents.
What it did to the thesisNothing moved. Xylem already buys back a lot of stock, and this lets it continue. Our Neutral view turns on whether sales grow again without acquisitions and margins hold, which a buyback does not change, and the shares trade about at what we think they are worth.
Waystar's shares fell about 4% from $29.18 on 9 November to $28.14 on 12 November, with no filing or company news. That is about 78% of the roughly $35.98 we think the business is worth, a little past the line where our 20% cushion begins.
What it did to the thesisNothing about the business changed. With floating-rate debt, owners who may sell their stake and Epic building similar billing tools, a cushion this thin is not enough: Waystar stays Neutral with medium conviction, and turns Attractive near $26.99, 75% of our value.
On a three-stage fair value at an 8% required return Waystar is worth about $35.98 a share against $29.18 at the 9 November close. Base case: trailin…
Vistra's shares rose about 8%, from $124.80 on 6 November to $134.51 on 12 November. The only filing was a routine one letting the seller of the Cogentrix plants resell the 5 million Vistra shares it was paid with. The price is about 78% of the roughly $173 we think Vistra is worth.
What it did to the thesisNothing about the business changed, so the view stays Attractive with medium conviction. The price is still just under the line where our 20% cushion runs out; it turns Neutral near $138.
On a three-stage fair value at an 8% required return Vistra is worth about $173 a share against $124.80 at the 6 November close. Base case: 2025 sale…
T1's quarterly filing, published on 12 November, says that in September the SEC began investigating what T1 has told investors about qualifying for the 45X manufacturing tax credit, and some other accounting matters. T1 says it will cooperate and cannot predict the outcome. Nobody has been charged. The shares closed at $1.97 on 12 November and $1.91 on 13 November, from $2.13.
What it did to the thesisThe tax credit is T1's whole profit, so an inquiry into what it said about qualifying adds weight to our worry without settling it. The view stays Unattractive with medium confidence; a credit sale to an outside buyer and a closed plant loan are still what would move it.
In November 2025 the DOJ subpoenaed T1 and a current executive and director over his 2023 share sales, and the SEC asked for documents; T1 is coopera…
SentinelOne agreed a $400M borrowing line with a group of banks led by Bank of America on 12 November. It has not borrowed any of it. Its other news since October was new products and partner awards, with no sales figures. The shares closed at $22.29 on 12 November, down 12% since early October as rival security stocks fell too.
What it did to the thesisNothing moved. The credit line adds a safety cushion to a company that already holds $813M of cash. Even after the fall, the price still needs profit margins SentinelOne has never reached, so Neutral holds until the 3 December report shows whether new subscriptions grow again.
Cash and investments were $813.2M at 31 July 2026 with no borrowing; the Israeli tax settlement is paid in shekels through fiscal 2031 at 7% interest…
At $25.43 on 5 October 2026 the market value was $8.70B, 7.9 times trailing revenue; the shares closed at $11.94 on 10 April 2026, about 4 times the…
Its filed rivals CrowdStrike and Palo Alto Networks trade at 52.4 and 30.0 times enterprise value to sales, growing 24.3% and 24.5%, against Sentinel…
At $8.70B the price needs stock pay to fall toward 15% of revenue and cash margins before it to reach about 25%, on revenue near analysts' $1.66B for…
Quanta's shares closed at $606 on 12 November, up 12% from 6 November, with no news from the company. That is about 40 times its yearly operating profit, against about 21 for three rivals. The government's November energy outlook still expects business and factory power use to keep rising into 2027.
What it did to the thesisThe view stays Unattractive and conviction rises from Low to Medium: the price now sits where even our best case values the company. Whether growth without acquisitions passed 20% waits for the annual report in February.
At a close of $580.44 on November 4, 2026 Quanta's enterprise value was about $97.0B, 38.1 times trailing operating profit against a median of 21.5 f…
What the price implies: at the cohort's median of 21.5 times operating profit, today's enterprise value of about $97.0B would need operating profit o…
The Energy Information Administration's October 2026 outlook has US electricity consumption up 4% in the third quarter of 2026 on a year earlier, com…
Navitas filed a second lawsuit against Japanese chipmaker Renesas in a Texas federal court on 12 November, saying Renesas's newly announced gallium-nitride power chips break six of its patents. It already sued Renesas in August over four patents, after Renesas accused Navitas's chief executive of taking trade secrets. Only the first paragraph of the announcement could be read.
What it did to the thesisNothing moved. Our worry is the two lawsuits against Navitas, from Wolfspeed and Renesas, which could cost money or block sales; suing back does not change them, and no court has ruled. Owning patents was already part of the case. We still rate it Unattractive.
From midday on 12 November, many businesses could not use Microsoft's Outlook email, Teams and its Copilot assistant. Microsoft said a number of its servers had stopped working, not a hacking attack. It was still recovering the next morning after more than 19 hours, which may make it the longest such outage it has had.
What it did to the thesisNothing moved. Our case leans on businesses paying more each year for Microsoft 365 and staying; an outage could test that, but no customer has left and no cost has been reported. We will watch seat and revenue growth in January's report. We still rate it Neutral.
IonQ said its chief financial officer, Inder Singh, left his roles on 13 November, effective at once, after fourteen months, and gave no reason. Gary Merrill, finance chief at the data-protection software company Commvault, takes over in early December. A new chief accounting officer, Thomas Austin, formerly of Juniper Networks, starts now.
What it did to the thesisOur view did not move. We doubt the price because it pays for a technology lead IonQ has not shown and for growth bought with new shares; a new finance chief changes neither. A sudden exit with no reason given is a small new worry. We still rate it Unattractive.
Niccolo de Masi, a director since September 2021 and chief executive of dMY III, the listed shell that took IonQ public, became chief executive on Fe…
On 9 November Grab, SoftBank and Sarawak's state oil company agreed to build AI data centres in Malaysia. Grab pledged $750M, paid in stages as projects reach milestones. Its shares then slipped to $3.24, about 78% of the roughly $4.15 we think the business is worth, just past the line where our 20% cushion begins.
What it did to the thesisGrab stays Neutral, with medium conviction. The pledge puts part of its cash into a costly business far from rides and delivery, with no visible return yet, while Uber and Indonesia remain open. We now want the price near $3.11, 75% of our value, before calling it Attractive.
Committed and pending deals claim about $2.0B to $3.4B of cash: $1.49B for Atome's 60%, $78M paid for Stash, and $0.4B to $1.8B for Atome's last 40%,…
On a three-stage fair value at an 8% required return Grab is worth about $4.15 a share against $3.41 at the 6 November close. Base case: trailing sal…
GDS will report its third quarter on 25 November, a week later than we expected. A Bloomberg report on 21 October said DayOne, the overseas data-centre business GDS part-owns, was weighing delaying its US share sale or raising about half the $5 billion it first aimed for. The shares are $20.05, 27% below the price our figures use.
What it did to the thesisNothing moved: we stay Neutral, medium conviction. The cheaper price is weighed against two answers still to come: whether orders and profit hold their pace on 25 November, and what DayOne is worth when it sets a price.
Forgent's shares closed at $22.15 on 12 November, down 9.8% on the day it reported sales above its forecast and raised its plan for the year. We already read that report. Our value is still about $27.66 a share, so the price is now about 80% of it.
What it did to the thesisNothing in the business changed, only the price. We turn Attractive at 80% of our value or less, and the price sits a few cents above that line. We hold Neutral with medium conviction: our worst case is far below, so a cushion this thin is not enough.
At $24.57 the company value is about $7.88B, about 12.9 times the $612M midpoint of the raised FY27 adjusted EBITDA guidance and the shares about 17.…
On a three-stage fair value at an 8% required return Forgent is worth about $27.66 a share against $24.57 at the 11 November close (about 89% of it).…
EMCOR agreed to buy P1 Construction, a Kansas firm that installs mechanical and electrical systems, including in data centers. P1 expects $600 million to $650 million of sales this year and about $60 million of cash profit. EMCOR pays from its own cash but did not say the price. The deal should close in early 2027.
What it did to the thesisNothing moved. P1 adds about 3% to EMCOR's sales, too little to change our value. Overpaying for a purchase this size would hurt the case, but without a price we cannot judge it. The view stays Attractive and conviction Medium; the yearly report should show the price.
Consensus' quarterly report, filed on 6 November, includes its new bank agreement. Its debt may not grow past 4 times a year's cash profit; it stands at about 2.35 times. Debt was $551.6 million at the end of September, with $106.7 million of cash. A director sold 8,000 shares on 9 November.
What it did to the thesisThe loan set aside to repay the 2028 bonds now has visible room, so we score the balance sheet stronger. The view stays Neutral: what holds it back is corporate customers leaving faster, and the February report is the next test of that.
Management launched eFax Protect in mid-2023 as a corporate e-commerce offering to capture small-business demand, and reports record sign-ups for it…
Management reports trailing twelve-month corporate net revenue retention of 103.1% in Q2 2026, up about 110 basis points sequentially and year on yea…
Management says VA revenue should be north of $9M in 2026 and estimates the rollout is 65% to 80% complete.
At 30 June 2026 Consensus owed $558.5M: $348M of 6.5% notes maturing 15 October 2028, a $146M term loan and $64M drawn on a revolver under a facility…
Management reports net debt of 2.45 times cash operating profit and total debt of 2.97 times at Q2 2026.
Tangible net worth is negative $351.6M: equity of $41.566M against goodwill of $352.924M and other intangibles of $40.213M at 30 June 2026.
No insider bought a share in the open market in the twelve months to 16 September 2026; three open-market sales of 10,400 shares were all discretiona…
Zoom shares closed at $98.08 on 11 November, up from $89.88 on 6 November, with no news from the company. Our value had left out Zoom's $3.79B of stakes in private companies, mostly Anthropic, which its last quarterly report carries on the balance sheet. Counting them, we think Zoom is worth about $93.65 a share.
What it did to the thesisNothing about the business moved. At about 105% of the corrected value the price is inside our safety margin, so the view stays Neutral with medium conviction. The 23 November report on big- and small-customer growth is the next test.
On a three-stage fair value at an 8% required return Zoom is worth about $81.02 a share against $89.88 at the 6 November close. Base case: trailing s…
Seagate closed at $551.72 on 11 November, up from $460.99 on 6 November, with no new results or filings. We value the business at about $434 a share, so the price is now about 127% of that value, above the 120% line we had marked as too dear.
What it did to the thesisOur view moves from Neutral to Unattractive, with medium conviction. The price now pays for the drive shortage lasting longer than our base case assumes. The business case itself is unchanged; prices fixed into 2029 or a fall back near $520 would change the view.
At $593.76 the shares cost about 14.8 times analysts' FY27 EPS and 9.0 times FY28's. FY28's consensus keeps about 53% of revenue as profit, against 2…
On a three-stage fair value at an 8% required return Seagate Technology is worth about $434 a share against $461 at the 6 November close. Base case:…
SpaceX said it plans to spend more than $24B on a computing site at its Starbase base in Texas, which will make its own electricity, and about $50B on a campus in Cochise County, Arizona. The Arizona site still needs the county's approval at a hearing in December, and local residents oppose it. No filing or customer contract came with the news.
What it did to the thesisNothing moved. Our case already counts SpaceX spending tens of billions a quarter on computers and power; this names two of the places. The view stays Unattractive with high conviction, because the price still sits far above our value and these sites earn nothing yet.
SoFi closed at $16.27 on 11 November, down from $16.75 on 9 November, with no new results or filings. We value the shares at about $20.36, so the price is about 80% of that value, exactly the line where we would normally call a stock cheap enough.
What it did to the thesisOur view stays Neutral. Our value assumes SoFi earns a much higher return on its net worth than forecasts show, so we now want a price near $15.27, 75% of our value, before calling it attractive.
On an excess-return value at an 8% required return SoFi is worth about $20.36 a share against $16.75 at the 9 November close. Base case: shareholders…
Ouster shares closed at $38.22 on 11 November, up from $28.22 on 2 November, most of it in the days after the third-quarter report. A Spanish toll-road company, Indra, said it picked Ouster's sensors, but gave no order size. Counting Ouster's cash, buyers now pay about $2.34B for the business.
What it did to the thesisThe business facts did not move, so the view stays Neutral with medium conviction. The higher price now needs about 40% sales growth a year for five years, the middle of management's own target, as it did in September. The next test is the December-quarter report.
Net of about $421M of cash and with no debt, buyers are paying about $1.61B for Ouster at the 2 November 2026 close - roughly 6.8 times annualised Q3…
At 30% compound growth - the floor of management's own framework - Ouster reaches about $814M of revenue and about $76M of operating profit in 2031,…
Ouster closed at $28.22 on 2 November 2026, 32% below the $41.37 of 24 September and 55.8% below its 252-day high of $63.79.
Nvidia's board accepted Jensen Huang's resignation on 11 November, after reports of two affairs, one with a woman US officials suspect of spying for China. Colette Kress, the finance chief, runs the company for now while the board looks for a permanent leader inside and outside. Harvey Jones became the first board chair. The board's investigation and Congress's questions continue. Results still come on 17 November.
What it did to the thesisNo sales, margin or cash figure moved, and the price fell further below our value, so we keep Attractive with medium confidence. Losing the founder is a real risk, now named: the results on 17 November, and who leads next, could change that.
Jen-Hsun Huang co-founded NVIDIA in 1993 and has been its president and chief executive since; Colette Kress joined as chief financial officer in 201…
Nutanix shares closed at $60.14 on 11 November, up from $58.37 on 6 November, with no news from the company. We think the business is worth about $49.30 a share, so the price is now about 122% of that value, past the line where we call it too dear, and it has sat there for three days.
What it did to the thesisWe now rate Nutanix Unattractive, with medium conviction. Our value already counts analysts' faster growth, and the price asks for about twice that. A fall back below about $59 would bring it back to Neutral; the report on 24 November is the next test.
On a three-stage fair value at an 8% required return Nutanix is worth about $49.30 a share against $58.37 at the 6 November close. Base case: trailin…
Reuters reported that China's drug regulator approved orforglipron, Lilly's daily weight-loss pill, sold in the US as Foundayo. Only the headline could be read, so we do not know whether it covers obesity, diabetes or both, when it launches or at what price. Lilly has not yet put out a release or filing.
What it did to the thesisNothing moved. The pill gains a large market, which Lilly had expected around now, but our view is about the share price against what the business can earn, and this approval changes no figure in that. We keep Unattractive and Medium confidence and test the business at the February results.
Oklo, which designs small nuclear reactors, turned its June letter of intent into binding multi-year contracts to buy high-grade fuel from Centrus's planned Ohio plant, enough for up to five reactors, with deliveries from 2029. Oklo pays part in advance, helped by Meta's advance payment for Oklo's power. Neither company gave the amount, the price or the size of the advance.
What it did to the thesisA promise became a contract, which strengthens the case that buyers want the plant's fuel. But with no amount given, it adds nothing we can value, and the share price already sits above even our best case. We keep Unattractive and High confidence.
Centrus signed definitive multi-year HALEU contracts with X-energy (6 August 2026, LEU and HALEU, with prepayments), Radiant (9 September) and Antare…
Ichor shares closed at $37.45 on 11 November, up from $30.97 on 6 November and $28.03 on 5 November, with no news from the company. We think the business is worth about $30 a share, so the price is now about 125% of that value, past the line where we call it too dear.
What it did to the thesisWe now rate Ichor Unattractive, with medium conviction. Our value already assumes margins back to its best years, and two customers set those margins, so nothing earns paying a quarter more. A fall back below about $36 would bring it back to Neutral; the next test is the February report.
On a three-stage fair value at an 8% required return Ichor is worth about $34 a share against $30.97 at the 6 November close, where enterprise value…
Robinhood's October figures: customers added $15.1 billion, a 46% yearly pace, though money paid into the new government-backed Trump Accounts for children is counted in it, much of it one family's gift. Customers reached 28.9 million and loans to traders $22.9 billion. Prediction-market trading was 136% above a year earlier; crypto trading fell 48%.
What it did to the thesisNothing moved. The deposit pace we watch for the December quarter looks safely met, and one month does not change what the business earns. The shares still cost about twice what we think they are worth, so the view stays Unattractive.
On 10 November Cohu told investors where it hopes to be in three to five years: reports put it at about $1.3B of sales, more than double this year. The same day it said one more unnamed chip designer chose its Eclipse handler. It did not say how many customers have now approved the handler, nor what profit margin it expects under ordinary accounting.
What it did to the thesisNothing moved. A target years away is a hope, not a result, and the questions we set were left open. The shares at $45.98 cost more than even our hopeful case, so the view stays Unattractive until the February results answer them.
Cohu puts its annual computing opportunity pipeline at about $1.0 billion, up 18% from about $850M a quarter earlier: $230M of annual revenue potenti…
On a three-stage fair value at an 8% required return Cohu is worth about $19.79 a share against $38.49 at the 6 November close. Base case: trailing s…
Arista shares closed at $196.68 on 11 November, up from $170.80 on 6 November, with no news from the company. We think the business is worth about $157 a share, so the price is now about 125% of that value, past the line where we call it too dear. Analysts have nudged their forecasts up, but not enough to change that.
What it did to the thesisWe now rate Arista Unattractive, with medium conviction. The business is solid, but our value already uses analysts' steep growth forecasts, and the price pays for more. A fall back below about $188 would bring it back to Neutral; the next test is the February report.
On a three-stage fair value at an 8% required return Arista is worth about $157 a share against $171 at the 6 November close. Base case: trailing sal…
AMD closed at $552.90 on 11 November, up from $449.04 on 6 November, with no new results or filings. We value the business at about $460 a share, so the price is now about 120% of that value, just above the 120% line we had marked as too dear. Product launches and a quantum-computing investment that week carried no figures that bear on the case.
What it did to the thesisOur view moves from Neutral to Unattractive, with medium conviction. The price now pays a fifth more than our value while the new AI racks are still unproven. Sales of those racks in the fourth-quarter results, or a fall back below about $552, would change it.
At $483.90 AMD trades at about 73 times the last four quarters' adjusted EPS of $6.65, 30 times the analysts' 2027 EPS of $16.07 and 20.7 times their…
On a three-stage fair value at an 8% required return AMD is worth about $460 a share against $449 at the 6 November close. Base case: trailing sales…
Wolfspeed's shares rose 15% since 4 November, to $26.23, without new company news. Its quarterly filing shows lenders turned $10.0M of notes into 0.8M shares, leaving $1,772.0M of debt, and the company used about $95M of cash in the quarter, counting spending on equipment. That leaves about seven quarters before it hits the lenders' minimum cash.
What it did to the thesisNothing in the business changed. Counting the lenders' notes as shares, the price is now about 4.4 times a year's sales, inside what profitable rivals cost, so we still rate it Unattractive. We would turn Neutral if sales pass $200M a quarter with a gross profit.
Debt principal was $1,782.0M: $635.9M of first-lien notes due 2030, now near 16% in cash, $296.4M of second-lien notes paying 7% cash or 12% in kind,…
There were 52,995,396 shares outstanding at August 13, 2026, plus 2.0M pre-funded warrants; Renesas holds a warrant for 4,943,555 shares at $23.95.
The three convertible notes turn into about 51.8M shares and the Renesas warrant into 4.9M more: 56.7M new shares against 55.0M today, so today's hol…
Much of that short position is likely hedging by convertible-note holders rather than outright bets: the notes convert into 51.8M shares, and five of…
At the $22.79 close of 2026-11-04, counting the notes and warrant as shares, the company is worth about $2.36B: 3.8 times trailing sales of $623.3M.…
At STMicroelectronics' 3.8 times, today's company value needs about $844M of yearly sales, 27% more than fiscal 2026 and above the $800M gross breake…
Cash above the $350M floor is $645.1M. At Q1 fiscal 2027's operating outflow of $84M a quarter, before capital spending, that is about seven to eight…
The 2026 annual meeting is on October 27, 2026: seven directors, a 2026 employee stock purchase plan of up to 1,700,000 shares at a 15% discount, an…
TSMC's board approved buying up to $500 million of Anthropic shares when Anthropic lists, and up to $500 million of OpenAI preferred shares. It also set aside up to $500 million for a new fund for chip-industry stakes, raised its quarterly dividend to NT$9.0 a share from NT$7.00, and approved about $40.9 billion of new factory spending.
What it did to the thesisNothing moved. The stakes come to less than 1% of TSMC's cash, too small to change its finances, and the dividend and factory spending fit what our case already assumed. The view stays Attractive.
Talen agreed to sell 750 MW of capacity, a promise to have power ready when the grid needs it, from its Guernsey gas plant for seven years from 2029, for about $100M a year. The buyer is unnamed but creditworthy. Shorter deals cover another 1.3 GW. Talen says 40% of its gross profit is now locked in through 2036.
What it did to the thesisOur view stays Neutral. Locked-in revenue lowers the risk from swinging power prices, but it is not the data-centre contract our case is waiting for. We would move to Attractive on a signed data-centre deal and debt falling toward the company's target.
Management describes a development pipeline of approximately 4 GW of land development and data-center contracting options, plus over 2 GW of gas and…
After the market closed, The New York Times reported that chief executive Jensen Huang had a relationship with an Nvidia executive who reports to him. This comes on top of the affair the board has been investigating since Sunday. Only the headline and a one-line summary could be read. Nvidia has not commented and filed nothing. The executive is not named in what we could read.
What it did to the thesisNothing in the business moved. A relationship with someone he manages makes it more likely the board's investigation ends with a change in who runs Nvidia. We keep Attractive and Medium confidence until its findings, or Huang's role, change, and test the business on 17 November.
Insight shares closed at $168.75 on 10 November, up from $158.25 on 6 November, with no news from the company. We think the business is worth about $140 a share, so the price is now about 121% of that value, just past the line where we call it too dear.
What it did to the thesisWe now rate Insight Unattractive, with medium conviction. Its business is middling and its vendors set its fees, so nothing earns paying a fifth above its value. A fall back below about $168 would bring it back to Neutral; the next test is the February report.
On a three-stage fair value at an 8% required return Insight is worth about $140 a share against $158 at the 6 November close. Base case: trailing sa…
Helios's shares fell 3% to $48.00 with no news from the company. That puts them at about 78% of the roughly $61.80 we think the business is worth, a little past the line where our 20% cushion begins.
What it did to the thesisNothing about the business changed. Its sales rise and fall with the economy and its first data-centre order still has no size, so a cushion this thin is not enough: Helios stays Neutral with medium conviction, and turns Attractive near $46.35.
On a three-stage fair value at an 8% required return Helios is worth about $61.80 a share against $49.48 at the 9 November close, about 80% of it. Ba…
GEO's shares rose 16% since 4 November, to $31.94. Its quarterly filing, out on 6 November, says four more centres it owns, 5,919 beds, were readied for sale in October, a step companies take when they expect a sale within a year. It still says no deal, price or date is agreed. Analysts also raised their forecasts after the results.
What it did to the thesisOur estimate of what GEO is worth rose to about $35.62 a share, so the price is about 90% of it: still Neutral. We would turn more positive if a second sale is signed near $300,000 a bed with GEO still running the centre, or the price falls near $28.50.
Management says GEO owns about 50,000 beds at 70 facilities, holds about 24,000 ICE detainees of a national 68,000, and will have about 29,500 ICE be…
GEO says it remains in an active process to sell several more company-owned facilities to ICE and keep operating them, subject to agreement on price;…
The shares closed at $13.26 on 2026-02-20, $32.34 on 2026-10-05 and $27.53 on 2026-11-04, down 14.9% since the Adelanto news; the 52-week range at 20…
At $27.53 enterprise value is about $4.95B on the 30 September balance sheet (about 132M shares, $1.53B of debt, $216.0M of cash); that is 9.1 times…
At the old 7 times, $570.5M supports about $4.0B of enterprise value, about $20 a share on the 30 September balance sheet; the $0.95B gap to the pric…
Management counts about 184,000 on ISAP, 54,000 of them on ankle monitors against 17,000 in early 2025, and says the pricier devices offset flat coun…
GEO reported its third-quarter 2026 results on 5 November 2026, the date the vendor calendar of 4 October gave; the 10-Q and the earnings call transc…
Pro forma for Adelanto's about $705M of net proceeds, enterprise value is about $4.24B at $27.53, 7.4 times the $570.5M 2026 guidance midpoint agains…
Analysts expect revenue of $2.99B in fiscal 2026, $3.27B in fiscal 2027, $3.47B in fiscal 2028, with operating profit of $603M in the last of those y…
On a three-stage fair value at an 8% required return GEO is worth about $29.65 a share against $27.80 at the 6 November close. Base case: trailing sa…
GoDaddy's shares rose about 1% to $113.13 with no news from the company. That puts them at about 80% of the roughly $141 we think the business is worth, just over the line where our 20% cushion runs out.
What it did to the thesisNothing about the business changed, and a fraction of a point is less than our estimate of value can tell apart, so GoDaddy stays Attractive with medium conviction. It moves to Neutral if the shares reach about $117.
On a three-stage fair value at an 8% required return GoDaddy is worth about $141 a share against $111.71 at the 9 November close, about 79% of it. Ba…
Forgent's shares closed at $21.48 on 10 November, down from $22.60. That is about 79% of the roughly $27.21 a share we think the business is worth, just past the 20% discount we usually ask for. Nothing new was filed or announced. Results are due on 12 November.
What it did to the thesisNothing moved. The price is only just past our line, and our estimate is very uncertain: the low case is near $7 and most of the value comes from years far ahead. We would call it Attractive below about $20.41, or if the results support next year's plan.
At $22.60 the company value is about $7.38B, about 12.3 times the $600M midpoint of FY27 adjusted EBITDA guidance and the shares about 17.0 times the…
On a three-stage fair value at an 8% required return Forgent is worth about $27.21 a share against $22.60 at the 9 November close. Base case: FY26 sa…
Flowco's shares closed at $20.67 on 10 November, down from $20.85 the day before. Our alarm for a cheap price went off, but only because it rounded the numbers: worked out exactly, the price is about 80.4% of the roughly $25.72 a share we think the business is worth. Nothing new was filed or announced.
What it did to the thesisNothing moved. We ask for a 20% discount before calling Flowco attractive, and with falling margins, growth mostly bought and financial controls that do not yet work, we want the full discount. We will move to Attractive if the price falls below about $20.58.
On a three-stage fair value at an 8% required return Flowco is worth about $25.72 a share against $20.85 at the 9 November close. Base case: trailing…
Figure Technology closed at $23.34 on 10 November, down from $24.52 the day before, with no news about the business. That is about 117% of the $19.96 a share we think the company is worth, just under the 120% mark we use as a guide. Its September-quarter results are due 12 November.
What it did to the thesisOur view stays Unattractive. One quiet day's dip does not change why the price looks dear: Figure keeps less of each loan and cash ran negative. We would move to Neutral if the price fell to about $21.96, or if the results show the slice it keeps holding.
On an excess-return value at an 8% required return Figure Technology Solutions is worth about $19.96 a share against $24.52 at the 9 November close.…
FICO shares closed at $730.66 on 10 November, up from $704.55 on 6 November, with no company news. We think the business is worth about $610 a share, so the price is about 120% of that. Its annual report, filed on 6 November, does not say how much revenue mortgage scores brought in.
What it did to the thesisWe now rate FICO Unattractive, with low conviction. Nothing earns a price a fifth above its value while FICO hides its mortgage prices and a cheap rival is allowed. A fall to about $702 would bring it back to Neutral; the next test is the February report.
Revenue from agreements with Experian, TransUnion and Equifax was 63% of FICO's Q3 FY2026 revenue against 54% a year earlier, and 51% of fiscal 2025;…
On a three-stage fair value at an 8% required return FICO is worth about $610 a share against $705 at the 6 November close. Base case: trailing sales…
AeroVironment said a customer in the Middle East ordered $405 million of its LOCUST X3 lasers, which shoot down small drones far more cheaply than missiles do. It also plans a local repair base there. The company did not name the buyer, say how many lasers, or say when they will be delivered.
What it did to the thesisThis is the biggest sign yet that the laser can become a large business, which helps the bullish side of our case. But the shares already cost about twice what we think the whole company is worth, so one order does not change our Unattractive view.
Waystar shares closed at $29.18 on 9 November, up from $28.35 on 6 November, with no company news. We now value the business at about $36 a share, a little lower than last week after we tightened our valuation rules, so the price is about 81% of our value.
What it did to the thesisThat is just short of the 20% cushion we ask for, and debt, a possible sale and Epic's own billing tools are the risks the cushion is for. We moved Waystar from Attractive to Neutral. Conviction stays Medium.
On a three-stage fair value at an 8% required return Waystar is worth about $37.80 a share against $28.35 at the 6 November close. Base case: trailin…
On a three-stage fair value at an 8% required return Waystar is worth about $35.98 a share against $28.35 at the 6 November close. Base case: trailin…
Vertiv closed at $200.47 on 9 November, up from $182.86 on 6 November, with no new results or filings. That is 29.6 times its last year of operating profit, above the 28.0 times we had marked as the cheap-enough line.
What it did to the thesisOur view moves from Attractive to Neutral. We value the shares at about $237 and ask for a 20% cushion; at $200.47 the cushion is about 15%. The business case and the fourth-quarter test are unchanged.
On a three-stage fair value at an 8% required return Vertiv is worth about $279 a share against $183 at the 6 November close. Base case: trailing sal…
On a three-stage fair value at an 8% required return Vertiv is worth about $237 a share against $183 at the 6 November close. Base case: trailing sal…
On a three-stage fair value at an 8% required return Vertiv is worth about $237 a share against $200 at the 9 November close. Base case: trailing sal…
Vale sells at a commodity price it does not set. We now value it on a normal year's margin, not the analysts' margin at today's price, and count the capital its own filings show it needs. On that basis the shares are worth about $21.99, down from $27.10.
What it did to the thesisThe price is about 53% of that value, so the view stays Attractive. Conviction stays Medium.
On a three-stage fair value at an 8% required return Vale is worth about $27.10 a share against $11.59 at the 6 November close. Base case: trailing s…
On a three-stage fair value at an 8% required return Vale is worth about $21.99 a share against $11.59 at the 6 November close. Base case: trailing s…
TTM Technologies's business goes through cycles, so we no longer assume a margin higher than it has already earned. On that basis the shares are worth about $146, down from $163.
What it did to the thesisThe price is about 46% of that value, so the view stays Attractive. Conviction stays Medium.
On a three-stage fair value at an 8% required return TTM Technologies is worth about $163 a share against $66.51 at the 6 November close. Base case:…
On a three-stage fair value at an 8% required return TTM Technologies is worth about $146 a share against $66.51 at the 6 November close. Base case:…
TSMC reported sales of NT$586.89 billion for October, 14.7% more than September and 59.7% more than October last year. For the first ten months of 2026 sales are NT$4,485.62 billion, up 43.3%. At recent exchange rates October is roughly $17.9 billion, a pace in line with the company's own guide for the quarter.
What it did to the thesisNothing moved. One month at that pace fits the guide of $52.3 to $54.3 billion for the quarter and the growth our case needs, but the quarter's results in January are the real test. The view stays Attractive.
On a three-stage fair value at an 8% required return TSMC is worth about $757 a share against $375 at the 6 November close. Base case: trailing sales…
Toast pays little tax today only because of past losses, so we now assume the full rate once they are used up. On that basis the shares are worth about $26.84, down from $28.90.
What it did to the thesisThe price is about 129% of that value, so we moved Toast from Neutral to Unattractive. Conviction stays Medium.
On a three-stage fair value at an 8% required return Toast is worth about $28.90 a share against $34.67 at the 6 November close. Base case: trailing…
On a three-stage fair value at an 8% required return Toast is worth about $26.84 a share against $34.67 at the 6 November close. Base case: trailing…
Turtle Beach shares closed at $17.04 on 9 November, up from $15.19 on 6 November. Nothing new was filed or reported in between. We value the business at about $13.61 a share on the cash it should produce.
What it did to the thesisThe price is now about a quarter above that value and already pays for a strong holiday that has not happened yet. We moved Turtle Beach from Neutral to Unattractive; conviction stays Medium.
On a three-stage fair value at an 8% required return Turtle Beach is worth about $14.45 a share against $15.19 at the 6 November close. Base case: tr…
On a three-stage fair value at an 8% required return Turtle Beach is worth about $13.61 a share against $15.19 at the 6 November close. Base case: tr…
Sterling Infrastructure shares closed at $290.67 on 9 November, up from $252.82 on 6 November. We found no company news in that window. We value the business at about $354 a share on its own future cash.
What it did to the thesisThe price is now 82% of that value, no longer far enough below it for us to call it cheap. We moved Sterling from Attractive to Neutral. Conviction stays Medium.
On a three-stage fair value at an 8% required return Sterling is worth about $354 a share against $252.82 at the 6 November close. Base case: trailin…
On a three-stage fair value at an 8% required return Sterling is worth about $354 a share against $290.67 at the 9 November close. Base case: trailin…
SoFi closed at $16.75 on 9 November, up from $16.21 on 6 November, with no new results or filings. That is 2.35 times what the bank owns after goodwill, above the 2.29 times we had marked as the cheap-enough line.
What it did to the thesisOur view moves from Attractive to Neutral. We value the shares at about $20.36 and ask for a 20% cushion; at $16.75 the cushion is about 18%. The business case itself is unchanged.
On an excess-return value at an 8% required return SoFi is worth about $20.36 a share against $16.21 at the 6 November close. Base case: shareholders…
Our value had left out the $8.65B of bank debt and convertible notes and $4.23B of preferred stock Supermicro owes. Counting them, the shares are worth about $50.83, down from $68.01, and we now hold a business we score Weak at Neutral however cheap it is.
What it did to the thesisThe price is about 57% of that value, cheap, but the business is weak, so we moved Supermicro from Attractive to Neutral. Conviction stays Medium.
On a three-stage fair value at an 8% required return Supermicro is worth about $70.27 a share against $28.76 at the 6 November close. Base case: trai…
On a three-stage fair value at an 8% required return Supermicro is worth about $68.01 a share against $28.76 at the 6 November close. Base case: trai…
Memory chips sell at a market price, and today's shortage prices sit inside the analysts' sales forecasts. We now assume half of SK hynix's fall to a normal margin comes from lower prices, which cuts its future sales. On that basis the shares are worth about $127, down from $314.
What it did to the thesisThe price is about 100% of that value, so we moved SK hynix from Attractive to Neutral. Conviction stays Medium.
On a three-stage fair value at an 8% required return SK hynix is worth about $314 a share against $127 at the 6 November close. Base case: trailing s…
On a three-stage fair value at an 8% required return SK hynix is worth about $127 a share against $127 at the 6 November close. Base case: trailing s…
Range Resources sells at a commodity price it does not set. We now value it on a normal year's margin, not the analysts' margin at today's price, and count the capital its own filings show it needs. On that basis the shares are worth about $55.54, down from $73.25.
What it did to the thesisThe price is about 88% of that value, so we moved Range Resources from Attractive to Neutral. Conviction stays Medium.
On a three-stage fair value at an 8% required return Range Resources is worth about $73.25 a share against $48.72 at the 6 November close. Base case:…
On a three-stage fair value at an 8% required return Range Resources is worth about $55.54 a share against $48.72 at the 6 November close. Base case:…
We re-valued PayPal with a fuller tax rate, which put the shares at about $73.79 and the price at about 80% of it, right on our cushion's line. We then weighed the whole thesis: the price assumes profits shrink a little, and even our gloomy case is only a little lower.
What it did to the thesisA cushion that close, with the downside already visible, is enough, so PayPal ends the day Attractive. Conviction stays Medium. It goes back to Neutral if the price reaches our value or margin dollars start to shrink.
On a three-stage fair value at an 8% required return PayPal is worth about $82.92 a share against $59.24 at the 6 November close. Base case: trailing…
Pattern closed at $19.43 on 9 November, up from $18.27 on 6 November, with no news about the business. Against the $23.07 a share we think the company is worth, the price is now about 84%, no longer far enough below it to call cheap.
What it did to the thesisOur view moves from Attractive to Neutral because the price no longer clears the margin we require. The business case and the open question, whether Thorne stays under P&G, did not change. Conviction stays Medium.
On a three-stage fair value at an 8% required return Pattern is worth about $23.07 a share against $18.27 at the 6 November close. Base case: trailin…
On a three-stage fair value at an 8% required return Pattern is worth about $23.07 a share against $19.43 at the 9 November close. Base case: trailin…
Palantir pays little tax today only because of past losses, so we now assume the full rate once they are used up. On that basis the shares are worth about $127, down from $137.
What it did to the thesisThe price is about 126% of that value, so we moved Palantir from Neutral to Unattractive. Conviction stays Medium.
On a three-stage fair value at an 8% required return Palantir is worth about $137 a share against $160 at the 6 November close. Base case: trailing s…
On a three-stage fair value at an 8% required return Palantir is worth about $127 a share against $160 at the 6 November close. Base case: trailing s…
We now decide each view by weighing the whole thesis, not only the price against our value. Penguin's price is about 62% of our value of about $67.91 a share, but most of the profit behind that value is memory sold at shortage prices, treated as the normal year.
What it did to the thesisOn a normal memory price the value falls toward the price, so we moved Penguin from Attractive to Neutral. Conviction stays Medium. The cluster business earning on its new buyers would move it back.
On a three-stage fair value at an 8% required return Penguin Solutions is worth about $80.27 a share against $41.83 at the 6 November close. Base cas…
Oscar Health pays little tax today only because of past losses, so we now assume the full rate. On that basis the shares are worth about $39.40, down from $44.85. They closed at $32.14 on 9 November, up from $30.65 on 6 November.
What it did to the thesisThe price is now about 82% of that value, no longer cheap enough, so our view moves from Attractive to Neutral. The business case did not change. Conviction stays Medium.
On a three-stage fair value at an 8% required return Oscar Health is worth about $44.85 a share against $30.65 at the 6 November close. Base case: tr…
On a three-stage fair value at an 8% required return Oscar Health is worth about $39.40 a share against $30.65 at the 6 November close. Base case: tr…
On a three-stage fair value at an 8% required return Oscar Health is worth about $39.40 a share against $32.14 at the 9 November close. Base case: tr…
We now decide each view by weighing the whole thesis, not only the price against our value. Oracle's price is about 66% of our value of about $177 a share, but that value arrives only if OpenAI pays for what it signed, while Oracle borrows and issues shares to build for it.
What it did to the thesisA discount is owed for a risk that large and that hard to see, so we moved Oracle from Attractive to Neutral. Conviction stays Low. Cash turning positive, or OpenAI showing its funding, would move it back.
On a three-stage fair value at an 8% required return Oracle is worth about $243 a share against $116 at the 6 November close. Base case: trailing sal…
On a three-stage fair value at an 8% required return Oracle is worth about $220 a share against $116 at the 6 November close. Base case: trailing sal…
The US drug regulator ordered every medicine of the GLP-1 type, including Novo's Ozempic and Wegovy and Lilly's Zepbound, to add a warning about NAION, a rare condition that damages the optic nerve and can cause sudden vision loss. Across 126 trials it found 6.4 cases per 100,000 patient-years on these drugs against 3.8 otherwise.
What it did to the thesisNothing moved. The warning covers the whole class and the risk is rare, so it hits Novo and Lilly alike and no prescribing limit was set. Our case rests on US volume offsetting price cuts and on the CagriSema decision; neither changed. The view stays Attractive.
On a three-stage fair value at an 8% required return Novo Nordisk is worth about $63.81 a share against $40.31 at the 6 November close. Base case: tr…
Nvidia's independent directors hired former federal prosecutor Joon Kim and his firm Wachtell Lipton to run the investigation they announced on Sunday. Earlier, President Trump said the FBI is looking into the matter, and House committee chairs asked the CEO for a briefing. A news report, not confirmed, says the woman's companies moved at least $7.5B of Nvidia chips into China.
What it did to the thesisNothing in the numbers moved. An outside investigation is the right step and its findings are what could change our view of who runs the company. No finding, charge or business figure has changed, so we keep Attractive and Medium confidence and test the business on 17 November.
On a three-stage fair value at an 8% required return NVIDIA is worth about $310 a share against $186.64 at the 6 November close. Base case: FY2026 sa…
We now assume that money reinvested late in the ten years earns what the business can earn for ever, not more. On that basis the shares are worth about $78.06, down from $81.42.
What it did to the thesisThe price is about 81% of that value, so we moved Netflix from Attractive to Neutral. Conviction stays Medium.
On a three-stage fair value at an 8% required return Netflix is worth about $81.42 a share against $63.41 at the 6 November close. Base case: trailin…
Marvell Technology's business goes through cycles, so we no longer assume a margin higher than it has already earned. On that basis the shares are worth about $325, down from $401.
What it did to the thesisThe price is about 43% of that value, so the view stays Attractive. Conviction stays Medium.
On a three-stage fair value at an 8% required return Marvell Technology is worth about $401 a share against $141 at the 6 November close. Base case:…
On a three-stage fair value at an 8% required return Marvell Technology is worth about $325 a share against $141 at the 6 November close. Base case:…
Checking our value against Mitek's filings, we found one cost line excused twice, which lifted the margin we assumed. On the margin it earns today, the shares are worth about $18.05, down from $21.86.
What it did to the thesisThe price is about 96% of that value, so we moved Mitek from Attractive to Neutral. Conviction stays Medium.
On a three-stage fair value at an 8% required return Mitek is worth about $21.86 a share against $17.24 at the 6 November close. Base case: trailing…
On a three-stage fair value at an 8% required return Mitek is worth about $18.05 a share against $17.24 at the 6 November close. Base case: trailing…
We now decide each view by weighing the whole thesis, not only the price against our value. MercadoLibre's price is about 77% of our value of about $1,966 a share, but that value assumes the profit margin recovers, and the last two reports showed it falling while lending grows fast.
What it did to the thesisA thin discount to a value that depends on an unproven recovery is not enough, so we moved MercadoLibre from Attractive to Neutral. Conviction stays Medium. A margin that turns up with credit steady would move it back.
On a three-stage fair value at an 8% required return MercadoLibre is worth about $2,075 a share against $1,510 at the 6 November close. Base case: tr…
Microchip's shares closed at $61.50 on 9 November, up from $58.35 three days earlier. No new results or filings came out. We kept our estimate of what the business is worth, about $49 a share, and checked the debt claim that had expired: on the 5 November call the company put its debt at 2.36 times yearly cash profit.
What it did to the thesisThe price is now about 126% of what we think the business is worth, which is more than 20% above it, so we moved Microchip from Neutral to Unattractive. The debt is falling as management promised. Conviction stays Medium.
Management put net debt at about $5.2B and net debt to adjusted EBITDA at 2.85 in June and expected it below 2.5 in September; net debt at September…
At $64.85 on November 5, 2026 company value was about $40.3B (543M shares and $5.09B of net debt), 7.2 times trailing sales of $5.60B against a six-y…
On a three-stage fair value at an 8% required return Microchip is worth about $51 a share against $58.35 at the 6 November close, where company value…
On a three-stage fair value at an 8% required return Microchip is worth about $49 a share against $61.50 at the 9 November close, where company value…
Lilly said its weight-loss pill Foundayo met the main goal of a 52-week trial in adults with obesity and moderate-to-severe sleep apnea. Breathing interruptions fell by up to an average of 44%, and up to 32% of people reached remission or mild disease. Lilly plans to ask the FDA to approve it for sleep apnea by the end of 2026.
What it did to the thesisNothing moved. It widens what the pill could be used for, but our view rests on the share price against a value near $983 and on volume beating price cuts, and a filing not yet made changes neither. The view stays Unattractive.
On a three-stage fair value at an 8% required return Eli Lilly is worth about $983 a share against $1,354 at the 6 November close. Base case: trailin…
Lumentum's shares closed at $596 on 9 November, up from $539 on 6 November. Our estimate of what the business is worth, about $710 a share, did not change, and no new report came with the move.
What it did to the thesisAt $596 the price is about 84% of that value, no longer clearly cheap, so our view moves from Attractive to Neutral. Nothing about the business changed. Conviction stays Medium.
On a three-stage fair value at an 8% required return Lumentum is worth about $710 a share against $539 at the 6 November close. Base case: trailing s…
On a three-stage fair value at an 8% required return Lumentum is worth about $710 a share against $596 at the 9 November close ($539 on 6 November).…
KLA's shares closed at $151.38 on 9 November, up from $138.49 three days earlier. Nothing new was filed and no results came out. We kept our estimate of what the business is worth, about $126 a share, and compared the new price with it.
What it did to the thesisThe price is now about 121% of what we think the business is worth, which is more than 20% above it, so we moved KLA from Neutral to Unattractive. The business is as strong as before; only the price moved. Conviction stays Medium.
On a three-stage fair value at an 8% required return KLA is worth about $126 a share against $138 at the 6 November close. Base case: trailing sales…
On a three-stage fair value at an 8% required return KLA is worth about $126 a share against $151 at the 9 November close. Base case: trailing sales…
Helios shares closed at $49.48 on 9 November, up from $47.44 on 6 November. Nothing new was filed or reported in between. We value the business at about $61.80 a share on the cash it should produce.
What it did to the thesisThe price is now about 80% of that value, no longer far enough below it for a cyclical business whose first data-centre order has no size. We moved Helios from Attractive to Neutral; conviction stays Medium.
On a three-stage fair value at an 8% required return Helios is worth about $63.46 a share against $47.44 at the 6 November close. Base case: trailing…
On a three-stage fair value at an 8% required return Helios is worth about $61.80 a share against $47.44 at the 6 November close. Base case: trailing…
We now assume that money reinvested late in the ten years earns what the business can earn for ever, not more, and that it pays the 25% tax a US company pays once state tax is counted. On that basis the shares are worth about $93.53, down from $104.
What it did to the thesisThe price is about 127% of that value, so we moved Hasbro from Neutral to Unattractive. Conviction stays Medium.
On a three-stage fair value at an 8% required return Hasbro is worth about $104 a share against $119 at the 6 November close. Base case: trailing sal…
We now assume money reinvested late in the ten years earns what the business can earn for ever, which puts the shares at about $141, down from $146. At $114 that read as only fair. The shares then closed at $111.71, about 79% of that value.
What it did to the thesisThe price now clears the 20% cushion we ask for, and nothing about the business got worse, so GoDaddy is back to Attractive with medium conviction. It returns to Neutral near $113.
On a three-stage fair value at an 8% required return GoDaddy is worth about $146 a share against $114.38 at the 6 November close. Base case: 2025 sal…
On a three-stage fair value at an 8% required return GoDaddy is worth about $141 a share against $114.38 at the 6 November close. Base case: 2025 sal…
Forgent Power Solutions shares closed at $22.60 on 9 November, up from $19.48 on 6 November. We found no company news in that window. We value the business at about $28.58 a share on its own future cash.
What it did to the thesisThe price is 79% of that value, still just under our 80% line at $22.86, so the view stays Attractive and conviction stays Medium. A close above $22.86 would move it to Neutral.
At $19.48 the company value is about $6.43B, about 10.7 times the $600M midpoint of FY27 adjusted EBITDA guidance and the shares about 14.6 times the…
On a three-stage fair value at an 8% required return Forgent is worth about $28.58 a share against $19.48 at the 6 November close. Base case: FY26 sa…
On a three-stage fair value at an 8% required return Forgent is worth about $28.58 a share against $22.60 at the 9 November close. Base case: FY26 sa…
Fabrinet shares closed at $365.94 on 9 November, up 12% in a day as optical stocks rose together, with no company news. That was about 81% of the $454 a share we think it is worth. On 10 November they fell back to $348.52, about 77%.
What it did to the thesisThe price briefly lost a sliver of our usual safety cushion. The business is strong, with sticky customers, fast growth and no net debt, so we keep it Attractive and will move it to Neutral near $386. Conviction stays Medium.
On a three-stage fair value at an 8% required return Fabrinet is worth about $471 a share against $327 at the 6 November close. Base case: trailing s…
On a three-stage fair value at an 8% required return Fabrinet is worth about $454 a share against $327 at the 6 November close. Base case: trailing s…
Flowco's shares closed at $20.85 on 9 November, up from $20.06 three days earlier. Nothing new was filed and no results came out. We left our estimate of what the business is worth, about $25.82 a share, unchanged and re-read the new price against it.
What it did to the thesisThe price is now about 81% of what we think the business is worth, just short of the 20% margin of safety we ask for, so we moved Flowco from Attractive to Neutral. The business case did not move. Conviction stays Medium.
On a three-stage fair value at an 8% required return Flowco is worth about $25.82 a share against $20.06 at the 6 November close. Base case: trailing…
On a three-stage fair value at an 8% required return Flowco is worth about $25.82 a share against $20.85 at the 9 November close. Base case: trailing…
Five9 pays little tax today only because of past losses, so we now assume the full rate once they are used up. We also found our value had left out the $738 million of convertible bonds it owes. Counting both, the shares are worth about $22.22, down from $35.92.
What it did to the thesisThe price is about 127% of that value, so we moved Five9 from Attractive to Unattractive over the day. Conviction stays Medium.
On a three-stage fair value at an 8% required return Five9 is worth about $35.92 a share against $28.12 at the 6 November close. Base case: trailing…
On a three-stage fair value at an 8% required return Five9 is worth about $33.89 a share against $28.12 at the 6 November close. Base case: trailing…
On a three-stage fair value at an 8% required return Five9 is worth about $31.77 a share against $28.12 at the 6 November close. Base case: trailing…
Figure Technology closed at $24.52 on 9 November, up from $22.73 on 6 November, with no news about the business. Against the $19.96 a share we think the company is worth, the price is now about 123%, more than 20% above it. Its results are due 12 November.
What it did to the thesisOur view moves from Neutral to Unattractive because the price now runs more than 20% above our value. The business case did not change, and the September results will test it. Conviction stays Medium.
On an excess-return value at an 8% required return Figure Technology Solutions is worth about $19.96 a share against $22.73 at the 6 November close.…
Expand Energy sells at a commodity price it does not set. We now value it on a normal year's margin, not the analysts' margin at today's price, and count the capital its own filings show it needs. On that basis the shares are worth about $103, down from $129.
What it did to the thesisThe price is about 82% of that value, so we moved Expand Energy from Attractive to Neutral. Conviction stays Medium.
On a three-stage fair value at an 8% required return Expand Energy is worth about $129 a share against $84.60 at the 6 November close. Base case: tra…
On a three-stage fair value at an 8% required return Expand Energy is worth about $103 a share against $84.60 at the 6 November close. Base case: tra…
Earlier today we re-valued EQT on a normal year for gas, which put the price about 20% above our value of about $41.01 a share, right on the line we called Unattractive. We now decide each view by weighing the whole thesis: EQT owns its pipelines, is cutting debt fast and keeps beating its guidance.
What it did to the thesisA well-run business a little above a cautious value is Neutral, not Unattractive, so EQT ends the day at Neutral. Conviction stays Medium.
On a three-stage fair value at an 8% required return EQT is worth about $138 a share against $49.40 at the 6 November close. Base case: trailing sale…
On a three-stage fair value at an 8% required return EQT is worth about $40.05 a share against $49.40 at the 6 November close. Base case: trailing sa…
On 9 November Entegris told investors it aims for about 15% yearly sales growth, a 35% adjusted operating margin and about 30% yearly profit-per-share growth, and authorised a $500 million share buyback. The shares closed at $140.06, up 9.4% in a day.
What it did to the thesisWe still think the business is worth about $109 a share, so the price is now 29% above that. We moved Entegris from Neutral to Unattractive. Conviction stays Medium.
Entegris will hold an investor day on 9 November 2026, at which management says it will update its target model.
Entegris will hold an investor day on 9 November 2026, at which management says it will update its target model.
On a three-stage fair value at an 8% required return Entegris is worth about $109 a share against $128 at the 6 November close. Base case: trailing s…
On a three-stage fair value at an 8% required return Entegris is worth about $109 a share against $140.06 at the 9 November close. Base case: trailin…
We now decide each view by weighing the whole thesis, not only the price against our value. EMCOR's price is about 82% of our value of about $739 a share, a little short of our usual 20% cushion. Behind it are a record backlog of signed work, no debt and cash matching profit.
What it did to the thesisThat is enough at a slightly thinner cushion, so we moved EMCOR from Neutral to Attractive. Conviction stays Medium. It goes back to Neutral if the price reaches our value or the backlog shrinks.
On a three-stage fair value at an 8% required return EMCOR is worth about $728 a share against $608.45 at the 6 November close. Base case: sales of $…
Everus closed at $84.43 on 9 November, up from $76.60 on 6 November, with no news about the business. The price line we set for a move to Neutral is $84.78, 80% of the $106 a share we think it is worth. The printed multiple had rounded that line down.
What it did to the thesisThe price is about 80% of our value, a hair under the line, so the view stays Attractive. We corrected the line to its exact figure. A move up of a few cents more would change the view. Conviction stays Medium.
On a three-stage fair value at an 8% required return Everus is worth about $106 a share against $76.60 at the 6 November close. Base case: trailing s…
We now decide each view by weighing the whole thesis, not only the price against our value. dLocal's price is about 69% of our value of about $20.34 a share, but that value assumes volume growth reaches profit, and the latest report showed the price per dollar still falling.
What it did to the thesisUntil that fall slows, the discount is fair rather than cheap, so we moved dLocal from Attractive to Neutral. Conviction stays Medium. The price per dollar holding while profit reaches the guide would move it back.
On a three-stage fair value at an 8% required return DLO is worth about $22.01 a share against $13.95 at the 6 November close. Base case: trailing sa…
Cisco shares closed at $98.65 on 9 November, up from $93.85 on 6 November. The only company news was a new set of AI security products, which does not change the business case. We value Cisco at about $79 a share, so the price is now about a quarter above that.
What it did to the thesisAt that price buyers are paying close to our best case, for growth that is partly a refresh cycle and price rises. We moved Cisco from Neutral to Unattractive. Conviction stays Medium. The 12 November results could lift our value.
On a three-stage fair value at an 8% required return Cisco is worth about $82.26 a share against $93.85 at the 6 November close. Base case: trailing…
On a three-stage fair value at an 8% required return Cisco is worth about $79.08 a share against $93.85 at the 6 November close. Base case: trailing…
CoreWeave said Wayve, which builds AI drivers for cars, will train its models on CoreWeave's cloud using NVIDIA's newest chips. The announcement gives no dollar value, length, or amount of computing power. Wayve was already a CoreWeave software customer.
What it did to the thesisNothing moved. A new named customer fits the case for a wider customer base, but without a value it adds nothing to the backlog we track. Our test is the earnings report due 10 November.
Management says more than $25B of net new commitments were signed early in Q3 2026, on top of a backlog of about $104B at Q2.
For Q3 2026 management guided revenue of $3.45B to $3.6B, adjusted operating income of $200M to $260M, interest expense of $860M to $940M and capex o…
Management raised 2026 guidance in August to revenue of $12.4B to $13.2B, adjusted operating income of $960M to $1.15B, capex of $35B to $39B and a y…
In the first half of 2026 operations brought in $3,663M of cash while capital spending took $14,117M; liquidity at June 30 was $15,553M, of which $10…
The shares closed at $61.39 on October 16, 2026, near the bottom of a $59.51 to $150.40 52-week range; over 126 sessions the price fell 47.5% while s…
Market value was about $33.9B and the vendor's company value about $79.1B, 10.4 times trailing sales of $7.59B.
Analysts' average forecasts put sales at $12.88B for 2026, $26.56B for 2027 and $42.65B for 2028; their profit per share turns positive in 2028 at $0…
At about $79.1B, company value is about 4.2 times the midpoint of the year-end 2026 run-rate guide and about 3.0 times analysts' 2027 revenue; the sh…
Interest guided at $860M to $940M for Q3 exceeds the $200M to $260M adjusted operating income guided, so the business keeps losing money after intere…
Management reported about 1.5 GW of active power and about 3.7 GW contracted at Q2, 4.2 GW contracted by the call, and targets more than 1.85 GW acti…
Counting the September convertible and the post-June draws, borrowings are about $41.7B of principal before leases, against $5.5B of cash at June 30.
Coherent's business goes through cycles, so we no longer assume a margin higher than it has already earned, and we assume the full tax rate once past losses are used up. On that basis the shares are worth about $281, down from $378. They then jumped 17% to $225 on 9 November.
What it did to the thesisAt $225 the price is about 80% of that value, no longer clearly cheap, so our view moves from Attractive to Neutral. Nothing about the business changed. Conviction stays Medium.
On a three-stage fair value at an 8% required return Coherent is worth about $378 a share against $193 at the 6 November close. Base case: trailing s…
On a three-stage fair value at an 8% required return Coherent is worth about $281 a share against $193 at the 6 November close. Base case: trailing s…
On a three-stage fair value at an 8% required return Coherent is worth about $281 a share against $225 at the 9 November close ($193 on 6 November).…
Ciena's business goes through cycles, so we no longer assume a margin higher than it has already earned. On that basis the shares are worth about $313, down from $432. The shares closed at $269.33 on 9 November, up from $243 on 6 November.
What it did to the thesisThe price is now about 86% of that value, no longer cheap enough, so our view moves from Attractive to Neutral. The business itself did not change. Conviction stays Medium.
On a three-stage fair value at an 8% required return Ciena is worth about $432 a share against $243 at the 6 November close. Base case: trailing sale…
On a three-stage fair value at an 8% required return Ciena is worth about $313 a share against $243 at the 6 November close. Base case: trailing sale…
On a three-stage fair value at an 8% required return Ciena is worth about $313 a share against $269.33 at the 9 November close. Base case: trailing s…
We now decide each view by weighing the whole thesis, not only the price against our value. Consensus's price is about 54% of our value of about $79.57 a share, but that value assumes growth returns, while corporate customers leave faster than ever.
What it did to the thesisValued with sales flat, the business is worth only a little more than the price, so we moved Consensus from Attractive to Neutral. Conviction stays Medium. Corporate customers staying and paying more would move it back.
On a three-stage fair value at an 8% required return Consensus is worth about $86.53 a share against $43.15 at the 6 November close. Base case: trail…
Cerebras said Bilt, a rewards app with more than 8 million members and 50,000 merchants, chose it to run Bilt's new AI assistant, which books tables, redeems rewards and plans trips. The announcement gave no price, size, length of contract or start date, and said more details will come as the work progresses.
What it did to the thesisNothing moved. It is a named new customer, which our case wants, but with no money attached it is far from the committed second buyer the thesis is waiting for. OpenAI remains nearly all of the contracted business, and the view stays Unattractive.
On a three-stage fair value at an 8% required return Cerebras is worth about $40.51 a share against $89.68 at the 6 November close. Base case: traili…
Bloom Energy's business goes through cycles, so we no longer assume a margin higher than it has already earned. Bloom Energy pays little tax today only because of past losses, so we now assume the full rate once they are used up. On that basis the shares are worth about $90.79, down from $148.
What it did to the thesisThe price is about 191% of that value, so we moved Bloom Energy from Neutral to Unattractive. Conviction stays Medium.
On a three-stage fair value at an 8% required return Bloom Energy is worth about $148 a share against $173 at the 6 November close. Base case: traili…
On a three-stage fair value at an 8% required return Bloom Energy is worth about $90.79 a share against $173 at the 6 November close. Base case: trai…
AppLovin's shares closed at $410.00 on 9 November, up from $391.22 three days earlier. No results or filings came out. Seven law-firm notices only repeated the 16 November deadline in a lawsuit we already track. We left our estimate of what the business is worth, about $508 a share, unchanged.
What it did to the thesisThe price is now about 81% of what we think the business is worth, just short of the 20% margin of safety we ask for, so we moved AppLovin from Attractive to Neutral. The business case did not move. Conviction stays Medium.
At the 2026-11-06 close of $391.22, 331M shares are worth about $129.5B, which is 26.5 times trailing free cash flow of about $4.88B (the $3.95B of 2…
On a three-stage fair value at an 8% required return AppLovin is worth about $508 a share against $391.22 at the 6 November close. Base case: 2025 sa…
On a three-stage fair value at an 8% required return AppLovin is worth about $508 a share against $410.00 at the 9 November close. Base case: 2025 sa…
At the 4 November annual meeting shareholders re-elected all six directors and approved executive pay in a non-binding vote, with about two votes in three in favour, up from barely half last year. The shares are about 14% lower than when we last checked the price.
What it did to the thesisNothing moved. A firmer pay vote eases one governance worry but says nothing about rent, funding or margins, which carry the case. The view stays Neutral, with medium confidence, until the January report shows whether rent is taking over from construction.
AMD's business goes through cycles, so we no longer assume a margin higher than it has already earned. On that basis the shares are worth about $494, down from $581.
What it did to the thesisThe price is about 91% of that value, so we moved AMD from Attractive to Neutral. Conviction stays Medium.
On a three-stage fair value at an 8% required return AMD is worth about $581 a share against $449 at the 6 November close. Base case: trailing sales…
On a three-stage fair value at an 8% required return AMD is worth about $494 a share against $449 at the 6 November close. Base case: trailing sales…
Applied Materials' shares closed at $370.55 on 9 November, up from $332.72 three days earlier, ahead of its 12 November results. We left our estimate of what the business is worth, about $423 a share, unchanged. We also refreshed four out-of-date facts, including Micron's new chip-factory spending estimate and the latest short-selling count.
What it did to the thesisThe price is now about 88% of what we think the business is worth, short of the 20% margin of safety we ask for, so we moved Applied from Attractive to Neutral. The business case did not move. Conviction stays Medium.
On a three-stage fair value at an 8% required return Applied Materials is worth about $451 a share against $333 at the 6 November close. Base case: t…
Micron Technology's own quarterly report estimates capital expenditure for property, plant and equipment, net of proceeds from government incentives,…
Short interest fell 9.7% to 14,108,387 shares at the 15 September 2026 settlement, 1.78% of the float, after rising 31.5% to 15,615,253 at the 31 Aug…
On a three-stage fair value at an 8% required return Applied Materials is worth about $423 a share against $333 at the 6 November close. Base case: t…
On a three-stage fair value at an 8% required return Applied Materials is worth about $423 a share against $371 at the 9 November close. Base case: t…
Akamai sold $2.2 billion of bonds that can turn into shares, to repay older bonds and build cloud capacity. Checking its value, we found it had left out the $7.6 billion of such bonds Akamai already owed in September. Counting them, the shares are worth about $54.15, not $104.
What it did to the thesisThe bonds confirm the build-out is paid for with debt, not new shares. With that debt counted, the price is about 153% of our value, so we moved Akamai from Attractive to Unattractive. Conviction stays Medium.
On the company's own figures cash and securities were $4.2B at September 2026 and fall toward $2.4B by December on about $1.7B of Q4 capital spending…
On a three-stage fair value at an 8% required return Akamai is worth about $112 a share against $83.09 at the 6 November close. Base case: trailing s…
On a three-stage fair value at an 8% required return Akamai is worth about $104 a share against $83.09 at the 6 November close. Base case: trailing s…
ACM Research shares rose 11.5% to $49.75 on 9 November, about 86% of the $57.65 a share we think the business is worth. Its full quarterly filing then showed operations used $70.4 million of cash in the September quarter, and named no order yet for its two newer tool lines.
What it did to the thesisThe price is no longer far enough below our value to call it cheap, so we moved it from Attractive to Neutral. The filing gives no reason to move back: cash and a new-tool order were what the case was waiting for. Conviction stays Medium.
On a three-stage fair value at an 8% required return ACM Research is worth about $57.65 a share against $44.61 at the 6 November close. Base case: tr…
On a three-stage fair value at an 8% required return ACM Research is worth about $57.65 a share against $49.75 at the 9 November close. Base case: tr…
Operating cash flow was negative in five of the last six quarters (FY2025 -$10.3M; Q1 2026 -$29.5M; Q2 2026 -$6.4M), driven in FY2025 by a $108.2M in…
ACM Research holds a direct 74.6% ownership interest in ACM Shanghai, its principal operating subsidiary listed on Shanghai's STAR Market (688082), d…
Management estimates its addressable wafer-fab-equipment market at about $22 billion (raised $1 billion in Q2 2026) based on Frost & Sullivan data, a…
As of the Q3 2026 release on 5 November, ACM's PECVD and Track platforms are not reported as separate product lines and the release names no producti…
On May 29, 2026, ACM Shanghai's board approved a plan, subject to shareholder approval, to issue new H Shares and list on the Main Board of the Hong…
Zoom closed at $89.88 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $84.53.
What it did to the thesisThe price is about 106% of that value, so the view stays Neutral. Conviction stays Medium.
Xylem said it has completed its purchase of two pump makers, Cornell Pump and Roper Pump, announced in August for about $1.46 billion in cash. It closed inside the quarter Xylem had given. Only the first paragraph of its announcement could be read, and it gave no new numbers.
What it did to the thesisNothing moved. The closing was expected and was already paid for with notes sold in September. Our case turns on growth without acquisitions and margins, which this does not touch; the first test of how the pump makers perform is the fourth-quarter report. Neutral holds.
Xylem agreed on 11 August 2026 to buy the Cornell Pump and Roper Pump businesses from Indicor for about $1.46B in cash, closing in Q4 2026. They are…
Waystar closed at $28.35 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $37.80.
What it did to the thesisThe price is about 75% of that value, so we moved Waystar from Neutral to Attractive. Conviction stays Medium.
Vishay closed at $23.28 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $43.32.
What it did to the thesisThe price is about 54% of that value, so we moved Vishay from Neutral to Attractive. Conviction stays Medium.
Vertiv closed at $183 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $279.
What it did to the thesisThe price is about 65% of that value, so we moved Vertiv from Neutral to Attractive. Conviction stays Medium.
Vishay Precision's shares closed at $41.22 on 5 November, under the price line our route to a better view names, then rose 7.3% to $44.21. The same route needs the profit margin to reach 8% for two quarters; the latest is 4.9%. VPG gave no robot-sensor sales figure in its September-quarter results.
What it did to the thesisThe price half of the route was met but the margin half was not, and robot-sensor sales slipped to February. Valued in three stages the price is now under what the business is worth, so the view moves to Neutral.
Voyager said NASA picked it as one of the companies allowed to bid for future moon-delivery missions through 2036. The contract can reach $10 billion in total, shared by every company in the pool. The part of the announcement we could read names no mission and no money for Voyager.
What it did to the thesisNothing moved. It is a later route to moon revenue through the Astrobotic landers, not an order. The things our Unattractive view rests on, the thin profit margin, the Starlab funding and a price that needs about 25% growth a year for a decade, are untouched.
Valmont closed at $404 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $383.
What it did to the thesisThe price is about 105% of that value, so the view stays Neutral. Conviction stays Medium.
Viking closed at $87.48 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $107.
What it did to the thesisThe price is about 81% of that value, so the view stays Neutral. Conviction stays Medium.
Vale closed at $11.59 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $27.10.
What it did to the thesisThe price is about 43% of that value, so we moved Vale from Neutral to Attractive. Conviction stays Medium.
Universal Technical Institute closed at $19.93 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $16.05.
What it did to the thesisThe price is about 124% of that value, so we moved Universal Technical Institute from Neutral to Unattractive. Conviction stays Medium.
Ubiquiti closed at $593 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $390.
What it did to the thesisThe price is about 152% of that value, so we moved Ubiquiti from Neutral to Unattractive. Conviction stays Medium.
Uber announced with McDonald's a wider partnership covering delivery and customer loyalty in 14 markets. We could read only the headline: Uber's wire host and the other pages we tried would not open, so the terms, restaurant counts and any figures are unknown to us.
What it did to the thesisThe news moved nothing. Valued the same day on its own future cash at an 8% return, Uber is worth about $77 a share, so the price is fair, not cheap: the view moves from Attractive to Neutral, conviction unchanged.
At $66.60 Uber's enterprise value of about $145.5B is 17.6 times trailing Non-GAAP Operating Income and 14.0 times trailing free cash flow, a free ca…
Uber's chief executive said on the Q2 2026 call that autonomous vehicles are doing 'hundreds of thousands of trips per week' against Uber's roughly 3…
Uber's answer to the substitute is to become its distribution layer rather than build it: management said on the Q2 2026 call that Uber is live with…
Uber's chief financial officer said on the Q2 2026 call that of the roughly 500 basis point year-on-year fall in Mobility revenue margin, about 400 b…
Growth is broadening rather than narrowing, on management's own account: less than 10% of eligible consumers in US sparse markets used Uber in the pa…
Unity closed at $51.49 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $10.17.
What it did to the thesisThe price is about 506% of that value, so we moved Unity from Neutral to Unattractive. Conviction stays Medium.
Tyler Technologies closed at $421 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $276.
What it did to the thesisThe price is about 152% of that value, so we moved Tyler Technologies from Neutral to Unattractive. Conviction stays Medium.
TTM Technologies closed at $66.51 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $163.
What it did to the thesisThe price is about 41% of that value, so we moved TTM Technologies from Neutral to Attractive. Conviction stays Medium.
TSMC closed at $375 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $757.
What it did to the thesisThe price is about 50% of that value, so the view stays Attractive. Conviction stays Medium.
Elon Musk said on X that Tesla will end Cybertruck production in Texas in about eight months so the space can build more Cybercab robotaxis, and that many deposits will be returned. Tesla does not report Cybertruck sales; outside estimates put the total near 71,000, far below the 250,000 a year once predicted.
What it did to the thesisNothing moved. It shows Tesla putting factory space behind robotaxis, the part of the story we say is unproven, while a vehicle line fades. Our case waits on the margin and any robotaxi revenue figure at the next results.
It sells five consumer vehicles - Model 3, Model Y, Model S, Model X and Cybertruck - plus the Semi, and two energy products, Powerwall for homes and…
Management names the constraint on Robotaxi as reliability rather than demand or regulation: 'It is really about going through what we call the march…
Texas Pacific Land closed at $272 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $227.
What it did to the thesisThe price is about 120% of that value, so the view stays Unattractive. Conviction stays Medium.
Toast closed at $34.67 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $28.90.
What it did to the thesisThe price is just under 120% of that value, so the view stays Neutral. Conviction stays Medium.
Teradyne closed at $218 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $236.
What it did to the thesisThe price is about 92% of that value, so we moved Teradyne from Unattractive to Neutral. Conviction stays Medium.
Tenable closed at $42.13 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $17.36.
What it did to the thesisThe price is about 243% of that value, so we moved Tenable from Neutral to Unattractive. Conviction stays Medium.
Tempus closed at $76.05 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $3.45.
What it did to the thesisThe price is about 2204% of that value, so the view stays Unattractive. Conviction stays Medium.
TE Connectivity closed at $207 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $249.
What it did to the thesisThe price is about 83% of that value, so the view stays Neutral. Conviction stays Medium.
Turtle Beach closed at $15.19 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $14.45.
What it did to the thesisThe price is about 105% of that value, so the view stays Neutral. Conviction stays Medium.
TAT Technologies closed at $37.00 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $34.20.
What it did to the thesisThe price is about 108% of that value, so the view stays Neutral. Conviction stays Medium.
Skyworks closed at $82.19 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $41.04.
What it did to the thesisThe price is about 200% of that value, so we moved Skyworks from Neutral to Unattractive. Conviction stays Medium.
Seagate Technology closed at $461 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $455.
What it did to the thesisThe price is about 101% of that value, so the view stays Neutral. Conviction stays Medium.
Sterling earned about 18 cents of operating profit on each dollar of sales over the last year, more than twice the 7.6 cents of 2020 and 2021. The shares closed at $252.82 on 6 November.
What it did to the thesisThe view stays Attractive, with medium conviction. Even with its margin falling back and growth slowing over ten years, it is worth about $354 a share against $253. On its old average margin it would be worth about the price.
Sensata closed at $39.31 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $39.52.
What it did to the thesisThe price is about 99% of that value, so the view stays Neutral. Conviction stays Medium.
Spotify closed at $603 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $431.
What it did to the thesisThe price is about 140% of that value, so we moved Spotify from Neutral to Unattractive. Conviction stays Medium.
SpaceX closed at $134 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $37.54.
What it did to the thesisThe price is about 358% of that value, so the view stays Unattractive. Conviction stays Medium.
SoFi closed at $16.21 on 6 November. We valued it on its shareholders' equity plus the earnings it should make above an 8% yearly return on it, with the equity growing on the analysts' path and then slowing toward 4%. On that basis the shares are worth about $20.36.
What it did to the thesisThe price is about 80% of that value, so we moved SoFi from Neutral to Attractive. Conviction stays Medium.
TD SYNNEX closed at $219 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $431.
What it did to the thesisThe price is about 51% of that value, so we moved TD SYNNEX from Neutral to Attractive. Conviction stays Medium.
Synopsys closed at $450 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $254.
What it did to the thesisThe price is about 178% of that value, so we moved Synopsys from Neutral to Unattractive. Conviction stays Medium.
Sandisk closed at $835 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $676.
What it did to the thesisThe price is about 124% of that value, so we moved Sandisk from Attractive to Unattractive. Conviction stays Low.
Supermicro closed at $28.76 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $70.27.
What it did to the thesisThe price is about 41% of that value, so we moved Supermicro from Neutral to Attractive. Conviction stays Medium.
SK hynix closed at $127 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $314.
What it did to the thesisThe price is about 41% of that value, so the view stays Attractive. Conviction stays Medium.
SiTime closed at $417 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $242.
What it did to the thesisThe price is about 172% of that value, so we moved SiTime from Attractive to Unattractive. Conviction stays Medium.
Silicon Motion closed at $163 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $169.
What it did to the thesisThe price is about 97% of that value, so the view stays Neutral. Conviction stays Medium.
Sanmina closed at $135 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $196.
What it did to the thesisThe price is about 69% of that value, so the view stays Attractive. Conviction stays Medium.
Adjusted for that extra week, the Q4 FY2026 revenue guidance midpoint implies $246.4M a week against $266.5M in Q3 - a 7.5% decline. The ZT Systems h…
Reaching the $16B management states for fiscal 2027 requires weekly revenue to rise 24.9% from the Q4 FY2026 guidance midpoint, from $246.4M to $307.…
Management states fiscal 2027 revenue of '$16 billion-plus' and says it is more confident than ever of it, having brought that target forward from fi…
Total debt rose from $300.5M at 2025-09-27 to $2,172.3M at 2026-06-27 while cash rose to $1,844.9M, leaving net debt of $327.4M.
Fiscal 2025 free cash flow was $478M on revenue of $8.13B, so fiscal 2026 is on course to generate no more cash than fiscal 2025 on close to twice th…
Buyers now pay about $34.80 for each dollar of trailing yearly profit against a six-year median near $12.45, and about $16.80 for each dollar of year…
At $11.2B of enterprise value, paying 8 times operating profit - an ordinary price for contract manufacturing - needs $1.4B of operating profit, whic…
SailPoint closed at $19.21 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $7.96.
What it did to the thesisThe price is about 241% of that value, so we moved SailPoint from Neutral to Unattractive. Conviction stays Medium.
Range Resources closed at $48.72 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $73.25.
What it did to the thesisThe price is about 67% of that value, so we moved Range Resources from Neutral to Attractive. Conviction stays Medium.
Rockwell Automation closed at $376 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $272.
What it did to the thesisThe price is about 138% of that value, so we moved Rockwell Automation from Neutral to Unattractive. Conviction stays Medium.
RKT closed at $15.06 on 6 November. We valued it on its shareholders' equity plus the earnings it should make above an 8% yearly return on it, with the equity growing on the analysts' path and then slowing toward 4%. On that basis the shares are worth about $15.82.
What it did to the thesisThe price is about 95% of that value, so the view stays Neutral. Conviction stays Medium.
Radware closed at $29.84 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $7.87.
What it did to the thesisThe price is about 379% of that value, so we moved Radware from Neutral to Unattractive. Conviction stays Medium.
Qnity closed at $117 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $114.
What it did to the thesisThe price is about 103% of that value, so the view stays Neutral. Conviction stays Medium.
PayPal closed at $59.24 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $82.92.
What it did to the thesisThe price is about 71% of that value, so we moved PayPal from Neutral to Attractive. Conviction stays Medium.
Quanta closed at $541 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $447.
What it did to the thesisThe price is about 121% of that value, so the view stays Unattractive. Conviction stays Low.
Pattern closed at $18.27 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $23.07.
What it did to the thesisThe price is about 79% of that value, so we moved Pattern from Neutral to Attractive. Conviction stays Medium.
Powell closed at $133 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $97.37.
What it did to the thesisThe price is about 137% of that value, so we moved Powell from Neutral to Unattractive. Conviction stays Medium.
Palantir closed at $160 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $137.
What it did to the thesisThe price is about 117% of that value, so the view stays Neutral. Conviction stays Medium.
Palomar closed at $156 on 6 November. We valued it on its shareholders' equity plus the earnings it should make above an 8% yearly return on it, with the equity growing on the analysts' path and then slowing toward 4%. On that basis the shares are worth about $121.
What it did to the thesisThe price is about 128% of that value, so the view stays Unattractive. Conviction stays Medium.
Penguin Solutions closed at $41.83 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $80.27.
What it did to the thesisThe price is about 52% of that value, so we moved Penguin Solutions from Unattractive to Attractive. Conviction stays Medium.
Paycom closed at $237 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $346.
What it did to the thesisThe price is about 69% of that value, so we moved Paycom from Neutral to Attractive. Conviction stays Medium.
UiPath closed at $13.00 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $10.04.
What it did to the thesisThe price is about 129% of that value, so we moved UiPath from Neutral to Unattractive. Conviction stays Medium.
Palo Alto Networks closed at $314 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $45.22.
What it did to the thesisThe price is about 694% of that value, so the view stays Unattractive. Conviction stays Medium.
Oscar Health closed at $30.65 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $44.85.
What it did to the thesisThe price is about 68% of that value, so we moved Oscar Health from Neutral to Attractive. Conviction stays Medium.
Bloomberg reports Microsoft chose not to renew a deal, begun in 2023, to rent AI computing capacity from Oracle, and has been switching it off because the Nvidia chips were too old for it. The deal's size was never disclosed. Oracle says demand stays strong, including for older chips, which it re-rented at a 20% higher price in September. Oracle shares closed up 0.74%.
What it did to the thesisThe news moved nothing: the lapse of one old rental does not cancel the $664B of signed future revenue. Valued on its own future cash at an 8% return, the price is about half of what the business is worth, so we moved Oracle to Attractive at Low conviction.
Ooma closed at $18.00 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $12.41.
What it did to the thesisThe price is about 145% of that value, so we moved Ooma from Neutral to Unattractive. Conviction stays Medium.
Onto closed at $173 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $207.
What it did to the thesisThe price is about 84% of that value, so the view stays Neutral. Conviction stays Medium.
Restructuring charges were $10.6 million in FY2023, $23.1 million in FY2024, $63.4 million in FY2025 and $30.7 million in the first half of 2026.
Management guides third-quarter 2026 GAAP operating margin to 21.4%-22.4% and non-GAAP to 31.5%-32.5%, with restructuring of $15-17 million.
Onto is the cheapest of the four on sales and book value and the dearest on operating profit, at nearly twice the cohort's median EV/EBIT.
Onto trades 12% to 36% above its own six-year median on price to sales, price to book, EV to sales and price to earnings.
Management said backlog exceeded $1 billion for the first time; the figure appears in a chief-executive quote and in no financial statement.
At roughly 66 times trailing operating profit against a cohort median near 35, the price requires the reported margin to converge on the adjusted one.
Okta closed at $169 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $43.87.
What it did to the thesisThe price is about 385% of that value, so the view stays Unattractive. Conviction stays Medium.
Novo Nordisk closed at $40.31 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $63.81.
What it did to the thesisThe price is about 63% of that value, so we moved Novo Nordisk from Neutral to Attractive. Conviction stays Medium.
NVE closed at $75.98 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $61.31.
What it did to the thesisThe price is about 124% of that value, so we moved NVE from Neutral to Unattractive. Conviction stays Medium.
Nvidia's board started an independent investigation into whether chief executive Jensen Huang was the target of a foreign intelligence effort. Huang told staff he had an affair with an alleged Chinese agent and will cooperate. Shares closed about 4% lower. The New York Times also reports a Commerce Department chip inquiry was halted after Nvidia intervened; only its headline could be read.
What it did to the thesisNothing in the numbers moved. The risk is about one person: Huang has led Nvidia since 1993 and holds 3.58% of the shares. Until the probe reports, we keep Attractive and Medium confidence and test both on the 17 November results.
Enterprise value is about 28.8 times trailing operating profit of $197,579M, and about 22.3 times Q2 FY2027's operating profit of $63,734M run for a…
At $233.95 the shares are about 25 times FY2027's expected earnings per share, 15 times FY2028's and 11 times FY2029's, and enterprise value is about…
Nu closed at $12.03 on 6 November. We valued it on its shareholders' equity plus the earnings it should make above an 8% yearly return on it, with the equity growing on the analysts' path and then slowing toward 4%. On that basis the shares are worth about $12.26.
What it did to the thesisThe price is about 98% of that value, so the view stays Neutral. Conviction stays Medium.
Nutanix closed at $58.37 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $58.88.
What it did to the thesisThe price is about 99% of that value, so the view stays Neutral. Conviction stays Medium.
NetApp closed at $169 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $135.
What it did to the thesisThe price is about 126% of that value, so the view stays Unattractive. Conviction stays Medium.
Insight closed at $158 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $146.
What it did to the thesisThe price is about 108% of that value, so the view stays Neutral. Conviction stays Medium.
ServiceNow closed at $102 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $46.62.
What it did to the thesisThe price is about 219% of that value, so we moved ServiceNow from Neutral to Unattractive. Conviction stays Medium.
Netflix closed at $63.41 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $81.42.
What it did to the thesisThe price is about 78% of that value, so we moved Netflix from Neutral to Attractive. Conviction stays Medium.
Cloudflare closed at $269 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $52.40.
What it did to the thesisThe price is about 513% of that value, so the view stays Unattractive. Conviction stays Medium.
NextEra closed at $86.95 on 6 November. We valued it on its shareholders' equity plus the earnings it should make above an 8% yearly return on it, with the equity growing on the analysts' path and then slowing toward 4%. On that basis the shares are worth about $85.45.
What it did to the thesisThe price is about 102% of that value, so the view stays Neutral. Conviction stays Medium.
MaxLinear closed at $49.18 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $11.62.
What it did to the thesisThe price is about 423% of that value, so we moved MaxLinear from Neutral to Unattractive. Conviction stays Medium.
Micron Technology closed at $690 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $736.
What it did to the thesisThe price is about 94% of that value, so we moved Micron Technology from Attractive to Neutral. Conviction stays Medium.
Metallus closed at $16.65 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $9.12.
What it did to the thesisThe price is about 183% of that value, so we moved Metallus from Neutral to Unattractive. Conviction stays Medium.
Bloomberg reports that Microsoft chose not to renew a deal, begun in 2023, to rent AI computing capacity from Oracle, and has spent recent months switching it off. People familiar say the Nvidia chips were too old for Microsoft's needs. The size of the deal was never disclosed, and Microsoft declined to comment. Microsoft also rents from other providers and is reported to be trimming that list.
What it did to the thesisThe price is about 84% of that value, so the view stays Neutral. Conviction stays Medium. The news itself moved nothing.
Marvell Technology closed at $141 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $401.
What it did to the thesisThe price is about 35% of that value, so we moved Marvell Technology from Neutral to Attractive. Conviction stays Medium.
Merck closed at $147 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $119.
What it did to the thesisThe price is about 123% of that value, so we moved Merck from Neutral to Unattractive. Conviction stays Medium.
Monolithic Power closed at $1,190 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $979.
What it did to the thesisThe price is about 122% of that value, so we moved Monolithic Power from Neutral to Unattractive. Conviction stays Medium.
MP Materials closed at $35.41 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $22.74.
What it did to the thesisThe price is about 156% of that value, so we moved MP Materials from Neutral to Unattractive. Conviction stays Medium.
MKS closed at $192 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $349.
What it did to the thesisThe price is about 55% of that value, so we moved MKS from Neutral to Attractive. Conviction stays Medium.
Mitek closed at $17.24 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $21.86.
What it did to the thesisThe price is about 79% of that value, so we moved Mitek from Neutral to Attractive. Conviction stays Medium.
Meta Platforms closed at $610 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $720.
What it did to the thesisThe price is about 85% of that value, inside our 20% cushion, so the view moves from Attractive to Neutral. Conviction stays Low.
MercadoLibre closed at $1,510 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $2,075.
What it did to the thesisThe price is about 73% of that value, so we moved MercadoLibre from Neutral to Attractive. Conviction stays Medium.
Medpace closed at $653 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $420.
What it did to the thesisThe price is about 155% of that value, so we moved Medpace from Neutral to Unattractive. Conviction stays Medium.
Microchip Technology closed at $58.35 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $48.89.
What it did to the thesisThe price is about 119% of that value, so we moved Microchip Technology from Attractive to Neutral. Conviction stays Medium.
Live Nation closed at $175 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $29.94.
What it did to the thesisThe price is about 585% of that value, so we moved Live Nation from Neutral to Unattractive. Conviction stays Medium.
Lattice closed at $105 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $83.68.
What it did to the thesisThe price is about 126% of that value, so we moved Lattice from Neutral to Unattractive. Conviction stays Medium.
Dorian LPG closed at $46.55 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $55.76.
What it did to the thesisThe price is about 83% of that value, so we moved Dorian LPG from Unattractive to Neutral. Conviction stays Medium.
Lilly and Hims & Hers agreed that people prescribed on the Hims platform can buy Zepbound from $299 a month and the pill Foundayo from $149, the same cash prices Lilly offers anyone. Hims said it has never offered copies of Lilly's drugs made by compounding pharmacies and will not. No sales or payment terms were given.
What it did to the thesisIt adds a large online channel for cash-paying patients and one copier-friendly seller steps back. But valued in three stages the price is well above what the business is worth, so the view moves to Unattractive.
Lumentum closed at $539 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $710.
What it did to the thesisThe price is about 76% of that value, so we moved Lumentum from Neutral to Attractive. Conviction stays Medium.
Centrus closed at $105 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $69.09.
What it did to the thesisThe price is about 151% of that value, so the view stays Unattractive. Conviction stays Medium.
Lennar closed at $88.74 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $77.53.
What it did to the thesisThe price is about 114% of that value, so the view stays Neutral. Conviction stays Medium.
Kratos closed at $35.10 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $9.93.
What it did to the thesisThe price is about 353% of that value, so we moved Kratos from Neutral to Unattractive. Conviction stays Medium.
Kulicke and Soffa closed at $64.01 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $51.83.
What it did to the thesisThe price is about 123% of that value, so the view stays Unattractive. Conviction stays Medium.
KLA closed at $138 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $126.
What it did to the thesisThe price is about 110% of that value, so we moved KLA from Unattractive to Neutral. Conviction stays Medium.
JOE closed at $69.97 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $33.98.
What it did to the thesisThe price is about 206% of that value, so the view stays Unattractive. Conviction stays Medium.
Jabil's annual report shows sales of $35.95 billion, up 20.6%, a 5.8% profit margin and $1.53 billion of free cash. Its AI-driven data-centre unit was half of sales, and one unnamed customer grew from 16% to 20%. The report gives no AI sales total.
What it did to the thesisThe news moved nothing. Valued the same day on its own future cash at an 8% return, Jabil is worth about $252 a share, so at $239 the price is fair, not cheap: the view moves from Attractive to Neutral, conviction unchanged.
At $277.18 the shares trade at 28.4 times filed fiscal 2026 diluted earnings of $9.75 against a six-year median of 15.9, and 21.2 times fiscal 2026 c…
At the company's six-year median of 15.9 times earnings, $277.18 needs about $17.43 of earnings per share, 33% above the $13.09 reported for fiscal 2…
Intuitive Surgical closed at $453 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $220.
What it did to the thesisThe price is about 206% of that value, so we moved Intuitive Surgical from Neutral to Unattractive. Conviction stays Medium.
IPG Photonics closed at $65.31 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $44.93.
What it did to the thesisThe price is about 145% of that value, so we moved IPG Photonics from Attractive to Unattractive. Conviction stays Medium.
Samsara closed at $40.98 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $5.10.
What it did to the thesisThe price is about 804% of that value, so we moved Samsara from Neutral to Unattractive. Conviction stays Medium.
Intel's chief executive Lip-Bu Tan bought 150,000 shares at $64.73 on 2 November, about $9.7 million, with his own money and no pre-set plan. It is his second purchase this year. Intel's shares are about 50% below their level a month ago.
What it did to the thesisNothing in the news moved the case. An insider buying shows confidence in the price, not that foundry customers exist. Valued on its own future cash at an 8% return, the price is nearly three times what the business is worth, so we stay Unattractive.
Illumina closed at $213 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $100.
What it did to the thesisThe price is about 213% of that value, so the view stays Unattractive. Conviction stays Medium.
IES closed at $158 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $162.
What it did to the thesisThe price is about 98% of that value, so we moved IES from Unattractive to Neutral. Conviction stays Medium.
Ichor Holdings closed at $30.97 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $32.09.
What it did to the thesisThe price is about 97% of that value, so we moved Ichor Holdings from Attractive to Neutral. Conviction stays Medium.
Interactive Brokers closed at $75.82 on 6 November. We valued it on its shareholders' equity plus the earnings it should make above an 8% yearly return on it, with the equity growing on the analysts' path and then slowing toward 4%. On that basis the shares are worth about $55.92.
What it did to the thesisThe price is about 136% of that value, so we moved Interactive Brokers from Neutral to Unattractive. Conviction stays Medium.
Hexcel closed at $80.40 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $42.64.
What it did to the thesisThe price is about 189% of that value, so the view stays Unattractive. Conviction stays Medium.
Hesai closed at $14.33 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $9.22.
What it did to the thesisThe price is about 155% of that value, so we moved Hesai from Neutral to Unattractive. Conviction stays Medium.
HP closed at $28.46 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $38.84.
What it did to the thesisThe price is about 73% of that value, so we moved HP from Neutral to Attractive. Conviction stays Medium.
Hewlett Packard Enterprise closed at $44.77 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $59.50.
What it did to the thesisThe price is about 75% of that value, so we moved Hewlett Packard Enterprise from Neutral to Attractive. Conviction stays Medium.
Robinhood closed at $80.91 on 6 November. We valued it on its shareholders' equity plus the earnings it should make above an 8% yearly return on it, with the equity growing on the analysts' path and then slowing toward 4%. On that basis the shares are worth about $42.40.
What it did to the thesisThe price is about 191% of that value, so we moved Robinhood from Neutral to Unattractive. Conviction stays Medium.
Hippo closed at $34.89 on 6 November. We valued it on its shareholders' equity plus the earnings it should make above an 8% yearly return on it, with the equity growing on the analysts' path and then slowing toward 4%. On that basis the shares are worth about $20.90.
What it did to the thesisThe price is about 167% of that value, so we moved Hippo from Neutral to Unattractive. Conviction stays Medium.
Hasbro closed at $119 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $104.
What it did to the thesisThe price is about 115% of that value, so the view stays Neutral. Conviction stays Medium.
Guidewire closed at $161 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $85.89.
What it did to the thesisThe price is about 188% of that value, so we moved Guidewire from Neutral to Unattractive. Conviction stays Medium.
Goldman Sachs closed at $866 on 6 November. We valued it on its shareholders' equity plus the earnings it should make above an 8% yearly return on it, with the equity growing on the analysts' path and then slowing toward 4%. On that basis the shares are worth about $953.
What it did to the thesisThe price is about 91% of that value, so the view stays Neutral. Conviction stays Medium.
Grab closed at $3.41 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $4.26.
What it did to the thesisThe price is about 80% of that value, so the view stays Neutral. Conviction stays Medium.
Generac closed at $177 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $195.
What it did to the thesisThe price is about 91% of that value, so we moved Generac from Attractive to Neutral. Conviction stays Medium.
Corning closed at $106 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $108.
What it did to the thesisThe price is about 98% of that value, so we moved Corning from Unattractive to Neutral. Conviction stays Medium.
Graham closed at $78.02 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $49.90.
What it did to the thesisThe price is about 156% of that value, so the view stays Unattractive. Conviction stays Medium.
GE Vernova closed at $774 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $602.
What it did to the thesisThe price is about 129% of that value, so we moved GE Vernova from Neutral to Unattractive. Conviction stays Medium.
GEO closed at $27.80 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $29.67.
What it did to the thesisThe price is about 94% of that value, so the view stays Neutral. Conviction stays Medium.
GE Aerospace closed at $323 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $202.
What it did to the thesisThe price is about 160% of that value, so we moved GE Aerospace from Neutral to Unattractive. Conviction stays Medium.
GoDaddy closed at $114 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $146.
What it did to the thesisThe price is about 78% of that value, so the view stays Attractive. Conviction stays Medium.
At $104.35 GoDaddy's 126,647,704 shares are worth about $13.22B, 7.8 times owner cash of $1,702.9M and 9.4 times after stock pay; at a 9% yearly retu…
Fortinet closed at $119 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $81.82.
What it did to the thesisThe price is about 145% of that value, so the view stays Unattractive. Conviction stays Medium.
FTAI closed at $180 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $288.
What it did to the thesisThe price is about 63% of that value, so we moved FTAI from Neutral to Attractive. Conviction stays Medium.
First Solar closed at $201 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $137.
What it did to the thesisThe price is about 147% of that value, so we moved First Solar from Attractive to Unattractive. Conviction stays Medium.
Forgent Power Solutions closed at $19.48 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $28.58.
What it did to the thesisThe price is about 68% of that value, so the view stays Attractive. Conviction stays Medium.
At $24.92 the company value is about $8.09B, about 13.5 times the $600M midpoint of FY27 adjusted EBITDA guidance and the shares about 18.7 times the…
Fabrinet closed at $327 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $471.
What it did to the thesisThe price is about 69% of that value, so we moved Fabrinet from Neutral to Attractive. Conviction stays Medium.
Flywire closed at $21.57 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $8.97.
What it did to the thesisThe price is about 240% of that value, so we moved Flywire from Neutral to Unattractive. Conviction stays Medium.
Flowco closed at $20.06 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $25.82.
What it did to the thesisThe price is about 78% of that value, so we moved Flowco from Neutral to Attractive. Conviction stays Medium.
Comfort Systems closed at $1,018 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $1,670.
What it did to the thesisThe price is about 61% of that value, so we moved Comfort Systems from Neutral to Attractive. Conviction stays Medium.
At a reference price of $1,658.91, the close of September 25, 2026, Comfort Systems trades at 30.8 times trailing enterprise value to operating profi…
As of the research pack's close of September 25, 2026 Comfort Systems traded at $1,658.91, 20.01% below its 252-day high of $2,073.99 and 119.14% abo…
Five9 closed at $28.12 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $35.92.
What it did to the thesisThe price is about 78% of that value, so we moved Five9 from Neutral to Attractive. Conviction stays Medium.
Figure Technology Solutions closed at $22.73 on 6 November. We valued it on its shareholders' equity plus the earnings it should make above an 8% yearly return on it, with the equity growing on the analysts' path and then slowing toward 4%. On that basis the shares are worth about $19.96.
What it did to the thesisThe price is about 114% of that value, so the view stays Neutral. Conviction stays Medium.
FICO closed at $705 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $645.
What it did to the thesisThe price is about 109% of that value, so the view stays Neutral. Conviction stays Low.
Extreme Networks closed at $24.03 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $12.68.
What it did to the thesisThe price is about 190% of that value, so the view stays Unattractive. Conviction stays Medium.
Expand Energy closed at $84.60 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $129.
What it did to the thesisThe price is about 66% of that value, so we moved Expand Energy from Neutral to Attractive. Conviction stays Medium.
Eaton closed at $342 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $265.
What it did to the thesisThe price is about 129% of that value, so we moved Eaton from Neutral to Unattractive. Conviction stays Medium.
Element Solutions closed at $31.35 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $27.51.
What it did to the thesisThe price is about 114% of that value, so the view stays Neutral. Conviction stays Medium.
EQT closed at $49.40 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $138.
What it did to the thesisThe price is about 36% of that value, so we moved EQT from Neutral to Attractive. Conviction stays Medium.
Eos Energy closed at $1.74 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $0.35.
What it did to the thesisThe price is about 497% of that value, so the view stays Unattractive. Conviction stays Medium.
Entegris closed at $128 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $109.
What it did to the thesisThe price is about 118% of that value, so the view stays Neutral. Conviction stays Medium.
EnerSys closed at $147 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $119.
What it did to the thesisThe price is about 123% of that value, so we moved EnerSys from Neutral to Unattractive. Conviction stays Medium.
EMCOR earned 10.4 cents of operating profit on each dollar of sales over the last year, a record. Since late September its shares fell 20% and its closest rivals fell 10% to 51%, so it no longer looks cheap beside them.
What it did to the thesisThe view moves from Attractive to Neutral. Valued on growth that slows over ten years and a margin a little below today's, it is worth about $728 a share against $608: fair, not cheap, inside our 20% cushion. Conviction stays Medium.
EMCOR trades at 23.4 times the midpoint of its own 2026 guidance and at 17.6 times trailing enterprise value to operating profit, the cheapest of the…
Excelerate closed at $36.81 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $44.25.
What it did to the thesisThe price is about 83% of that value, so the view stays Neutral. Conviction stays Medium.
Everus closed at $76.60 on 6 November, down from $112.73 on 3 November, the day it reported record results and raised its forecast again; 29% of the fall came on the day of its call. Its profit margin is well above the mid-7% management calls normal.
What it did to the thesisThe view stays Attractive. Valued on growth that slows over ten years and a margin near what management calls normal, it is worth about $106 a share against $77: cheap. Conviction stays Medium.
The shares closed at $112.73 on 3 November 2026, a market value of about $5.75B, 34.3% below the May high of $171.58 and 18.8% above the $94.91 of 23…
At $112.73, with $326.7M of net debt at 30 September (which includes the $295M paid for Epsilon), enterprise value is about $6.08B: about 12.4 times…
DLO closed at $13.95 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $22.01.
What it did to the thesisThe price is about 63% of that value, so we moved DLO from Neutral to Attractive. Conviction stays Medium.
Digi closed at $63.21 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $49.19.
What it did to the thesisThe price is about 129% of that value, so we moved Digi from Neutral to Unattractive. Conviction stays Medium.
Deere closed at $672 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $413.
What it did to the thesisThe price is about 162% of that value, so we moved Deere from Neutral to Unattractive. Conviction stays Medium.
Dave closed at $279 on 6 November. We valued it on its shareholders' equity plus the earnings it should make above an 8% yearly return on it, with the equity growing on the analysts' path and then slowing toward 4%. On that basis the shares are worth about $218.
What it did to the thesisThe price is about 128% of that value, so we moved Dave from Neutral to Unattractive. Conviction stays Medium.
Constellium closed at $21.81 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $35.12.
What it did to the thesisThe price is about 62% of that value, so we moved Constellium from Neutral to Attractive. Conviction stays Medium.
Cisco closed at $93.85 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $82.26.
What it did to the thesisThe price is about 114% of that value, so the view stays Neutral. Conviction stays Medium.
CrowdStrike closed at $217 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $37.52.
What it did to the thesisThe price is about 578% of that value, so the view stays Unattractive. Conviction stays Medium.
Salesforce closed at $214 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $227.
What it did to the thesisThe price is about 94% of that value, so the view stays Neutral. Conviction stays Medium.
Credo closed at $121 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $146.
What it did to the thesisThe price is about 83% of that value, so the view stays Neutral. Conviction stays Medium.
Cricut closed at $8.78 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $5.80.
What it did to the thesisThe price is about 151% of that value, so we moved Cricut from Neutral to Unattractive. Conviction stays Medium.
Corpay closed at $455 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $653.
What it did to the thesisThe price is about 70% of that value, so we moved Corpay from Neutral to Attractive. Conviction stays Medium.
Cohu closed at $38.49 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $22.47.
What it did to the thesisThe price is about 171% of that value, so the view stays Unattractive. Conviction stays Medium.
Coherent closed at $193 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $378.
What it did to the thesisThe price is about 51% of that value, so we moved Coherent from Unattractive to Attractive. Conviction stays Medium.
Celestica closed at $207 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $584.
What it did to the thesisThe price is about 35% of that value, so we moved Celestica from Unattractive to Attractive. Conviction stays Low.
Ciena closed at $243 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $432.
What it did to the thesisThe price is about 56% of that value, so we moved Ciena from Neutral to Attractive. Conviction stays Medium.
Chime closed at $31.33 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $17.89.
What it did to the thesisThe price is about 175% of that value, so we moved Chime from Neutral to Unattractive. Conviction stays Medium.
Consensus closed at $43.15 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $86.53.
What it did to the thesisThe price is about 50% of that value, so we moved Consensus from Neutral to Attractive. Conviction stays Medium.
Cerebras closed at $89.68 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $40.51.
What it did to the thesisThe price is about 221% of that value, so we moved Cerebras from Neutral to Unattractive. Conviction stays Low.
BWX Technologies closed at $120 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $82.82.
What it did to the thesisThe price is about 144% of that value, so we moved BWX Technologies from Neutral to Unattractive. Conviction stays Medium.
BorgWarner closed at $48.81 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $73.53.
What it did to the thesisThe price is about 66% of that value, so we moved BorgWarner from Neutral to Attractive. Conviction stays Medium.
At $61.32 the whole company, shares plus net debt and minority stakes, costs about $14.1B, or about 10.3 times its guided 2026 operating profit of ab…
On management's figures the turbine's first year earns about $45M of operating profit, about 3% of 2026 guided adjusted operating profit of about $1.…
The shares closed at $53.98 on 10 February 2026 and $66.10 on 11 February, a 22.5% rise on the day the turbine award was announced, fell back to $53.…
Webull closed at $4.92 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $5.65.
What it did to the thesisThe price is about 87% of that value, so the view stays Neutral. Conviction stays Medium.
Brookfield closed at $41.38 on 6 November. We valued it as a holding company, adding up what it owns at market prices or as reported and taking off what it owes, with an 8% yearly return asked of anything valued on its earnings. On that basis the shares are worth about $47.72.
What it did to the thesisThe price is about 87% of that value, so we moved Brookfield from Attractive to Neutral. Conviction stays Medium.
Baker Hughes closed at $47.87 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $46.98.
What it did to the thesisThe price is about 102% of that value, so the view stays Neutral. Conviction stays Medium.
BILL Holdings closed at $52.41 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $17.88.
What it did to the thesisThe price is about 293% of that value, so we moved BILL Holdings from Neutral to Unattractive. Conviction stays Medium.
Bloom Energy closed at $173 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $148.
What it did to the thesisThe price is about 117% of that value, so we moved Bloom Energy from Unattractive to Neutral. Conviction stays Medium.
Axon closed at $313 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $169.
What it did to the thesisThe price is about 185% of that value, so we moved Axon from Neutral to Unattractive. Conviction stays Medium.
AeroVironment said a US customer, not named, signed a multiyear contract that can reach $940 million, with about $315 million ordered now for products and support from its drone business. The company's page could not be read in full, so the products, delivery years and whether the money is already set aside are not known.
What it did to the thesisThe award helps the drone half of our case, but it came after the quarter our next test measures. Valued in three stages the price is well above what the business is worth, so the view moves to Unattractive.
At $137.11 the company is worth about $6.97B; adding $747.5M of notes and taking away about $675M of cash and investments gives a company value of ab…
Discounted at 9% a year and valued at 15 times EBITDA in fiscal 2030, today's company value needs about $630M of fiscal 2030 adjusted EBITDA, about 8…
ASML closed at $1,425 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $1,732.
What it did to the thesisThe price is about 82% of that value, so the view stays Neutral. Conviction stays Medium.
Aramark closed at $52.54 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $50.75.
What it did to the thesisThe price is about 104% of that value, so the view stays Neutral. Conviction stays Medium.
Digital Turbine closed at $10.38 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $8.52.
What it did to the thesisThe price is about 122% of that value, so the view stays Unattractive. Conviction stays Medium.
AppFolio closed at $231 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $181.
What it did to the thesisThe price is about 128% of that value, so we moved AppFolio from Neutral to Unattractive. Conviction stays Medium.
AppLovin closed at $391 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $508.
What it did to the thesisThe price is about 77% of that value, so the view stays Attractive. Conviction stays Medium.
The price pays 24.5 times free cash flow for a business that grew revenue 47.6% over the trailing year, earns 63.8% on invested capital and carries n…
At the 2026-11-04 close of $271.75, 331M shares are worth about $89.9B, which is 18.4 times trailing free cash flow of about $4.88B (the $3.95B of 20…
Amphenol closed at $74.59 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $83.43.
What it did to the thesisThe price is about 89% of that value, so the view stays Neutral. Conviction stays Medium.
Arista closed at $171 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $165.
What it did to the thesisThe price is about 103% of that value, so the view stays Neutral. Conviction stays Medium.
Amazon closed at $259 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $260.
What it did to the thesisThe price is about 100% of that value, so the view stays Neutral. Conviction stays Medium.
AMD closed at $449 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $581.
What it did to the thesisThe price is about 77% of that value, so we moved AMD from Neutral to Attractive. Conviction stays Medium.
Applied Materials closed at $333 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $451.
What it did to the thesisThe price is about 74% of that value, so we moved Applied Materials from Neutral to Attractive. Conviction stays Medium.
Allient closed at $81.32 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $40.90.
What it did to the thesisThe price is about 199% of that value, so the view stays Unattractive. Conviction stays Medium.
Astera Labs closed at $191 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $141.
What it did to the thesisThe price is about 135% of that value, so we moved Astera Labs from Neutral to Unattractive. Conviction stays Medium.
Akamai said it plans to sell $1.1 billion of notes due in 2028 and $1.1 billion due in 2031, which holders can swap into shares. Interest rate and swap price are not set yet. The money repays part of $1.15 billion of notes due in September 2027 and pays for cloud servers.
What it did to the thesisThe price is about 74% of that value, so we moved Akamai from Neutral to Attractive. Conviction stays Medium. The news itself moved nothing.
Agilysys closed at $121 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $56.56.
What it did to the thesisThe price is about 214% of that value, so we moved Agilysys from Neutral to Unattractive. Conviction stays Medium.
AudioEye closed at $12.37 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $6.07.
What it did to the thesisThe price is about 204% of that value, so we moved AudioEye from Neutral to Unattractive. Conviction stays Low.
Aehr Test Systems closed at $53.57 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $9.34.
What it did to the thesisThe price is about 574% of that value, so we moved Aehr Test Systems from Neutral to Unattractive. Conviction stays Medium.
Adeia closed at $15.50 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $28.94.
What it did to the thesisThe price is about 54% of that value, so we moved Adeia from Unattractive to Attractive. Conviction stays Medium.
Reuters reports that Disney and Adobe will co-develop custom AI models made for Disney. Reuters could not be opened from here, and the company release was not found, so only the headline is known: no price, length of deal or number of users.
What it did to the thesisNothing moved. A large media customer is the kind of enterprise demand our case wants to see, but without figures it cannot answer the open question on enterprise growth. The view stays attractive, with low confidence.
After about $2.07B of stock pay, trailing cash profit is about $8.52B against a company value of about $94.4B: a 9.0% yearly return, which on a 9% re…
ACM Research closed at $44.61 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $57.65.
What it did to the thesisThe price is about 77% of that value, so we moved ACM Research from Neutral to Attractive. Conviction stays Medium.
Reuters reported on 9 November that China's regulator registered Apple Intelligence for tablets and laptops; we could read only the headline. Separately, Apple's filing shows it sold $7.5B of bonds on 6 November, maturing from 2028 to 2036, and says the money may fund share buybacks and dividends.
What it did to the thesisThe price is about 181% of that value, so we moved Apple from Neutral to Unattractive. Conviction stays Medium. The news itself moved nothing.
Apple bought back $89.3B of stock and paid $15.4B of dividends in fiscal 2025, and $62.1B and $11.8B in the nine months to June 2026, then $24B and $…
At September 26, 2026 Apple held $136.9B of cash and marketable securities against about $80B of total debt, about $57B net; operating cash flow in t…
Applied Optoelectronics closed at $50.13 on 6 November. We valued it on the cash it should produce over ten years, with growth slowing toward 4%, stock pay counted as a cost and an 8% yearly return asked. On that basis the shares are worth about $14.05.
What it did to the thesisThe price is about 357% of that value, so we moved Applied Optoelectronics from Neutral to Unattractive. Conviction stays Medium.
Vishay Precision closed at $41.22 on 5 November, down from $54.24 on 3 November, after reporting record orders but a 4.9% adjusted operating margin. Counting its cash, the whole business now costs about 16.7 times its average yearly operating profit since 2018, down from 22.7.
What it did to the thesisOur route to Attractive needs the price below 18 times and the margin at 8% for two quarters. The price is there; the margin is 4.9%. So the view stays Unattractive, but the price now pays for less, about 8 times the plan's profit, so the price score improves.
At $54.24 on 2026-11-03 VPG's enterprise value is about $657M: 13.32M shares make $722M of equity, less about $65M of net cash. That is 22.7 times th…
Sterling's shares closed at $244.34 on 5 November, down from $345.91 on 30 October. The company filed nothing new about its business; the only items were a shareholder's ownership notice and a conference announcement. At this price the shares cost about 11 times the profit per share Sterling expects this year.
What it did to the thesisThe price we had set for a better view, 12 times this year's expected profit per share, has been reached, so we moved Sterling from Neutral to Attractive. Conviction stays Medium because signed work fell last quarter and that is still unresolved.
The shares closed at $345.91 on 30 October 2026, 65.6% below the 52-week high of $1,005.68, for a market value of $10.58B. Over the 126 sessions to t…
At $345.91 Sterling trades at about 15.8 times the guided 2026 adjusted EPS midpoint of $21.83 and 17.9 times guided GAAP EPS, 16.5 times analysts' 2…
Micron closed at $656.39 on 5 November, down from $1,065.11 on 30 September, with no new results. On the last quarter's profit, the whole company now costs about 4.0 times a year of it, down from 6.7.
What it did to the thesisWe said 4.5 times a year of the latest quarter's operating profit would make the price low enough to rate it Attractive. It is there, so the view moves from Neutral to Attractive at Medium. The business facts are unchanged; December's results are the test.
Counting every diluted share, Micron is worth about $1,224.9B at $1,065.11, and its enterprise value is about $1,169B after $68.3B of net cash, treat…
At about $1,169B of enterprise value, a 6% after-tax yield at a 15.5% tax rate needs about $83.0B of GAAP operating income a year, indefinitely. That…
At about $1,169B the enterprise value is 6.7 times FQ4 2026 GAAP operating income annualised ($175.0B), 5.8 times the FQ1 2027 guided pace and 11.8 t…
The vendor's panel has fiscal 2028 EPS at $199.85 from 22 analysts, so $1,065.11 is 5.3 times it. Its positive share is 91.8% of 49 analysts, up from…
Lilly and Hims & Hers announced that patients prescribed by a provider on the Hims & Hers platform can buy Zepbound from $299 a month and Foundayo from $149 a month, the same self-pay prices open to anyone. Hims & Hers committed not to sell compounded copies of Lilly's drugs.
What it did to the thesisNothing moved. It adds a sales route at existing prices and removes one seller of unapproved copies, which supports our note on copies, but it gives no volume or revenue figure. The 2027 results remain the test. The view stays Neutral.
Lumentum's shares closed at $509.70 on 5 November, down 19% from $626.75 the day before. The company filed only a routine deal notice. Counting every share, it is now worth about $51 billion, or 35 times a full year of last quarter's operating profit. Its price is tied to Marvell's by the deal agreed on 2 November.
What it did to the thesisThe price we had set for a better view, 40 times that profit, has been passed, so we moved Lumentum from Unattractive to Neutral. Conviction stays Medium: one customer is 37% of sales and the price still needs profit to rise 2.5 times.
At the $626.75 close of 4 November 2026 and counting every share, Lumentum is worth about $63.3B and its enterprise value is about $62.7B, which is a…
Generac's shares closed at $172.33 on 5 November, down 11% in a week with no news from the company. The value of the whole company is now about 12 times the profit it guided for this year, the line we wrote down on 28 October. Its quarterly filing, published 3 November, repeated figures we had already read.
What it did to the thesisWe said that at 12 times this year's profit the price would ask for little of 2027's data-centre growth. It has got there, so we move from Neutral to Attractive. Confidence stays medium: the orders can still be cancelled and the fall was not caused by the company.
At $193.71 on about 59.0M shares the equity is worth about $11.43B; adding $1.33B of borrowings and taking away $0.39B of cash gives a company value…
Analysts' 2027 figures (set before the Q3 results) need sales up about a third to $6.52B, which only the data-centre backlog and the Amazon deliverie…
The shares closed at $193.71 on 27 October 2026, the session before the Q3 results: down 13.9% from $224.94 on 9 October, up 0.9% in 252 sessions, ag…
Fastly closed at $15.38 on 5 November, down from $21.07 on 3 November, after its results and a slower sales guide. On the latest filed figures the business is now worth about 3.4 times its last year of sales, down from about 4.7 times.
What it did to the thesisWe said 4.5 times sales on an unchanged business, with customers spending at least 10% more than a year before, would make us Neutral. Both hold, so the view moves from Unattractive to Neutral at Medium. Growth outside the biggest is still slow: not Attractive.
At $21.07, 161.2M shares are worth about $3.40B; with $324M of notes and $365.2M of cash and securities the business is valued at about $3.36B, about…
Brookfield Asset Management, 74% owned by Brookfield Corporation, reported fee earnings of $864 million and distributable earnings of $763 million, each up 15% on the year, and raised $25 billion in the quarter. Brookfield Infrastructure reported cash earnings of $0.91 a unit, up 10%.
What it did to the thesisBoth support the idea that the asset manager keeps growing, which is most of the value behind the shares. But they are partial, and Brookfield Corporation's own earnings on 12 November are the real test. Nothing moved; the view stays Attractive.
NTT DATA, a large technology services group, announced an agreement for 900 megawatts of Bloom's fuel cells across several data centre projects, with first shipments in 2027. Bloom calls it its largest international project. The release gives no price, no contract value and no binding terms. Bloom's shares fell that day, in step with other fuel cell companies.
What it did to the thesisIt is a new named customer, which our case wanted, but nothing is booked as revenue until 2027 and the release does not say how firm it is. The two big buyers still hold 69% of sales. Unattractive at Medium stays.
Amazon Prime members in the US can now order from Uber Eats inside Amazon's site and app, with no Uber account and no delivery fee on orders over $25. Amazon's deal with Grubhub ended the same day. Neither company gave order volumes, and Uber did not say what the perk costs it.
What it did to the thesisNothing moved yet. It gives Uber's delivery business a large new door to customers and takes one from a rival, which fits our view that its two products feed each other. Without figures on orders or cost it cannot change the view; Attractive holds.
Tenable filed its quarterly report. Revenue was $276.4M, up 9.5%. Contracted future revenue is $1.063B, up 14.4%. It holds $495.3M of cash and investments against $800.0M of new convertible notes, and had 104.5M shares outstanding on 30 October.
What it did to the thesisNothing moved. The filing confirms what we already read. Net debt of about $305M is small against profit, and pay in shares, the hinge of our Neutral view, is unchanged. The shares are 41% above our price figures.
Contracted future revenue is growing faster than reported revenue: remaining performance obligations reached $1.03B at 30 June 2026, 15.4% above a ye…
Shares outstanding fell 6.8% in six months, from 118.5 million to 110.4 million - but the company issued 3.3 million new shares over the same half, a…
On 15 September 2026 Tenable repaid its $358.1M secured term loan and replaced it with $800M of unsecured 0.25% convertible notes due September 2031;…
On 30 June balances the financing takes Tenable from about $60M of net debt to about $316M, 1.2 times its guided 2026 adjusted operating profit, whil…
SiTime's shares closed at $403.27 on 4 November, down 9.4% after its results. Its quarterly filing shows 30.2 million shares and $324 million of cash against $1.35 billion of convertible notes. Company value is now about $13.2 billion, 11 times a year of last quarter's sales. What the company said about December sales was on a call we could not yet read.
What it did to the thesisThe price we had set for a better view, 12 times sales, has been reached, so we moved SiTime from Neutral to Attractive. Conviction is low because the December outlook, which shows whether orders are real demand, is unread.
At $509.20 and about 30.1M shares, SiTime is worth about $15.3B, and $16.3B with net debt: about 14 times September-quarter guided sales annualised (…
Analysts' 2027 EPS of $14.92 is barely above the guided September quarter annualised ($14.30), so at 34.1 times 2027 EPS the price still asks for gro…
Quanta's quarterly filing shows its electric business kept 12.6 cents of each sales dollar in September, above the 12 cents the chief executive called its best case in July. Over twelve months it earned $2.55 billion from operations, so its shares now cost about 38 times that, down from 51.
What it did to the thesisThe business is better than we assumed, but the shares are still priced at 38 times operating profit against 21.5 for rivals. Unattractive holds, with low confidence. We move to Neutral if the price falls to 32 times profit with growth still above 15%.
At a close of $649.13 on September 25, 2026 Quanta's enterprise value was about 51.0 times trailing operating profit against a median of 21.5 for the…
What the price implies: at the cohort's median of 21.5 times operating profit, today's enterprise value of about $103.7B would need operating profit…
The Energy Information Administration forecasts US electricity sales of 4,135 billion kilowatt-hours in 2026, almost 2% above 2025, with commercial-s…
Allocating the $1.32B of trailing corporate costs to the segments by revenue, Electric earned about $1.78B of operating profit after its share over t…
MaxLinear closed at $56.85 on 4 November, down from $75.79 on 21 October, with no news from the company since its 22 October results. Counting its debt and cash, the company is worth 7.96 times its last year of sales. Analysts raised their 2027 sales estimate to $1.38 billion after the results.
What it did to the thesisThe price we said would make us reconsider, 8 times sales, is reached, so our view moves from Unattractive to Neutral. The business has not changed. The price now needs about $1.3 billion of sales at a 30% margin, which analysts expect next year.
At $75.79 on 21 October 2026 the market value is about $6.90B on 91.0M shares; adding the $125.0M term loan and $40.0M of revolver and taking off $81…
For a 6% after-tax yield at 21% tax, the $6.98B enterprise value needs about $530M of GAAP operating profit. At a 30% operating margin that is about…
The vendor's snapshot counts 11 Buy and 6 Hold ratings; its dated series shows 63.6% positive of 11 analysts, up from 36.4% in February. Average reve…
Meta, Google and TikTok each sued California's attorney general to block a law, due to start in January, that bans automatic video and personalised feeds for users under 16. Companies that do not comply face fines of up to $50,000 per affected child. Meta says the law breaks free-speech rules. The details come from a news report, since the court filing was not read.
What it did to the thesisNothing moved. It adds a new youth-safety legal front to the ones we already watch, but no ruling or amount is set and the law covers only users under 16. We keep Attractive with Low confidence.
Lumentum's quarterly report shows one customer bought 37% of its sales in the quarter, and a second bought 11%. It also gives the share count and cash. Counting every share, Lumentum is worth about $62.7 billion after its shares fell to $626.75, or 43.6 times a full year of last quarter's operating profit.
What it did to the thesisOur price test was not met: we wait for 40 times, and the count of shares in the daily check was too low. The price worry has eased, but depending on one customer for 37% of sales worsens the other worry. View stays Unattractive.
One unnamed end customer was 26.6% of fiscal 2026 revenue (15.4% a year earlier) and a second was 15.0% (16.0%). The 10-K says most customers buy on…
At 27 June 2026 Lumentum held $2,738.4M of cash and short-term investments against $1,554.3M of convertible note principal (2026 notes $54.8M, 2028 $…
Lumentum had 89.7M common shares on 14 August 2026 against 69.8M on 28 June 2025, plus 2.9M NVIDIA preferred shares that convert one-for-one. It issu…
Comfort Systems says its board added 994,606 shares to its buyback. By 4 November it had bought 11,752,570 shares in all, against about 11.1 million at 30 September. That is roughly 660,000 shares in five weeks, about $0.8 billion by our subtraction, while the shares fell.
What it did to the thesisIt supports the buyback leg of our next test: management is using the cash customers paid up front. We stay Neutral at Medium. The price has now crossed our line for Attractive, but the route also needs growth and margin to hold at the February report.
Comfort Systems stopped buying its own shares for the first half of 2026, then restarted in the third quarter. Share repurchases were $8,232 thousand…
Consensus signed a new bank agreement on 30 September: a $225M revolving line and a $300M loan, both running to 2031. The $300M can only be used to pay off its $348.2M of 6.5% bonds, which it expects to do around 15 October 2027. The agreement itself has not been filed.
What it did to the thesisThe thesis feared all the debt falling due in one quarter of 2028. Now the bank debt runs to 2031 and the bonds have a committed way to be paid. The loan's covenant tests are unpublished, so the balance-sheet score and the Neutral view stay.
At 30 June 2026 Consensus owed $558.5M: $348M of 6.5% notes maturing 15 October 2028, a $146M term loan and $64M drawn on a revolver under a facility…
The 6.5% 2028 notes may be redeemed in whole or part at any time on or after 15 October 2026, at specified redemption prices plus accrued interest.
In Q2 2026 revenue rose 4.1% to $91.361M: Corporate up 9.3% to $60.456M, SoHo down 4.7% to $30.905M.
Consolidated growth rises each year with no change in either half's own rate, because the declining half carries less weight: Corporate's 9.3% on a 6…
Corporate monthly churn rose from 1.49% in 2023 to 2.36% in 2024 to 3.03% in 2025, and was 3.16% in Q2 2026 against 2.91% a year earlier.
Revenue per corporate account fell from $315.51 a month in 2023 to $300.03 in 2025, recovering to $304.86 in Q2 2026, while corporate accounts grew f…
Corporate revenue growth is coming from account count rather than from spend per account: in Q2 2026 accounts rose 9.4% and revenue per account about…
Management guides FY2026 to revenue of $350M to $364M, adjusted cash operating profit of $182M to $193M, adjusted earnings of $5.55 to $5.95 a share,…
The US Federal Trade Commission and 22 states sued Amazon on 31 August, saying it secretly pushed up the prices advertisers pay in its ad auctions, most on busy days like Prime Day and Black Friday. A 5 November Wall Street Journal headline says prices tripled on those days; we could not open it. Amazon says the claim is false.
What it did to the thesisAdvertising is Amazon's third growth engine, so this is a risk to watch, but it is an unproven claim with no penalty set. Nothing in our case moved; it turns on cloud growth, backlog and cash flow, next tested at the fourth-quarter report.
Applied Optoelectronics closed at $59.27 on 4 November, down from $67.51 on 23 October, with no company news about the business. Counting the shares it sold in August and all its cash, the company is worth at least 7.5 times its last year of sales. It also filed a new $200 million bank credit agreement.
What it did to the thesisThe price we said would make us reconsider, 8 times sales, is now reached, so our view moves from Unattractive to Neutral. The business is unchanged and the price still needs about $1.7 billion of sales. Tonight's results replace the figures this rests on.
At $67.51 on 23 October 2026 the market value is about $6.09B on about 90.26M shares (84.57M on 3 August plus the 5.69M sold in the finished August p…
For a 6% after-tax yield at 21% tax, an enterprise value of at least $5.21B needs about $396M of operating profit. At a 20% operating margin that is…
Management guides third-quarter 2026 revenue of $255M-$290M, non-GAAP gross margin of 29%-30.5% and non-GAAP net income of $10.1M-$24.0M on about 92.…
Management targets about $471M a month of data center transceiver revenue by mid-2027 (100G and 400G $90M, 800G $217M, 1.6T $164M), raised in May 202…
In the first half of 2026 operating cash flow was minus $73.8M, capital expenditure $335.1M and investing outflow $633.7M, while financing brought in…
Shares outstanding rose from 75,198,817 on 24 February 2026 to 84,569,237 on 3 August 2026, 12.5% in five months, after selling about 7.78M shares at…
At $59.27 on 4 November 2026 the market value is about $5.35B on about 90.26M shares (84.57M on 3 August plus the 5.69M sold in the finished August p…
For a 6% after-tax yield at 21% tax, an enterprise value of at least $4.47B needs about $340M of operating profit. At a 20% operating margin that is…
IonQ said it finished buying Elisity, a company that secures corporate networks, on 4 November. It paid in IonQ shares and the release does not say how many. Elisity has more than 100 business customers and will keep its current leaders.
What it did to the thesisNothing moved. We already counted this deal as adding roughly 6 to 10 percent more shares. The exact count and Elisity's sales come with IonQ's filing and its results on 5 November. View stays Unattractive.
HP named Emma Walmsley, who ran drug maker GSK until December 2025, as chief executive from 4 January 2027. Bruce Broussard, who has filled in since February, becomes chair. Separately, Intel said high memory prices have cut PC demand; HP's shares fell 9.6% that day and are 16% lower than on 22 October.
What it did to the thesisA named leader removes one open risk, but she has said nothing yet about costs, dividend or buybacks. Intel's warning leans on the unit outlook our view already doubts. The test is the 24 November forecast; Neutral holds.
Chief executive Enrique Lores left on 2 February 2026 to take a job outside HP. Director Bruce Broussard, a former Humana chief executive, is interim…
The shares closed at $33.76 on 22 October 2026, up 19.9% in a year and 62.1% in 120 sessions, from a 52-week low of $17.56 in February; over six mont…
At $33.76 the shares are 10.4 times the fiscal 2026 non-GAAP guide midpoint, 11.1 times it without refunds and 10.6 times fiscal 2027 consensus; the…
BWXT launched a $500M bond due 2034. It will use the money and cash on hand to buy back all of its $800M of 4.125% bonds due 2028 and 2029. It also pushed its $1.25B bank credit line out a year, to November 2031, and loosened some conditions if it earns investment-grade ratings.
What it did to the thesisNothing in our argument moved. Debt would fall by about $300M, and the cost of the new bond is not yet known. The business case rests on naval work and nuclear orders, not on this refinancing. Neutral and medium confidence hold.
Vishay closed at $25.52 on 2 November, down from $38.18 on 2 October. The company filed nothing and reported nothing. It is now valued at about 1.08 times a year of sales, down from 1.67, and inside the 0.85 to 1.15 range it fetched at past year-ends.
What it did to the thesisWe moved our view from Unattractive to Neutral. We called the shares full only because they paid for peak profit; at this price they count only part of it. The business has not changed, and the 4 November results test the orders and the margin.
The shares closed at $38.18 on October 2, 2026, up 147.6% in 252 sessions: sales per share rose 35.6% and the price paid per dollar of them 82.6%. Th…
At $38.18 the 153.4M shares are worth about $5.86B and, less about $315M of net cash, the company about $5.54B: 1.67 times the $3,319.4M of filed tra…
The price pays for record sales at near-peak margins: 2028 consensus EPS of $2.64 puts it at 14.5 times, and implies about $0.6B of operating profit,…
West Virginia's Department of Education chose Tyler's cloud software for finance and payroll across 65 education agencies, including 55 county school districts, serving about 250,000 students. It won a competitive bidding process. No price or length of contract was available, and the company's own release could not be read; this comes from a summary of it.
What it did to the thesisNothing moved. It fits our view that Tyler's finance software still wins state bids, but it is one contract with no value given. The risk we watch is a large state project going wrong, as two did in 2025.
Telos says the State Department gave it a one-year contract for Xacta 360, its software that tracks whether government computer systems meet security rules, plus related services. The announcement we could read gave no dollar value or start date.
What it did to the thesisNothing moved. It fits the point that agencies keep paying for Xacta, but with no size it adds nothing to the $500M of bids we are waiting on. We keep Neutral and wait for the 9 November results.
Seagate closed at $593.76 on 2 November, down from $887.09 on 5 October, while analysts raised what they expect it to earn next year to $40.14 a share. Buyers now pay about 15 times that profit, below the 15 times we set in October as the price that would move our view. No new results or filings arrived.
What it did to the thesisWe moved our view from Unattractive to Neutral. The price no longer pays a peak price for peak profit, but next year's forecast still needs margins drive makers never kept through a downturn, so conviction stays Medium.
Seagate closed at $887.09 on 5 October 2026, a market value of $198.9B, 22.5% below its 252-day high of $1,145. Over 252 trading days the price rose…
Analysts' average forecast is $36.16 of adjusted earnings a share for the year to July 2027 on sales of $18.73B (12 analysts), $57.02 for the year to…
At $887.09 the shares cost about 24.5 times analysts' FY27 EPS and 15.6 times FY28's. FY28's consensus keeps about 52% of revenue as profit, against…
The Washington Post reported on 2 November that SpaceX is talking with EchoStar about buying Boost Mobile, a phone service with about 7.5 million customers that rents its network from AT&T and T-Mobile. Neither company has confirmed it, and there is no price. Barron's headline says buying; the other reports we read say talks.
What it did to the thesisNothing moved. We rate SpaceX Unattractive on price and heavy spending. A phone-service purchase would add cost and could need the carriers' consent, but with nothing agreed or priced there is no figure to add to the argument yet.
NetApp says it has completed its purchase of PEAK:AIO, a UK company whose software helps very large AI computer clusters find their files quickly. The deal was announced in late September with no price. The completion release itself could not be read, so no terms or dates beyond the title are known.
What it did to the thesisNothing moved. It strengthens NetApp's AI storage product against private rivals VAST and WEKA, but with no price or revenue given it changes none of our figures. Our case turns on the 1 December results.
Marvell closed at $171.41 on 2 November, down from $272.29 on 2 October, and 12.7% down from 30 October, the day before it agreed to buy Lumentum for stock. At that price it costs about 25.4 times analysts' profit forecast for the year to January 2028, down from 40.3. No new results or filings arrived.
What it did to the thesisWe moved our view from Unattractive to Neutral. The shares were full because they paid for this plan and much of the next year; now the next year comes at a discount. The business has not changed, but forecasts predate the Lumentum deal, so conviction stays Medium.
Marvell closed at $272.29 on 2 October 2026, a market value of $237.55B, against a 52-week range of $70.69 to $329.88. Over 252 trading days the pric…
At $272.29 the shares cost about 40.3 times analysts' FY28 EPS of $6.76 and about 26.0 times FY29's $10.47. Counting this year's rate of stock pay as…
Meta sold $15 billion of bonds in five parts that come due between 2031 and 2056, paying interest of 5.85% to 7.5% a year. It says the money is for general purposes and it may sell more bonds in euros. This follows the $37.5 billion of shares and preferred stock it sold on 26 October.
What it did to the thesisNothing moved. The borrowing confirms Meta is paying for its AI build with outside money, which our caution already reflects. Cash and debt rose by the same amount, so its net cash stays near $1.5 billion. We keep Attractive with Low confidence.
Helios announced the date of its third-quarter results and call; our calendar puts it on 5 November, three days later than the date we assumed. We could read only the headline. It filed nothing else, and other news was awards and a partnership.
What it did to the thesisNothing moved. Our guidance and order claims expired on 2 November waiting for this report, so we pushed their dates to 5 November. The test, whether earnings reach $0.70 to $0.77 and a data centre order arrives, is unchanged. View stays Neutral.
Alphabet closed at $278.04 on 2 November, down from $340.35 on 2 October. Buyers now pay about 22 times its yearly operating profit, down from about 28, and below the 22.5 times we set in October as the price that would make it attractive. No new results or filings arrived.
What it did to the thesisWe moved our view from Neutral to Attractive. The price now pays for the AI spending working as planned and little beyond it. Cash is still below zero and 2027 spending rises, so conviction stays Medium.
The shares closed at $340.35 on October 2, 2026, a market value of $4.13T and enterprise value of $4.19T by the vendor's count; over 252 sessions the…
The vendor puts enterprise value at 28.3 times trailing operating profit against 22.5 for Meta, 25.5 for Microsoft and 30.4 for Amazon, and the trail…
On the vendor's six-year history the trailing P/E has a median of 24.8; free cash flow yield is 1.3% against a median of 3.5%, and return on invested…
At $340.35 the market value is about 34 times trailing operating profit after a 17% tax. To fall to the six-year median P/E of 24.8, operating profit…
CrowdStrike said on 3 November it has signed agreements to buy Dreadnode, which tests AI systems for security weaknesses, and Fiddler AI, which watches what AI agents do. We could read only the start of each announcement. Neither price, closing date nor revenue was in what we could read.
What it did to the thesisNothing moved. We already count a steady run of purchases paid mostly in cash, and we rate CrowdStrike Unattractive on its high stock pay and thin profit. Two more deals add to that spending, but without prices there is nothing to restate; the next filing will give them.
Ciena closed at $284.34 on 2 November, down from $391.34 on 2 October. It filed and reported nothing. Counting its debt, it is now valued at about 55 times a year of operating profit, down from 76, which pays for about 69% of management's 2029 plan rather than almost all of it.
What it did to the thesisOur view stays Neutral. The lower price meets half of the route to Attractive; the other half is order backlog of $10B or more, which is only reported in December. The price now looks fair for the plan, so we scored it Fair rather than Full.
At $391.34 Ciena's company value is about $55.96B, 75.7 times trailing GAAP operating profit and about 26 times the roughly $2.2B of adjusted operati…
TTM's quarterly filing says one customer bought 20% of September-quarter sales and two customers together 27% of the first nine months, under the 30% we had set as a worry line. TTM also spent $100 million buying back 1.16 million shares at about $86 each and approved another $100 million.
What it did to the thesisThe customer worry we set before the filing is met, but the other half of our condition, the new boards reaching about $300 million, only shows in the report due early February. The view stays Neutral. The lower share price did not change the facts.
Two customers were about 26% of net sales in the June quarter and first half of 2026, against one customer at about 12% a year earlier; in 2025 two c…
There were 105,348,864 shares at 31 July 2026; the June-quarter diluted count of 107.6M was 2.6% above a year earlier, first-half stock pay was $37.6…
Telos's board named Mark Griffin chief executive. He joined in 1984 and ran its main security business. Founder John Wood, who ran the company for most of 30 years, becomes executive chairman on the same pay and with no severance. The company says there was no disagreement.
What it did to the thesisNothing in our case moved. It rests on the profit guide, the unwon bids and a subcontract held by another company, none of which this touches. We keep Neutral and watch whether the 9 November results and any new awards fit the new leadership.
Oracle filed on 2 November to sell $10 billion of new shares and $10 billion of bonds. At the 30 October share price that is about 76.5 million new shares, taking the total to about 3,100 million from 3,024 million. Prices were not set yet. Management had said on 28 October it would raise this much more through 2030.
What it did to the thesisThe view holds. This is the planned raise, not a surprise, and it adds about 2.5% to the share count. It does break our rule of no new shares this year, so we re-set that rule above this sale. Neutral and low conviction stay until the 9 December results.
In the year to May 2026 Oracle raised $43B of debt and $5B of mandatory convertible preferred stock. In the August 2026 quarter it sold 141M new shar…
Marvell signed a deal to buy Lumentum, which makes lasers for AI networking. Lumentum holders get 4.5 Marvell shares each, and would own about a third of the combined company. It should close in the first half of 2028 if shareholders and regulators agree. Marvell also said its September-quarter revenue is on its guide.
What it did to the thesisMarvell's cash, debt and growth plan are unchanged, because it pays in shares. The cost is dilution and a big integration. Its price is nearer our Neutral line but has not reached it. View stays Unattractive.
Reuters reported that Alphabet began selling about 6 billion euros of bonds, roughly $7 billion, in Europe to help pay for its building of AI data centres. Alphabet already owed $125.1 billion at the end of September. We could not read the terms, because the filing was not out and the news sites block us.
What it did to the thesisNothing moved. It is more borrowing on top of a plan we already expected, which keeps cash tight while spending runs near $200 billion this year. It does not change the cloud or search case. Neutral and Medium hold; the next test is the February results.
GEO said it has a contract for its Big Spring complex in Texas with 2,329 beds. We could read only the headline: the customer, the length and the money are not known. GEO's annual report lists two idle Texas prisons it owns, Big Spring and Flightline, with 2,376 beds between them, which may be what is now being filled.
What it did to the thesisNothing moved yet. If idle beds are being put to work it helps the cost of empty beds, but without the customer, term or fee we cannot say how much. The 5 November results should give the terms.
Flowco's board raised its share buyback limit from $50 million to $200 million. It has spent about $31.5 million of the old limit so far. The company is not required to buy anything and can stop at any time. It also declared its usual $0.09 quarterly dividend. Quarterly results are due on 4 November.
What it did to the thesisNothing moved. A buyback would help our worry about a steady flow of new shares, but nothing says how much will be bought or how it is paid for. Flowco borrowed $113 million in October for an acquisition, so the 4 November results are where we check.
Baker Hughes said on 2 November it has closed the sale of Waygate Technologies to Hexagon. Its quarterly filing of 28 October said the all-cash price was about $1.45 billion before closing adjustments, with the sale due in the fourth quarter. We could read only the headline of the closing release, so the final cash is not confirmed.
What it did to the thesisNothing moved. The sale closing in the quarter the filing gave was already in our case as a way to pay down the Chart debt. We keep Neutral until the final cash and the next results show the debt coming down.
In April PayPal reorganized into three businesses: checkout, Venmo and consumer finance, and payment processing with crypto. Each got a new leader, and two senior managers left. Its latest quarterly report still gives one set of figures for the whole company.
What it did to the thesisNothing in the view moved. Our case already noted that no filing splits checkout from Venmo; the new structure does not change that until PayPal reports the three separately.
We checked a review of Nebius against the company's own filings. They confirm that Microsoft's capacity has all been delivered, in eleven blocks rather than nine. Most of the first quarter's profit was a paper gain on a stake. Nebius has $12 billion of leases signed that have not started. Q3 results come on 12 November.
What it did to the thesisThe view and conviction did not move. One way to be wrong, Microsoft cancelling late capacity, has mostly gone. The unstarted leases add to what the build has to fund, which the funding test already watches.
The four Q2 2026 deals averaged more than $1B each at $20M to $25M a year per megawatt, against about $12M in 2026's base, with prepayments covering…
Microsoft committed to pay up to $17.39B through 2031, about $6.96B upfront, but may cancel any GPU service Nebius delivers late beyond a grace perio…
Its 2025 annual report disclosed two material weaknesses in internal control, over fixed assets and over TripleTen revenue, after an adverse 2024 opi…
In November 2025 MP, the US Department of War and Saudi miner Maaden agreed to build a rare-earth refinery in Saudi Arabia. Maaden owns at least half; MP and the department share the rest, and the department pays the US side's cost. MP brings its know-how. Its annual and latest quarterly reports never mention the project.
What it did to the thesisNothing in the view moved. It costs MP little and could add refining abroad, but no size, date or profit share is given, and the company's own filings leave it out, so it adds no number to the case.
In October 2025 CoreWeave tried to buy Core Scientific, which owns data centers CoreWeave rents, paying in its own shares. Core Scientific's shareholders voted no, so the deal ended. The two said they would keep working together. CoreWeave's later annual and quarterly reports do not name Core Scientific.
What it did to the thesisNothing in the view moved. CoreWeave still rents much of its capacity rather than owning it, which the case already counts as a cost. The failed deal confirms that rather than changing it.
Vistra said it finished buying Cogentrix Energy, ten natural gas power plants totalling about 5,500 megawatts, from funds run by Quantum Capital. All regulatory approvals were in. Vistra's fleet is now nearly 50,000 megawatts.
What it did to the thesisThe deal closed inside the window we expected, so one risk on our list is gone. Our 2027 profit range excludes these plants, so nothing else moved. We keep Neutral until the early-November results.
Vistra agreed to acquire Cogentrix Energy (10 gas facilities, about 5,500 MW across PJM, ISO-NE and one ERCOT cogeneration facility) for approximatel…
T1 says it signed new contracts to supply more than 1.58 gigawatts of solar modules in 2027 and 2028, with subsidiaries of Avantus among the buyers. It says over 4 gigawatts of its 2027 capacity is now under contract. We read only a summary of the release; prices were not disclosed.
What it did to the thesisNothing moved. Another buyer besides Trina is a step toward our test of third-party sales, but no price, payment or tax-credit sale is given, and the cell plant still needs financing. We keep Unattractive and Medium confidence.
Reports say US agencies watched a Singapore cloud executive, whose firm is accused of selling Nvidia chips to China, over concerns she gathered information from CEO Jensen Huang. Nvidia says its customer contacts are routine. Separately, The Information says Nvidia is talking about credit support for Nscale's deal with Anthropic.
What it did to the thesisNothing moved. Our outlook already assumes no China data-centre sales, and the credit-support talks are unconfirmed; we already track Nvidia's guarantees. We keep Attractive and Medium confidence and test both on the 17 November results.
Microsoft filed papers to sell ten series of bonds. The amounts are blank in the filing; news reports say about $25 billion. It says the money is for general purposes, including building data centers and buying back shares. Its debt was $35.5 billion at 30 September.
What it did to the thesisNothing moved yet. It shows the AI build is large enough that Microsoft borrows on top of its cash flow, which our free cash flow test watches. The size and use of the money are unconfirmed until the bonds are priced.
Headlines from CNBC and Reuters say the credit rating firm S&P Global changed its outlook on Meta to negative, over cash flow and spending on AI. We could not open either article, so we do not know the rating or what S&P would need to see.
What it did to the thesisNothing moved. Cash flow and spending are already the heart of our caution, and our scores for funding already reflect them. We keep Attractive with Low confidence and will read S&P's actual words when we can.
GEO said it has a new contract to manage its 1,635-bed immigration detention centre in Tacoma, Washington. We could read only the headline: the length, the price and whether ICE guarantees any minimum number of detainees are not confirmed. The shares rose about 3.5% the next session.
What it did to the thesisNothing moved. Keeping a contract that was due to lapse on 27 October fits our view and removes one renewal risk, but without terms it adds no evidence on the November test.
Rivian said in its 29 October results presentation that it expects to hit the next milestone in its robotaxi deal with Uber by the end of the year. Hitting it would unlock another $250 million of Uber's investment in Rivian, to fund Rivian's self-driving work.
What it did to the thesisNothing moved. It shows Uber is still paying into a driverless partner as planned, which our file already counts as part of its answer to driverless rivals. It adds no trips or bookings, so the 3 November results remain the test. The view stays Attractive.
Centrus said on 29 October that its Tennessee factory finished its first new uranium centrifuge and is shipping it to Ohio for final assembly, and that its supply chain is in place. It beat the year-end target the company set earlier. The first new capacity in Ohio is still expected in 2029. The release gives no cost, size or machine count for the plant.
What it did to the thesisNothing moved. It is real progress on building the machines, which our case already assumed, and the 2029 date is unchanged. Our view turns on the plant's cost and size, which Centrus still has not given, so those stay the test for the 4 November results.
On 29 October EQT's chief executive told CNBC the Range Resources purchase will save over $625 million a year, about half from cutting overhead and half from better pipes and demand capture. He said Appalachian gas demand is now over 25 billion cubic feet a day, up from 20, across a range of odds.
What it did to the thesisNothing moved. The saving matches the figures already in our file, and the demand number is the company's own estimate. Our view turns on falling debt and an earlier pipeline date, which this interview does not touch. The view stays Neutral.
At an investor day on 28 October, Oracle set a fiscal 2030 target of $225 billion or more in revenue. It said cash flow after spending turns positive in the second half of fiscal 2028 and reaches $30 billion or more in fiscal 2029. It will raise no more than $20 billion of new money through fiscal 2030, half in shares.
What it did to the thesisOur Neutral view held. The dated cash plan answers a worry we had listed, but it is a promise: no new named buyer was announced and spending keeps rising until then. The 9 December results are the next test.
The chief financial officer gives no date for positive free cash flow, but says each project, once ramped, converts close to 100% of after-tax operat…
CNBC reports the US Justice Department has asked Nvidia how buying Hugging Face, a popular site for sharing AI models, could affect competitors. The deal costs about $12.9 billion and is due to close in the first half of 2027. It is a request for information, not a lawsuit.
What it did to the thesisNothing moved. The purchase is a side bet beside our case, which waits on the 17 November results. A longer review could push the closing past mid-2027, which we will watch.
ACM Research said ahead of its 5 November report that third-quarter sales will be $360 to $365 million, up 34% to 36% on a year ago and about a quarter above the second quarter. Orders shipped to customers will be $335 to $340 million, up 27% to 29%. It gave no split by product.
What it did to the thesisNothing moved yet. Sales are strong, but our test is whether the core cleaning business grows again and whether a new product wins a first production order. Neither is in this notice, so we wait for 5 November.
Vertiv said it completed its purchases of King Environmental Services and UtilityInnovation Group, both expected to close this quarter. We could not cite a price or sales figure for either.
What it did to the thesisNothing moved. The deals were already in our write-up as expected to close, and no figure we hold changed. The 28 October results are the test, and we will fold the closings into that review. View stays Neutral.
At its Oracle AI World event Oracle said it will build OpenAI's ChatGPT and Codex into its business software, offer Google's AI chips on its cloud from next year, and expand its Nvidia Vera Rubin capacity to multi-gigawatt scale. None of the announcements gave a contract value, customer count or date for revenue.
What it did to the thesisNothing moved. These are products and supply choices that spread Oracle's chip risk, but our case rests on the $664 billion backlog, mostly OpenAI, and on spending. The 9 December results test both.
Meta priced its new share sales late on 26 October. The ordinary shares were raised from $22.5 billion to $25 billion, sold at $625 each. The preferred shares pay 6.5% a year and turn into ordinary shares in 2029. Press reports say Nvidia will buy $3 billion of the offering; Meta's filings do not name buyers.
What it did to the thesisThis confirms the funding plan we scored yesterday and makes it about $2.5 billion bigger, roughly 0.1% of Meta's value. Nothing moved: we keep Attractive and Low confidence, and the scores for funding and dilution stay where they were.
On 26 October 2026 Meta launched about $35 billion of underwritten offerings: 250,000,000 depositary shares (about $12.5 billion at a $50 liquidation…
IonQ said the Air Force Research Laboratory awarded it $7.5 million of follow-on funding for quantum networking work. We saw the headline only, so the term and when the money counts as sales are unknown.
What it did to the thesisNothing moved. It is small against IonQ's spending and share pay, and fits the government demand we already describe. The 4 November results are the test. View stays Unattractive.
Intel announced it will buy Classiq, an Israeli quantum software company, to offer both the hardware and software for quantum computers. Intel gave no price; Bloomberg reports about $2.3B, and Israeli press says part is paid in shares. The deal needs regulatory approval and is expected to close in the first half of 2027.
What it did to the thesisAlmost nothing moved. Our case turns on chip prices, outside customers for Intel's factories and the share count. At $2.3B the deal is small beside Intel's cash, and we cannot yet say if shares are used. The view stays Unattractive.
Guidewire will buy hyperexponential, a London company selling AI software that helps commercial insurers price and underwrite risk, for $1.7 billion in cash plus up to $400 million if sales targets are met. It is already a Guidewire partner.
What it did to the thesisNothing in our argument moved yet. This is the company's first large purchase after years of small ones and no price, closing date or sales figure is out. Our next test is still the December results; we will read the deal terms then. View stays Neutral.
Oracle said at its AI World event that Google's own AI chips, called TPUs, will be rented through Oracle's cloud, starting next year and growing over several years. Reuters reported it; no amount of chips, price or customer was named, and Google's own announcement was not found.
What it did to the thesisNothing moved yet. It points to Google selling its chips beyond its own data centres, which our case already notes, but gives no revenue. Tomorrow's results carry the real test.
EnerSys will offer $16.00 a share in cash for Ultralife, a maker of batteries for military radios, drones and munitions, valuing it at about $320 million. Ultralife sold $191 million in its 2025 fiscal year. EnerSys expects $15-20 million of yearly savings and to pay from cash it holds. Closing is expected in early 2027.
What it did to the thesisNothing moved. It adds to the defence side we already follow and spends cash that also funds the lithium plant and buybacks. EnerSys says profit per share only gains after about 18 months. Our test is still the 4 November results.
Constellation announced a conditional loan commitment of up to $5 billion from the US Department of Energy to expand nuclear output. One summary says the money would raise output at existing plants. We could not read the announcement itself, so the interest cost, the plants and the conditions are unknown. Nothing has been borrowed yet.
What it did to the thesisNothing moved yet. Cheaper money could help growth without straining the balance sheet, which our case watches. Until we can read the terms and see what is actually borrowed, the view stays where it was.
AMD said its first Helios racks, full server racks for AI, are installed at Meta and being tested, and that Meta uses AMD chips in its AI agent and in production. It also said AMD will put $1B into Meta's share offering. It gave no Helios revenue or shipment dates.
What it did to the thesisSmall change. The $1B adds to the money AMD already puts behind its own customers, which our case counts as a cost to shareholders. Racks in testing are not yet sales. The view stays Neutral until the 3 November results show Helios revenue.
AMD is now paying toward part of its own demand: up to $5B of equity in Anthropic, up to $4.1B of lease guarantees, credit support for TensorWave's l…
Tempus told the SEC it will earn $137.5 million from Bristol Myers Squibb over about five years for cancer data, and up to $55 million from Pathos AI, a company its own chief executive helps run, for brain-disease records. Separately, Tempus said a European regulator certified one of its tumour RNA tests; we could not read that announcement.
What it did to the thesisNothing moved. The deals add contracted data revenue, but about $38 million a year is small against what the price needs, and the Pathos part adds to the related-party share we watch. The 2 November results will show how much it matters.
Elon Musk said on X on 25 October that SpaceX has secured $40 billion of debt to buy the graphics chips that train AI models. He gave no lender, interest rate or repayment date, and we found no filing. We read a Business Insider copy, as CNBC and Reuters block our reader.
What it did to the thesisNothing moved. We already rate SpaceX Unattractive partly because it spends far more than it earns. $40 billion of new borrowing against $39.4 billion of existing debt and leases adds to that. Without terms we cannot size it; the filing will tell.
Soluna said it repaid the last of a $28.7 million loan from Generate Capital: $19.1 million in August and the rest in October. The loan is closed and the lender's claim on the company's sites is released. Total debt falls from $37.9 million, counted at 30 June, to $9.2 million.
What it did to the thesisThe view stays Unattractive. The lender test we feared is gone, but the repayment used cash, and the real problems remain: no signed AI lease, constant share sales, and preferred holders ahead of ordinary shareholders.
Management concluded it will probably fail its lender's forward test, which counts only contracted revenue, within a year; waiving June's test cost a…
At 30 June 2026 the company held $113.4M of cash and $17.9M restricted, owed $37.9M of loan principal, and carried a $19.3M liability to Hewlett Pack…
EQT, another big Appalachian gas producer, agreed to buy Range. Each Range share turns into 0.987 EQT shares, with no cash. Range's owners would hold about 27% of the combined company. Both companies' shareholders must vote yes and regulators must clear it; the deal is due to finish by 25 October 2027.
What it did to the thesisOur view stays neutral. Until the deal closes, Range's price will follow EQT's rather than Range's own gas contracts. We also rate EQT neutral, so the two views agree. The market had not yet priced the news when we wrote this.
RadNet will buy ONRAD, which supplies remote radiologists to over 225 hospital sites. Owners get $350M in cash and 5M RadNet shares, plus up to $210M more if ONRAD hits a 2027 profit target. RadNet says it should add $190M to $200M of sales and $60M to $65M of profit in its first year. The deal should close in early 2027.
What it did to the thesisNothing moved yet. On RadNet's own numbers it is cheap next to its own price, but the profit is unchecked, new shares dilute owners, and it adds a business outside our case. The view stays Unattractive until filed figures and the call show the profit is real.
Microsoft told staff on 26 October that about 60,000 employees, over a quarter of the company, can choose to leave with severance-style pay. Sales, data-center and some engineering teams are left out. People have until early December to decide, and no second offer is planned.
What it did to the thesisNothing moved. It is a cost-saving step, not a change in demand for Azure or in the backlog our case turns on. We will see how many accept, and what it costs, in later results. View stays Neutral; results on 28 October are the test.
On 26 October Meta launched about $35 billion of share offerings: $22.5 billion of common stock and about $12.5 billion of preferred stock that turns into common shares in 2029. It also plans a further $60 billion of gradual stock sales from 2027, about $95 billion in all, to help pay for its AI data centres. Meta still holds about $82 billion of cash.
What it did to the thesisMeta said on 22 October it had no financing plan; now it does. New shares mean each existing holder owns a smaller slice. Funding strength and protection from dilution each fall one level. We keep Attractive and Low confidence, since the shares are cheaper than when we wrote the case.
Meta's board approved on 19 October 2026 a new class of non-voting Class C common stock, effective 19 January 2027, with a one-for-one stock dividend…
Fabrinet closed at $314.94 on 23 October, down from $463.69 on 2 October. Other optical makers fell too, and the company filed nothing new. The whole company is now worth 22.5 times last year's operating profit, down from 34 times.
What it did to the thesisThe price now needs about 14% growth a year to 2029, not 31%, so we call it fairly priced rather than full. The view stays Neutral: becoming attractive also needs its AI module sales to grow again, which the 2 November results will show.
At $463.69 Fabrinet is worth about $16.6B on 35,834,864 shares and, net of $875.1M of cash, about $15.7B as a company: 34.0 times fiscal 2026 operati…
Carried three years at 10% and divided by 20, today's company value needs about $1.05B of fiscal 2029 operating income, about $10.5B of revenue at a…
EQT agreed to buy Range Resources, another large Appalachian gas producer. It pays 0.987 EQT shares for each Range share, no cash, so Range's owners would hold about 27% of the combined company. Both sets of shareholders must vote yes and regulators must clear it. The two companies expect $325 million a year in savings.
What it did to the thesisOur view stays neutral. The deal adds scale and a vote to pass, but our case turns on pipelines, export deals and falling debt, which it does not answer. The savings figure is the companies' own estimate. Results on 27 October still carry the test.
Everus closed at $94.91 on 23 October, down from $126.17 on 5 October. The company filed nothing and reported nothing. Counting the debt taken on for its Epsilon purchase, it is now valued at about 11.8 times the profit management expects this year, down from 15.4.
What it did to the thesisWe moved our view from Neutral to Attractive. We called the shares fair only because they paid for a peak profit margin; at this price even management's normal margin is paid for. The business has not changed, and the 3 November results test whether the margin holds.
The shares closed at $106.00 on 21 October 2026, a market value of $5.41B, 38.2% below the May high of $171.58 and 16.0% below the $126.17 of 5 Octob…
At $106.00, adding the $295M paid for Epsilon to June's net debt, enterprise value is about $5.83B: about 13.1 times guided 2026 EBITDA of $417.5M pl…
Four financial firms said they will fund a $63 billion vehicle that buys Broadcom's AI chips and networking and leases them to Anthropic, with deliveries starting in 2027. Broadcom will give residual value support equal to the senior loan, meaning it stands behind the equipment's resale value. The size of that senior loan was not given.
What it did to the thesisGood for demand, since the chips get paid for. But Broadcom again stands behind its customer, so its exposure to Anthropic's ability to pay grows by an amount not yet disclosed. View and confidence stay; the December report should show the terms.
In June 2026 Broadcom launched the AI XPV platform with an initial $35 billion tranche led by Apollo with Blackstone and global banks, to fund more t…
Broadcom's largest planned customer for 2027 is a company whose rent Broadcom guarantees and may fund: the backstop covers 85% of Anthropic's outstan…
On 23 October Amazon chief executive Andy Jassy said capacity for AWS, its cloud business, is largely sold out for 2027, with a good chunk of 2028 also spoken for, and gave no dollar amount. On 26 October Verizon said in its results release that it signed a deal worth over $2 billion with AWS for AI computing, without giving terms or length.
What it did to the thesisNothing moved. Both match what we already hold: a $496 billion order backlog and management saying it lacks capacity. The Verizon deal is about 0.4% of that backlog. Our test is the 29 October results: cloud growth, backlog and cash flow.
Applied Materials agreed to buy more shares of Besi, a Dutch maker of machines that bond chips together, so it owns about 20%. It first bought in April 2025. It says it will not go higher or seek a board seat. The price was not disclosed, and the deal waits on a US antitrust waiting period.
What it did to the thesisNothing moved. It is a sign Applied wants a strong position in chip packaging, which fits our case, but without a price we cannot weigh it against its cash. The view stays Neutral; the November results remain the next test.
Applied Optoelectronics closed at $67.51 on 23 October, down from $99.26 on 30 September. Other optical makers fell 22% to 32% over the same weeks, and the company filed nothing new. Counting the shares it sold in August and all the cash raised, the company is worth at least 8.7 times its last year of sales.
What it did to the thesisOur view stays Unattractive. The price we said would make us reconsider, 8 times sales, was flagged as reached only because of a dating slip in our own figures; correctly dated it is not reached. The price now needs about $2 billion of sales instead of $3.1 billion.
At $99.26 on 30 September 2026 the market value is about $8.39B on 84.57M shares; adding $92.8M of bank debt and $125M of convertibles and taking off…
For a 6% after-tax yield at 21% tax, the $8.10B enterprise value needs about $615M of operating profit. At a 20% operating margin that is about $3.1B…
The shares fell from $29.10 on 6 November 2025, after a third-quarter print 9.8% below the revenue estimate, to $19.49 on 20 November; rose 56.9% the…
NVE's shares closed at $68.36 on 22 October, down 33.7% from $103.07 the day before, the first session after September's sales fell 47% to $5.8M. At that price the shares cost 18.5 times the last year's profit, near the 20.6 times they have usually cost over six years. Four law firms announced investigations, which are not company news.
What it did to the thesisWe moved our view from Unattractive to Neutral. We called the shares full because they counted on June's sales returning; at the lower price they do not. The business has not changed, and December's sales still decide whether September was a pause.
The shares closed at $102.05 on 20 October 2026, the session before the results, down 12.4% from $116.53 on 6 October.
At $102.05 the shares are worth about $494M, about $450M net of cash and securities. That is 27.7 times trailing earnings against a six-year median o…
Forgent closed at $24.92 on 22 October, down 21.5% on six times the usual trading. The shares opened 14% lower minutes after the company said its finance chief was leaving, seven months after listing and without severance. That afternoon it added that he left over no disagreement and said its quarter beat its forecast, and the shares recovered part of the fall.
What it did to the thesisWe moved our view from Neutral to Attractive: the price now pays for the year already ordered. Confidence stays Medium because the finance chief's exit raises a question about the accounts; a restatement or a control weakness in the 12 November report would make it Unattractive.
At $40.35 the company value is about $12.78B, about 21.3 times the $600M midpoint of FY27 adjusted EBITDA guidance and the shares about 30 times the…
The shares closed at $40.35 on 2 October 2026, 38.9% below the $66.00 high. From the 22 June close of $61.84 they fell 54% to $28.64 on 14 September,…
If FY28 sales reach consensus at FY27's guided margin, today's company value is about 15.7 times FY28 profit before interest, tax and depreciation; a…
The shares closed at $24.92 on 22 October 2026, 62.2% below the $66.00 high and 13.0% under the $28.64 low of 14 September. They rose about 41% after…
A filing shows Teradyne, which makes chip-testing machines, will buy 2,234,887 new FormFactor shares for about $300 million, expected to close in the fourth quarter. The partnership release names no customers, revenue or products. FormFactor also announced its Texas plant opened; that release could not be read.
What it did to the thesisNothing moved yet. The cash would about double what FormFactor held in June and adds about 2.8% to the share count, but it has not closed and the partnership has no stated revenue. The view stays Unattractive; the 4 November results are the test.
FICO said it is holding its mortgage credit score fee at $10 for lenders enrolled in its preferred program, in answer to cheaper rivals. We could read only the headlines. How long the $10 lasts, who qualifies and whether lenders must promise volume are unknown.
What it did to the thesisNothing moved. We already assume about $10 for 2027, so a hold adds no new fact until we see the period and the terms. The 4 November results and fiscal 2027 guidance are the test of the fee and of volume.
EQT said its third-quarter results come after the close on 27 October, with the call on 28 October, a week later than we had pencilled in. It raised its quarterly dividend 3% to $0.17 a share and set up a $3.5 billion short-term borrowing programme, none of it used yet.
What it did to the thesisNothing moved in the argument. Only the test date changed: the same questions on the Southgate pipeline, export deals and falling debt are now answered on 27 to 28 October. The dividend rise is small beside the debt paydown we are watching.
Filings show the chief executive bought 55,803 shares at $18.04 and the president bought 300,000 at about $18.86 on 16 October, with their own money and no pre-set plan. Until then nobody inside had bought in over a year, while 20 sales were made.
What it did to the thesisOur note that no insider bought is now out of date and was corrected. The buying is small next to the stock they own and says nothing about rent or debt, so the view stays Neutral and confidence stays Medium.
Insiders made no open-market purchases in the last year and twenty open-market sales; nineteen of the twenty, and 98.8% of the shares sold, were disc…
ACM Research's shares closed at 49.12 on 22 October, 32.5% below where we last measured them, and its larger rivals Lam Research and Applied Materials were marked down too. No new filing explains it. ACM also said it will report third-quarter results on 5 November, not 4 November.
What it did to the thesisThe business evidence did not move, but the price notes did. ACM now trades level with its own past instead of well above it, and still cheap against Lam and Applied. We keep Neutral: cash still lags profit.
ACM trades at a TTM P/E of 32.25x and EV/EBITDA of 14.83x, both above their prior-three-fiscal-year medians of 20.99x and 10.83x; TTM ROIC is 4% vers…
Against the two listed, filing-confirmed competitors (Lam Research, Applied Materials), ACM trades at a discount on every cohort multiple - EV/EBIT 2…
At today's price, ACM's 29.1x EV/EBIT prices in continued high-20s/low-30s percent revenue growth and a narrowing (not full closing) of its discount…
T1 announced that the Commerce Department gave it a waiver tied to the new polysilicon tariffs. We could not read the release, so we do not know what it covers or for how long. Separately, T1 filed that it will pay $30 million of its patent price in 9,962,645 new shares, about $3.01 each.
What it did to the thesisNothing moved. We cannot judge the waiver without its terms, and it does not touch the funding or credit-sale tests due 13 November. The share payment was already in our funding stress case; it adds to the pile of new shares.
Nebius signed a $3.5 billion loan with Citi, due 16 October 2027. It costs a floating rate plus 2.75 percentage points, rising to 3.5 over nine months, and is backed by nearly all of the company's assets. The money pays for data centers and chips. Nebius says it keeps its options open for longer-term financing.
What it did to the thesisNothing in the view moved. Our case needs the build funded without heavy new shares; this is debt, so that holds for now. But it is short, dearer than July's loan and has to be replaced within a year, so funding stays the thing to watch.
Merck and Moderna gave the full results of a large trial of intismeran, a cancer shot made for each patient, added to Keytruda after melanoma surgery. After about two years, it cut the risk of the cancer returning or death by 42% against Keytruda alone. Survival data is not mature yet. They are talking to regulators and will present at the ESMO cancer congress.
What it did to the thesisThe case holds. We already counted this trial as a win. The numbers make it firmer and the talks with regulators fit our filing-by-2027 check, but no filing exists, survival is unproven, and the price already pays for new medicines working. Neutral stays.
On 19 August 2026 Merck and Moderna said intismeran, a personalised mRNA cancer treatment, added to Keytruda cut melanoma recurrence at a planned int…
Forgent's chief financial officer, Ryan Fiedler, stepped down on 21 October; Amy Ard, who has run its finance team since January, replaces him, and a filing says it was no disagreement over accounting. Later that day Forgent said its September-quarter sales and adjusted earnings will beat the top of its forecast ($465M and $100M), with no exact figures. Results come 12 November.
What it did to the thesisOur view held. A stated beat with no figures does not tell us the size or the margin, and the case rests on orders, prices and capacity. The 12 November report shows how big the beat is and whether the full-year forecast moves.
Gary Niederpruem has been chief executive since May 2025 after six years at Vertiv, where he helped lead its carve-out and listing; Ryan Fiedler, chi…
Forgent guides FY27 revenue of $2.4B to $2.6B, up about 76% at the midpoint, adjusted EBITDA of $575M to $625M (about 24%) and adjusted EPS of $1.26…
Gary Niederpruem has been chief executive since May 2025 after six years at Vertiv, where he helped lead its carve-out and listing. Ryan Fiedler, chi…
Affirm says it launched as the exclusive pay-over-time provider at Sam's Club, the warehouse chain. We could read only the headline, so how long the deal runs, how much it may bring in and whether it covers stores or online are unknown.
What it did to the thesisNothing moved. A large new merchant could widen Affirm's base beyond its biggest partner, but no volume or terms were readable. The 5 November results are the next test of whether returns per loan hold.
Adeia says it signed a multi-year renewal of its patent licence with TCL, a television maker. We could read only the headline. The length of the deal, which patents it covers and what TCL pays were not readable.
What it did to the thesisNothing moved. A renewal fits management's claim that most customers renew, but without the terms we cannot tell whether payments rose or fell. The 2 November results are the next test.
Soluna agreed to form a joint company with Applied Digital, which would own 51% and provide the money, to develop a 50 MW AI data centre on Soluna's Texas site. A company Applied owns signed a non-binding letter of intent to rent it. Closing depends on a local tax abatement and final contracts.
What it did to the thesisA partner funding the build is the kind of deal our case wanted, but there is no signed lease, no money or rent stated, and the tenant is owned by the partner. The shares are down 46% to $0.577. The view stays Unattractive.
No AI lease is signed. For Kati 2 the company has a letter of intent, with exclusivity, with an unnamed tenant, and its 10-Q says it cannot assure a…
Applied Digital, which Soluna's 10-K names as a rival, had signed leases for about 1,410 MW of AI load worth about $36.2B over 15-year terms at 31 Ma…
At $1.06 on 246.7 million shares the common is worth about $262M, behind a $158.1M preferred claim and $37.9M of loan principal, against $113.4M of J…
Kati 2's first 100 MW at a rival's $11M to $13M a megawatt costs $1.1B to $1.3B; with 80% project debt the equity is $220M to $260M, more than June's…
CNBC reports that OpenAI will sell its models on Google's cloud, widening where business customers can buy them beyond Microsoft's Azure. Copies of the story say customers can pay through Google's marketplace. CNBC itself could not be read here, and no figures were given.
What it did to the thesisNothing moved. Microsoft agreed in April that OpenAI could sell through any cloud, so this is that deal in use. What matters is whether OpenAI shifts its Azure spending, which Microsoft would report on 28 October. View stays Neutral.
IREN announced a 300 megawatt campus in Spain aimed at European governments' own AI needs. We could not open the announcement itself. IREN's website shows the site, Badajoz, as planned for 2028 or later, with no customer, cost or start of power given.
What it did to the thesisNothing moved. The Spanish site was already counted in the roughly 5 gigawatts of power IREN holds. Without a customer or a cost, it adds no new evidence. The 5 November results remain the next test.
Reuters and CNBC report that OpenAI will sell its top models on Google Cloud. Outlets that copied the story say business customers can buy them through Google's marketplace using money they already committed to Google Cloud, with the newest models due in weeks. No sales, prices or terms were given.
What it did to the thesisNothing moved yet. It gives Google Cloud another product to sell, but Google already says it cannot supply enough capacity, so extra demand may not lift growth soon. The 28 October report is the test. View stays Neutral.
On 20 October Super Micro said that, before audit, its September quarter sales were $18.5 billion to $19.5 billion, against a forecast of $14.5 billion to $15.5 billion. It put its profit margin on sales at 12.0% to 12.5%, against a forecast of 10.4% to 10.8%. Full results come on 3 November.
What it did to the thesisThe margin and sales parts of our case look better, but nothing moved the view. The case turns on whether growth is paid for from cash it earns, and the release says nothing on cash, stock on hand or funding. View stays Neutral.
Q1 fiscal 2027 gross margin is guided to 10.4%-10.8%.
Fiscal 2027 revenue is guided to $65.0B-$72.0B, and Q1 to $14.5B-$15.5B with GAAP diluted earnings of $0.89-$0.98 on 745 million diluted shares.
At its 16 October annual meeting Soluna's shareholders voted to raise the most shares it may have from 375 million to 1 billion, and to let an equity line (a deal to sell new shares to an investor over time) sell 20% or more of the current shares. The change took effect that day. Dan Golding was elected a director.
What it did to the thesisOur case already expected Soluna to keep funding itself by selling shares, so the view did not move. The vote removes the cap on how many it can sell; it does not mean it will. We now watch how many are sold in the September quarter.
The 16 October 2026 meeting asks holders to raise authorised common shares from 375 million to 1 billion, and to allow the $250M equity line to issue…
Marqeta said Block's Square will run its business credit card, backed by the American Express network, on Marqeta, joining its debit and prepaid cards there. Marqeta also announced a stablecoin-backed card tie-up with Coinbase. Neither announcement gave volumes, revenue or terms, and only the opening of the Block release could be read.
What it did to the thesisNothing moved. Block is already Marqeta's largest customer, and Cash App's new cards are leaving. Square's credit card staying shows some Block volume remains, but without volume figures it cannot change our growth view. The 3 November results are the test.
Salesforce signed a deal to buy Braze, which sells software for messaging customers in real time, for about $5.66 billion in cash ($47.50 a share). It expects to close in its fiscal 2028, pending Braze shareholder and regulator approval. Salesforce says this year's outlook is unchanged and it has not yet given next year's.
What it did to the thesisNothing moved yet. Our case already names Salesforce's habit of buying growth with cash and borrowed money. This is another purchase of that kind, but it closes next year, so it changes no figure or test until then.
TTM will pay about $650 million in cash for Ophir Optics, which MKS currently owns. It makes infrared cameras' lenses and laser optics for defence, security and industry. TTM expects to fund it from cash, future cash flow and its credit line, and to close in the second quarter of 2027. No sales or profit figures were given.
What it did to the thesisNothing in our case moved yet. It adds more debt to a company already borrowing for Epiq, and a third defence-related purchase, but closes only in 2027 and gives no figures. The leverage test and September-quarter print are still what decide.
MKS will sell Ophir Optics, which makes lenses for infrared cameras and laser optics for defence, security and industry, to TTM for $650 million in cash. MKS keeps its laser measurement business and the Ophir brand. The sale should close in the second quarter of 2027. MKS gave no sales or profit figures for what it is selling.
What it did to the thesisNothing moved. The business sits in the smallest of MKS's three markets, outside chip equipment, which is what our case is about. The cash helps pay down debt in 2027, but no sales figure is given, so we cannot yet size the effect on guidance.
Lilly said its Omvoh injection met the main goal of a one-year trial in children aged 6 to 17 with ulcerative colitis: 50% of those who responded early were in remission at week 52. Lilly plans to ask regulators for a wider label. Separately, Reuters reported a deal worth up to $1.1 billion with Metis TechBio; we could read only the headline.
What it did to the thesisNothing moved. Omvoh is part of immunology, about 6% of sales, so a children's label adds little to our case, which turns on volume against price and the 29 October results. The Metis terms are unknown.
Centrus bought Westerman Holdings on 16 October for about $116 million: $95 million in cash and $21 million in new shares. Westerman builds casings and other parts for Centrus's uranium centrifuges and also sells equipment to oil and gas customers. Centrus says it will lower project costs. It gave no figures for Westerman's sales or profit, and none for the cost of its planned plant.
What it did to the thesisNothing moved. Owning a parts supplier may help the plant get built, but our case turns on the plant's cost and size, which Centrus has still not disclosed. The cash is small beside what it holds; the new shares make each existing holder's slice slightly smaller.
On 13 October K&S's pay committee said that for fiscal 2027 bonuses will pay half on operating profit and half on gross margin, instead of net income and operating margin. Executives will also get 15% of their award from personal goals.
What it did to the thesisA small update to our note on how the new chief executive is paid. Nothing in the plan pays for growth or cash, which is the point we already made. The case and the view are unchanged.
The new chief executive's annual bonus targets 110% of a $750,000 salary, paid between 0% and 200% on corporate results whose metrics the compensatio…
IES's official filing on the DBM purchase shows a price of about $691 million: $545 million in cash and 430,974 IES shares. The cash came from IES's own money and a credit line enlarged to $700 million. A separate filing shows IES's largest owner, Tontine, still holds about 52% and has not traded in 60 days.
What it did to the thesisNothing moved. We had counted the deal at $685 million; the difference is only the shares' value on the day before closing. DBM still costs about 7.5 times its yearly profit. IES's shares are about 22% lower than when we wrote, which changes the price paid, not the business.
IES agreed on 10 August 2026 to buy DBM Global for about $685M, $545M in cash and $140M in shares, and both companies announced on 5 October 2026 tha…
GEO announced it finished repaying every one of its senior secured notes due 2029. In an October filing it had said it would repay $650 million of 8.625% notes on 15 October using money from selling its Adelanto facilities. We could read only the headline of the new announcement.
What it did to the thesisNothing moved. This is the step our notes already expected, and it fits the first part of the November test, which asks whether the sale money went to debt. The interest saved will show in the 5 November results.
DayOne Data Centers, which GDS partly owns, filed public listing documents on October 5. They show sales of $512 million in the first half of 2026, up from $152 million a year earlier, a half-year loss of $77 million, 666 megawatts being billed, and GDS owning 19.4%. The price and size of the offering are left blank.
What it did to the thesisNothing moved in our view. The filing shows DayOne is growing fast and still losing money, as we already had it, and gives no listing price, which is what the value of GDS's stake waits for. GDS's own shares fell about 16%.
Expand's board named Danny Brown chief executive on 19 October, to start about 26 October. He ran Chord Energy and spent two decades at Anadarko. The firing was in February, so the search took about eight and a half months, within the six to nine the chairman promised. Earlier this month it also named a chief accounting officer and lengthened its bank credit line by a year.
What it did to the thesisThe leadership gap, the biggest open question in our case, is now closed on paper. The view stays Neutral, confidence Medium, because the rest of the case is untested: what Twin Eagle cost, net debt against our billion line, and cash earnings still not cheaper than rivals'.
On February 6, 2026, Expand's board terminated CEO Domenic (Nick) J. Dell'Osso, Jr. without cause, effective immediately; he also resigned from the b…
On the Q2 2026 earnings call held 2026-07-29, Interim President and CEO Michael Wichterich disclosed a timeline for the CEO search that no 8-K carrie…
Expand's senior leadership turned over almost completely across 2026 in a sequence no single filing shows: the CEO was terminated 2026-02-06 (C09); M…
Below the interim chief executive and the new CFO (C09, C28), Joshua Viets has been EVP and chief operating officer since February 2022, after twenty…
Before its full report on 5 November, Eos said third-quarter sales were $82 to $83 million, up about a fifth. The loss on making and selling its batteries narrowed from 71 cents per sales dollar to about 54. Orders on hand fell to about $765 million from $807 million, and full-year sales are now expected in the lower half of its $300 to $350 million range.
What it did to the thesisThe test we set cannot be scored yet: Eos did not say how much came from customers other than its related Frontier venture, or give the adjusted margin. Sales and margin moved the right way, backlog and the forecast the other way. Our view is unchanged.
Bitdeer's last monthly update says it mined 1,355 bitcoin in September and ran 82.3 exahash per second of its own mining power, up from 79.9. Its AI cloud contracts now total about $2.9 billion, up from $0.9 billion. It will report quarterly from now on. It said nothing on its Norway site funding.
What it did to the thesisNothing moved. Our concern is how the Norway site is funded and whether more shares are sold; this update says nothing on either. The bigger AI order book is real but small next to that funding need. November 9 results are the test.
X-energy and utility AEP signed a study agreement for 12 small nuclear reactors in Indiana (about 960 megawatts), with Amazon paying part of the development and first in line for the power; no amount or date. Amazon also said new free software, TorchNeuron, lets developers run their existing PyTorch code on its own Trainium AI chips with few changes.
What it did to the thesisNothing moved. The reactor study ties to the power limit on the build; no cost came with it. The software makes Amazon's chips easier to adopt, but is a beta and the claim is Amazon's own. Our test is the 29 October results.
NioCorp said it had $405.1M in cash at 30 September, down from $415.0M. It reported $3.7M of profit, but that came from $8.5M of non-cash gains as its share price fell. Operations used $6.1M and the mine entrance $5.9M. Its filing on the Traxys deal lets either side cancel if EXIM has not approved the loan by end-2027.
What it did to the thesisNothing moved in the view. Spending matches plan and the profit is not real earnings. The new cancel date ties the niobium sales deal to the EXIM loan, which is still not approved. Scandium still has no bound buyer.
On 13 October 2026 NioCorp signed a binding definitive agreement with Traxys North America: Traxys will buy 50% of planned ferroniobium on a take-or-…
Vistra said it is redeeming all of its 8.0% Series A preferred stock, $1.0 billion in total, on 15 October. Preferred stock is a security that pays a fixed dividend ahead of ordinary shareholders. The company said no unpaid dividends were owed.
What it did to the thesisNothing moved. September's new notes were announced as a way to do this, so it matches the thesis. A second $1.0 billion of preferred stock comes up for the same choice on 15 December. The view stays Neutral.
TTM told the SEC on 12 October it plans to spend another $400 million expanding five factories, four in China and one in Malaysia, mostly for the advanced boards used in AI data centres. This is on top of the $1.2 billion already promised for 2025 to 2029. It gave no dates, sales goal or funding plan.
What it did to the thesisNothing in our case moved. It shows demand is strong enough for TTM to spend more, but it also adds to debt that is already rising for the Epiq purchase. Management said it will say more on the September-quarter call.
On 14 October the board made Mark Long chief financial officer, and David Weigand left that role. Long ran finance at Western Digital from 2016 to 2019. The filing gives no reason and no new figures.
What it did to the thesisNothing moved in our case. We updated who runs finance. A new finance chief weeks before the 3 November results is worth watching, but the test stays gross margin and cash from operations. View stays Neutral.
Charles Liang founded Super Micro in September 1993 and has been president, chief executive and chairman since; David Weigand has been chief financia…
Venture Global, a US gas exporter, signed a framework with GE Vernova and Baker Hughes for up to 16 gas power units of 720 MW each. It paid to reserve factory space for eight of them, expects its first order by the end of 2026, and may buy the rest until 2027 to 2029.
What it did to the thesisNothing moved yet. It is another reservation, the kind our case needs to turn into firm orders, and it was signed after the September quarter ended. The deal is optional beyond the eight reserved, so it tests nothing until orders follow.
Venture Global told the SEC it signed a framework deal on 9 October with GE Vernova and Baker Hughes for up to 16 power plant units, delivered through 2034. Almost none of it is binding yet. It expects to place the first order by the end of 2026, and neither side must buy or supply more until orders are signed.
What it did to the thesisNothing moved. It shows a customer we already track may buy more power equipment, but it adds no order to Baker Hughes' backlog and its share of the work is not stated. Our case turns on the October results.
SentinelOne said it would sell $1.25 billion of convertible notes due 2031 and then announced that they priced at 0% interest. Holders can swap them for shares later. The shares fell 6.4% on the day of the proposal. We could not read the terms, such as the conversion price.
What it did to the thesisNothing moved yet. The raise adds debt to a company that had $813.2M of cash and no borrowing, and may add shares, but the terms are unread. The case rests on new subscriptions growing and stock pay falling, which show in the December results.
Rocket Lab said its new large rocket, Neutron, will now make its first flight in 2027 instead of this year. Reuters reported the shares fell about 6% in after-hours trading. Rocket Lab had already warned that a launch this year was getting less likely. We could read only the first sentence of the announcement, so any new date is unknown.
What it did to the thesisOne claim changed: the end-of-2026 target no longer holds. Our test line is a first flight by mid-2027, which is not yet broken, so the view stays unattractive, mainly on price. The 9 November results should name whether a firm date exists.
Neutron's Stage 1 tank production is currently aligned with a target delivery of the vehicle to the launch pad in Q4 2026, though the window for an e…
Netflix is cutting about 1,000 jobs, around 6% of its staff, mostly in product, technology, legal and human resources. It is the biggest cut since 2022 and comes six days before results on 20 October. Press reports say the two chief executives told staff the full-year forecast is still on track. The Journal article itself could not be opened.
What it did to the thesisNothing moved. Our case watches the full-year forecast and whether profit margin keeps widening. Fewer staff could help margin, but no savings figure was given and the forecast was only reported secondhand. The 20 October results are the real test.
IonQ sold 50 million new shares at $40 each and gave the buyer warrants, which are rights to buy 100 million more shares at $69.46 within seven years. It raised about $1.99 billion after fees. It had 408.9 million shares before, and the shares fell about 6% to 9% that day.
What it did to the thesisCash roughly doubles, so running out of money is much less likely. But each existing holder owns a smaller slice: 12% more shares at once, up to 37% more with the warrants, plus the Elisity deal. Our case rests on price and dilution, so the view stays.
Cipher priced its $850 million sale of convertible notes, which pay no interest and fall due in November 2032. They convert into shares at about $15.31. It will also hand over about 40.7 million shares to holders of $165.9 million of its 2030 notes. Part of the money buys protection against dilution; the rest goes to Barber Lake and new sites.
What it did to the thesisNothing in the thesis moved yet. More debt and about 40.7 million new shares test our assumption of no large new share issue, but those shares were already counted as possible dilution. The case still turns on Barber Lake rent and new leases, due with 2 November results.
Berkshire announced a further $330M investment in Bending Spoons, the app company, after putting in $600M at its stock-market debut. Headlines put its holding near 4%. We could read only the headlines, not the release or the articles, so the terms are unconfirmed.
What it did to the thesisNothing moved. About $0.93B in total is small beside $359.2B of cash and bills and $340.8B of securities. It shows Abel buying a new stock, which we track, but it changes neither the cash pile nor our view of Berkshire.
NioCorp signed a binding agreement with metals trader Traxys, which will buy half the mine's planned niobium alloy for 15 years, paying even if it does not take delivery. The other half is already contracted to ThyssenKrupp. Traxys also gets the exclusive right, but no duty, to buy and sell its other products.
What it did to the thesisPart of our open question is answered: all the niobium alloy now has a buyer. But scandium, the biggest part of the mine's value, still has no buyer bound, and the loan to build is uncommitted. The view stays Neutral.
The only binding sales agreements are two ferroniobium offtakes, each for ten years: 25% of annual output up to 2,067 short tons a year to a US metal…
LightPath said a counter-drone and defence systems supplier placed another $6.3 million order for optical assemblies. That customer has now ordered more than $19 million since July, double its total for the year to June. No profit margin or term was given.
What it did to the thesisLittle moved. It adds to orders we already track, but our case turns on profit margin and backlog at the November results, and an order this size gives neither. The view stays Unattractive.
On 22 July 2026 LightPath announced $13M of follow-on optical assembly orders from a leading counter-UAS and defence systems supplier. In fiscal 2025…
Jabil and India's Adani Enterprises signed a non-binding memorandum, a statement of intent, to build a 50:50 joint venture making AI and data-center equipment in India. It follows a June alliance announcement. No investment, sales figures or start date were given, and definitive agreements are still needed.
What it did to the thesisNothing moved. Our case already treated the Adani plan as unproven and not before fiscal 2028. The memo adds a 50:50 structure but no money, volume or contract, so it is not yet evidence for AI growth. The view stays Neutral.
IonQ says it will buy Elisity, a company that controls which devices and people can reach a company's network, paying only in new IonQ shares worth up to $1.3 billion, with up to $150 million tied to Elisity's performance. It should close in the fourth quarter. The shares fell about 9% that day.
What it did to the thesisNothing in our view moved yet. The deal adds roughly 6% to 10% more shares, which pushes our share-dilution warning closer without crossing it. Elisity's sales and profit were not disclosed, so we cannot judge the price paid.
Digi Power X says a lender has issued a letter committing $200 million of debt for its 40 MW Alabama data center, to close within 90 days if paperwork and the lender's checks finish. It says no shares were sold under its share-sale programme in the third quarter, and cash is about $135 million.
What it did to the thesisA step toward the funding route our case wants, debt not share sales. But the loan is not signed, its rate and length are not given, and the company still guarantees it until completion. The view stays Unattractive until results on 12 November.
Cipher announced a proposed $850 million private sale of convertible notes that pay no interest and fall due in November 2032, with an option for $150 million more. At the same time it will swap some of its 2030 convertible notes for shares. Price and conversion terms are not yet set.
What it did to the thesisNothing in the thesis moved yet. It adds debt and possibly shares to the funding and dilution claims, but the size and terms are unknown until pricing. The Barber Lake rent start and new leases, due with 2 November results, remain the test.
A shareholder class action was filed alleging Webull understated how much its engineering and data work depends on China, for investors who bought between April 2025 and October 2026. Webull also filed a statement saying US customer data and cash stay in the US and the report cites no misuse.
What it did to the thesisThe suit rests on the committee report we already weighed and orders nothing. Our trigger is a US government action restricting Webull, and none exists. Trading and profit claims did not change, so Neutral holds.
GEO filed the details of what it announced on 6 October: on 15 October it will repay all $650 million of its 2029 bonds for about $678 million, using the Adelanto sale money. Its bank credit line of $550 million now runs to 2031.
What it did to the thesisMost of the $705 million Adelanto money goes to debt, as we assumed, so less is left for buybacks. Debt falls but the business is no bigger, so the price still pays for sales not yet agreed. View stays Neutral.
At 2026-06-30 GEO held $55.0M of cash against about $1.54B of debt: $650M of 8.625% secured notes due 2029, $625M of 10.25% notes due 2031 and $248.9…
GEO's board raised the share repurchase authorization on 2026-10-05 from $500M to $1.25B, effective through 2029-12-31; GEO says it will use the Adel…
SpaceX said it will buy a nationwide block of low-frequency radio spectrum from Grain Management, to make Starlink phone service work indoors. It needs US regulator approval and no price was given. SpaceX says most phones already work on that band. AST shares fell 10.5% on the day.
What it did to the thesisOur view stays Unattractive. We narrowed one claim: AST's edge of working on phones people already own is a shorter window, since SpaceX says this band needs no new phone. No carrier has switched to SpaceX, so no warning sign fired.
The edge AST still holds is broadband on phones people already own: SpaceX's own filing says today's phones lack the radio hardware for its new bands…
SpaceX said it will buy a nationwide block of low-frequency radio spectrum from the investment firm Grain Management, to let Starlink Mobile work indoors. It needs US regulator approval and no price was disclosed. Phone carriers' shares fell on the news.
What it did to the thesisNothing moved yet. It shows SpaceX widening its spending on phone service, on top of the EchoStar spectrum we already track, but without a price we cannot say what it adds to the cash SpaceX owes. November results are the test.
OpenAI told investors its revenue is running at about $50 billion a year, lower than the $68 billion figure reported in late September. A person familiar says the higher number counted partners' gross revenue. OpenAI also reported 77% annual growth. Oracle's shares fell about 5.6% that day, as did other AI names.
What it did to the thesisNothing moved. Most of Oracle's $664 billion of signed future revenue rests on OpenAI, so its ability to pay matters. A different way of counting revenue is not a missed payment or a cancelled contract. The December results are the test.
OpenAI told investors its yearly sales pace was about $50 billion at the end of September, below a $68 billion figure that had circulated, which counted partners' sales. It also said growth ran at 77% in the quarter. Nvidia, Oracle and CoreWeave shares fell.
What it did to the thesisNothing moved. We lean on OpenAI only through the loans Nvidia has guaranteed for its data centres, and our case uses neither figure. It is a reminder that those customers must keep growing. Nvidia's November 17 results are the test.
Bitdeer told the SEC it may buy back up to $100 million of its own shares by October 2028. It also signed a 10-year agreement for a new 67MW AI data centre site in Malaysia, with no customer signed for it yet, and says the deals it is discussing are worth over $10 billion.
What it did to the thesisNothing moved. We worry about funding growth by selling new shares, and a buyback of this size does not change that while a $1 billion share-sale programme is open. The new site adds cost before any customer. November 9 results are the test.
OpenAI told investors its revenue runs at about $50 billion a year, below the $68 billion reported last month; the larger number counted partners' gross revenue. Broadcom's shares fell about 4.4%. Bloomberg also said Broadcom is in early talks to finance OpenAI's chips, which repeats yesterday's report.
What it did to the thesisNothing moved. We need OpenAI and Anthropic to pay for the chips Broadcom plans. A lower count of OpenAI's revenue does not cancel anything, and financing talks are not a deal. Broadcom's December results should show financing and who backs it.
The US defence department offered Wolfspeed up to $1.5 billion over 30 years, with the first $600 million repaying its costly 2030 notes. Nothing is signed. It needs Congress to fund it, most convertible notes to turn into shares, $750 million of new money from others, and warrants for up to 7.5% of the company.
What it did to the thesisNothing moved yet. It could cut the interest bill but adds shares, and the case still turns on sales passing breakeven. The 4 November results are the test. View stays Unattractive.
On 7 October Unity said it is partnering with Google on a platform where people describe a game in words and get one back. Google's Playground is live now; Unity Spark, built on Unity's engine, follows later this year. The release gives no revenue, cost or contract terms.
What it did to the thesisNothing moved. It touches the engine half, which has been shrinking, but without numbers there is nothing to score. The test is whether engine sales stop falling in the November results. The view stays Unattractive.
News outlets say SpaceX is in talks to borrow about $40 billion, mostly investment-grade bonds plus bank loans with Apollo leading, to buy Nvidia chips. SpaceX has not confirmed it. Separately the US communications regulator approved 15,000 more Starlink satellites that connect directly to phones and allowed SpaceX to use its own radio spectrum.
What it did to the thesisNothing moved. The borrowing is unconfirmed, and if real it would weaken our assumption that spending is paid from the $100 billion raised. The approval lets Starlink offer more services but gives no sales figure. The results in November remain the test.
The Wall Street Journal reports that Oracle is in talks with Apollo and Goldman Sachs. Investors would fund a separate company that buys the chips for a large data centre, and Oracle would lease them over time. Oracle hopes to finish this year. The size is unclear and nothing is signed. The article is paywalled, so details come from summaries.
What it did to the thesisNothing moved yet. Rented chips would not show as Oracle's own cash spending, so the $70 billion spending limit we track could look met while commitments grow. It also points away from new share sales. We will read it against leases and debt, not cash spending alone.
Ondas says it won more than $165 million of orders from mid-August to October 1, which with about $105 million announced in August makes over $270 million since June 30. It named no customers apart from the $56 million European order already reported, and gave no sales figures.
What it did to the thesisNothing moved yet. This is the company's own count of orders, not sales or cash, and our view rests on whether orders turn into the guided revenue. The November quarterly report is the test, so we keep our view.
At its 6 October investor day Marvell said it now expects about $20 billion of sales in the year to January 2028, up from $18 billion in August, and $70 billion to $90 billion in fiscal 2031. We only found news reports of this, not the company's slides.
What it did to the thesisOur case assumed about $18 billion, so a key input moved up, but nothing changes until the company's own slides are read. No dated target for fiscal 2029, the year we asked about, was reported. The view stays Unattractive.
IonQ says it has moved into Stage C, the last stage, of a US defence research agency contest on quantum computers. The agreement is worth up to $300 million, runs through 2029, and money beyond the first payment depends on future government funding. The agency's own announcement and the list of other companies were not found.
What it did to the thesisA step we had listed as good news happened, so we updated the notes. It does not change our view: the worry is the price and the many new shares issued, and neither moved. The amount is a ceiling, not cash received.
DARPA picked 11 companies for Stage B of its Quantum Benchmarking Initiative in November 2025, including IonQ, Quantinuum, IBM, QuEra and Xanadu; it…
A US House committee published a report saying Webull's China links, including engineers in China and how data and customer cash are handled, are a national-security risk. The report orders nothing and carries no fine. Webull says it has significant inaccuracies. The shares fell about 19%. We could not open the report itself, only news accounts.
What it did to the thesisThis is the risk we already listed, now written down by lawmakers. Our trigger is an actual US action that restricts Webull, and none exists, so it is closer but not hit. Trading and profit claims did not change, and Neutral holds.
About 800 of Webull's 1,396 employees work in research and technology, much of it at a development centre in Changsha, China; 14 state attorneys gene…
The Wall Street Journal reports that Broadcom is working to arrange more than $50 billion of financing so lenders can pay for the custom AI chips it builds with OpenAI. Apollo and Blackstone are among those approached. Talks are early, could change, and a deal is hoped for before year-end. The article is behind a paywall, so details come from summaries.
What it did to the thesisNothing moved. We want a second funding round led by outside lenders, and this is a step toward one, but nothing is signed. What matters is whether Broadcom guarantees any of it, which the reports do not say. The December results should show.
Arista announced complete liquid-cooled racks that link up to 144 AI processors over Ethernet, and up to 1,024 across racks, plus racks for the wider network between racks. It named partners such as AMD, Broadcom, Meta and Microsoft but no customer, order, price or delivery date. It will show them at a trade event on 12 to 15 October.
What it did to the thesisNothing moved. Our notes say Arista's chief executive expects little role in the links inside Nvidia's own systems and that moving off Nvidia's technology will take time. This is a product launch to test that, not an order. Results on 3 November are the next check.
Aehr said its lead cloud-computing customer placed more orders for Aehr's Sonoma chip-testing machines, this time for a newer AI processor, its second chip program on those machines. We could only read the headline and a one-line teaser, so the order's size and delivery dates are unknown.
What it did to the thesisNothing moved. This customer's repeat orders are already part of our case, and without a dollar figure the news cannot show whether the sales guide is safe. The price already assumes strong growth, so Unattractive holds until bookings are measured on 6 November.
Uber said on 6 October it will buy ezCater, which lets businesses order food from over 140,000 restaurants for meetings and events. The price is $2.3B in cash. ezCater handled over $2.5B of orders in the last twelve months, growing in the high teens, and is profitable.
What it did to the thesisNothing moved. The deal adds about 1% to Uber's order volume and uses cash while the Delivery Hero purchase is already under way. We watch the cash and debt claims, and the Delivery Hero timing, but the release gives no closing date or financing.
Navitas finished buying Claros, a young company making power delivery that sits right under an AI chip. The filing confirms the closing but not new terms. Navitas says the deal doubles the market it can sell into. Claros revenue and losses are not disclosed.
What it did to the thesisNothing moved. The cash and new shares were already counted in our case, and the market-size claim is management's own. We still need signed 2027 demand and revenue. The November results are the test.
Navitas agreed to buy Claros, a 2024 start-up making power delivery that sits under the processor, for up to $232.8M: $216.0M at closing in cash and…
The Financial Times reported, and Reuters repeated, that SpaceX is raising $40 billion, about $10 billion of bank loans and $30 billion of bonds led by Apollo, to buy Nvidia chips, closing in 2027. Neither company has confirmed it, and no filing exists. Only press copies could be read.
What it did to the thesisNothing moved. It fits demand we already assume and shows a buyer paying with borrowed money, which our financing worry already covers. Unconfirmed, with no Nvidia contract or guarantee reported, it is not evidence for the numbers. November 17 results remain the test.
Ofcom, the UK communications regulator, is investigating whether Meta checked properly for illegal content and child access before launching Instagram Instants. Possible outcomes range from a warning to a fine of up to 10% of global revenue. Meta says it did a risk analysis and will cooperate. Separately, Meta joined a group of firms on a standard for dealing with AI bots; we read only that headline.
What it did to the thesisNothing moved. It adds to the legal scrutiny we already track on youth safety, but no finding or fine exists yet. The bot-standard news is a membership, with no revenue figure, so it does not answer our question about AI revenue.
FICO told the SEC it will remove about 15% of its positions, by simplifying layers, tools and using AI in product work. Staff were told from the week of 5 October and the plan should finish by mid-2027. It expects about $27.0M of one-off severance costs this quarter.
What it did to the thesisNothing moved. Our view turns on the mortgage score price and volume, which this does not touch. Lower costs could lift profit margins later, but the company gave no savings figure, so we wait for the November results.
Google and Constellation announced a long-term deal for 890 megawatts of new nuclear capacity on the grid that serves the mid-Atlantic and Midwest (PJM). Google is the third named buyer after Walmart and Amazon. The announcement could not be opened, so the length, price, start date and whether it is part of the 920 megawatts signed in August are not known.
What it did to the thesisNothing moved yet. Our case needs named, sized power deals to keep arriving, and this is the largest so far. Without terms we cannot say how much it adds beyond the August batch. The next results, due 9 November, should show whether it is new.
Applied Digital said it has secured access to up to 1 gigawatt of potential power in Finland, its first project outside the United States. It is marketing the site and talking to the largest cloud companies, but has no customer signed. More spending depends on demand and approvals. We could only read a news report of the announcement.
What it did to the thesisNothing moved. Our case rests on already-signed leases in the United States and on whether recurring rent takes over from construction revenue. A Finland site with no customer adds no rent and no cost yet; it is an option, and the results are the test.
Zeta Global says it agreed to buy Senso, which it describes as adding AI engineering and a way to connect to the leading AI models. We could read only the headline. The price, whether it is paid in cash or shares, and how big Senso is were not readable.
What it did to the thesisNothing moved yet. Zeta has paid for several smaller companies already. Until we see the price we cannot say whether it strains the cash Zeta holds or adds to the shares it issues.
The US Energy Department said it will offer Vistra a conditional loan commitment of up to $4.2 billion to expand and modernize its nuclear plants in two states. That matches last weekend's reports. The interest rate, repayment terms and conditions have not been published, and Vistra has filed nothing.
What it did to the thesisNothing moved yet. The thesis already counts nuclear upgrades for the Meta contracts, and cheap government debt could ease paying for them. Until the terms are known we cannot say whether it adds debt or lowers costs. Our view stays Attractive.
Vertiv named Michael Resha, who ran stamping and injection operations at the carmaker Stellantis, to lead its factories, logistics and operational improvement. He replaces Anders Karlborg, who moves to a special projects role. The release gives no reason and no numbers.
What it did to the thesisNothing moved. Our case watches whether Vertiv delivers its second-half ramp, and it has had execution slips before. A new factory chief is worth noting but says nothing yet about output or margins. The October 28 results are the test.
Teradyne said on 5 October it made a strategic investment in Bright Machines, a company that builds AI and data-centre equipment in small automated factories. The two will look at using Teradyne's robots and test equipment there. No price, stake or order size was given in the text we could read.
What it did to the thesisNothing moved. The deal touches Teradyne's robotics business, which earned a small loss last quarter, and our case rests on chip testing. Without an amount or an order there is nothing to measure it by, so it waits for the October results.
Navitas and Microchip announced a shared reference design, a blueprint other makers can copy, for 800-volt power in AI data centers. Only the headline could be read. No order, volume or date is known.
What it did to the thesisNothing moved. A blueprint is a step toward sales, not a sale. Our case needs signed 2027 demand and revenue that has not yet arrived. The November results are the test.
Stockholders of the chip startup Groq sued Nvidia, alleging they were shortchanged when Nvidia paid $20 billion to license Groq's technology and hire its people. Only the headline could be read. A video also recapped Nvidia's $235 billion buyback, announced September 28.
What it did to the thesisNothing moved. The Justice Department is already examining the same deal, and a private suit adds legal risk we cannot size without the complaint. The buyback is old news already in our numbers. The November 17 results are the test.
Norway temporarily banned using camera glasses, including Meta's, in places such as parks, schools and beaches. Sale of the glasses is still allowed. Separately, Meta, TikTok and X are contesting the UK regulator's demands for data about their services. We read the Norway article in full and only the UK headline.
What it did to the thesisNothing moved. The glasses earned $431M last quarter against a $4.6B loss in that unit, and a use restriction in one country does not change that. The UK case adds to the legal scrutiny we already track; no penalty or figure is attached.
Elon Musk said talks are under way for TSMC to join Terafab, his Texas chip venture whose named manufacturing process is Intel's. He called them 'just discussions'. Intel shares fell about 2.6% the next session. Only a headline and a second outlet's copy could be read.
What it did to the thesisNothing moved. Our case already assumes Intel has no named outside customer with committed volume, so a possible rival at Terafab removes hope rather than a fact. It leans the same way as our Unattractive view, and the October results are the real test.
IES Holdings and the seller, INNOVATE, each announced on 5 October that IES has finished buying DBM Global, a steel and modular builder. We could read only the headlines. The final price, any change to the terms and the exact closing date were not readable, and IES has not yet filed its closing report.
What it did to the thesisNothing moved in our view. We already counted the purchase at about $685 million. What changed is wording: the deal is done, so the seller's right to walk away has lapsed. DBM's profit now counts inside IES, and the first results that show it come in 2027.
IES agreed on 10 August 2026 to buy DBM Global for about $685M, $545M in cash and $140M in shares.
Either side can walk away from the DBM purchase without a fee if it has not closed by 8 February 2027, or 8 August 2027 if regulators are still revie…
GEO sold three Adelanto, California centres with 2,644 beds to the Department of Homeland Security for $950 million, about $359,300 a bed. It expects $705 million after tax and fees, will keep running them under its ICE contract, and raised its share buyback limit to $1.25 billion.
What it did to the thesisThis is the sale our view was waiting on, at a better price a bed than CoreCivic got. It covers about 38% of what the share price counts on, and no further sale is agreed, so the view stays Neutral.
CoreCivic says the four sales averaged about $307,000 a bed; GEO sold its 2,388-bed Lawton prison to Oklahoma in 2025 for $312M, about $131,000 a bed.
GEO says it is in an active process to sell several turnkey facilities to ICE and keep operating them, with ICE re-procuring four sites; no agreement…
By 2026-09-27 GEO had filed no 8-K reporting a sale, and Clearfield County extended the Moshannon Valley agreement only to mid-March 2027, on a 2-1 v…
The shares closed at $13.26 on 2026-02-20 and $31.22 on 2026-09-25; the 52-week range is $12.51 to $33.15.
At $31.22 enterprise value is about $5.60B; that is 10.8 times trailing Adjusted EBITDA of $519.4M and 10.1 times the $555M 2026 guidance midpoint; t…
At the old 7 times, $555M supports about $3.9B of enterprise value, about $18 a share; the $1.7B gap is what about 7,600 beds would net at CoreCivic'…
BWXT says its BANR microreactor, a small reactor built in a factory and moved by rail, ship or truck, was chosen for a Canadian transportable nuclear plant project. We could read only the headline: who the customer is, how many reactors, and whether any money is committed were not readable.
What it did to the thesisNothing moved yet. Our case already counts the US Army's choice of BANR. A selection is not an order, so the claim that BWXT may win a new-build order by year-end is untested until the terms are read.
A filing on 5 October shows Berkshire's insurance subsidiaries bought about $193M of homebuilder Lennar's shares on 1 and 2 October, at $77 to $82 each. They now hold 28.4M Class A shares. Barron's puts Berkshire's stake at 12%. Three earlier Berkshire filings on Lennar were made in September.
What it did to the thesisNothing moved. It is about $0.19B against $340.8B of investments, so it changes neither the cash pile nor the biggest holdings in our case. It does show Abel putting cash to work in a stock, which we track, but one stake does not settle that.
Baker Hughes announced on 5 October that it signed two Venezuela agreements: an alliance with the state oil company and two partners to build a gas business from wells to LNG exports, and a memorandum with New Stratus Energy on future oil and gas projects. As we read it, no dollar value, order or date was given.
What it did to the thesisNothing moved. Neither deal is an order, and the alliance needs separate project agreements first. Our case turns on equipment orders and margins in the October results, so this is a possible future customer, not evidence.
Adeia says it renewed the patent licence it holds with Spectrum, the cable and internet brand of Charter. We could read only the headline. The length of the deal, which patents it covers and what Spectrum pays were not readable.
What it did to the thesisNothing moved. Charter was already on our list of licensed customers, and a renewal fits management's claim that most customers renew. Without the terms we cannot tell whether the payments rose or fell.
The company said on 5 October it finished its third programme of selling new shares on the open market. It sold 5,694,845 shares at an average $105.36 and kept $588.0M after fees. It plans to spend the money on equipment and machinery for production and research.
What it did to the thesisThe case already counted dilution as a cost, so nothing moved. The share count is now about 90.3M against the 100M line in our criteria, and the money lowers the funding risk while each existing holder owns a smaller slice of the business.
Shares outstanding rose from 75,198,817 on 24 February 2026 to 84,569,237 on 3 August 2026, 12.5% in five months, after selling about 7.78M shares at…
Reuters and Bloomberg, quoting unnamed sources, say the US Energy Department will lend Vistra about $4.2 billion to squeeze more output from three of its four nuclear plants. The Energy Secretary is expected to announce it on Monday. Neither Vistra nor the department has confirmed it, and no terms are public.
What it did to the thesisNothing moved yet. The thesis already counts nuclear uprates for the Meta contracts, and cheap government debt could ease how they are paid for, but without terms or confirmation nothing in the ledger can be changed.
Powell's financial year ended on 30 September. The results are not out until 17 November, so the last forecast management made about margins cannot yet be checked against a full year.
What it did to the thesisNothing moved. The case rests on backlog and margins, and the first full-year check is the November report, which is already our next test.
The count of analysts rating Chime was re-read from the data vendor. It shows 16 saying buy, 1 saying hold and none saying sell, up from 13 buy and 1 hold in August.
What it did to the thesisNothing moved. The ratings were a side fact our case does not rest on; the view still waits for November's results to show the margin the company has promised.
Tesla said it delivered 486,532 vehicles from July to September, 1.3% more than the spring quarter but 2.1% fewer than a year ago. It built 464,391, so it sold more than it made again, and it installed 13.7 gigawatt-hours of storage batteries. It will report profits on 21 October.
What it did to the thesisNothing moved in our view. After a 25% jump last quarter, sales have stalled rather than kept climbing, but the release says nothing on profit margin or self-driving income, which is what our case turns on. The 21 October results are the test.
Reuters reports Apple will warn users when AI apps ask for Mac data, after complaints about Meta's new Muse app, which a journalist said read his private messages after he denied access. Meta's AI chief called its first explanation inaccurate. A Dutch glasses chain also stopped selling Meta's glasses over privacy. We read only headlines for both Reuters items.
What it did to the thesisNothing moved. Both items are privacy friction around new AI products, and no sales figure for Muse or the glasses exists to measure it. Our case rests on advertising growth and the spending bill, which the October results test.
The FDA approved Lilly's cancer pill Jaypirca for adults with chronic lymphocytic leukemia or small lymphocytic lymphoma who have not been treated before and lack a 17p deletion. In a trial of 282 patients it cut the risk of the disease progressing by 80% compared with chemotherapy plus rituximab. Until now it was used only after other treatments.
What it did to the thesisNothing moved. Jaypirca sold $192 million last quarter, part of the growth beyond the two big weight-loss medicines. A wider label could grow it, but no sales figure came with the approval and our tests are volume against price and the 29 October results.
First Solar, a rival solar panel maker, says it sued American Panel Solutions, a Corning subsidiary, and China's JA Solar for patent infringement. Only the article's first paragraph was readable, so the patents, damages and demands are unknown.
What it did to the thesisNothing moved. Corning's solar arm lost $7 million on $438 million of sales in Q2, and this does not change the optical-fibre case. It is a possible legal cost to watch, with no amount known.
Flowco closed its purchase of Lifting Solutions of Edmonton, which makes continuous rod and progressing cavity pumps for oil wells in Canada, the US and the Middle East. It paid about $113 million cash, borrowed on its revolving credit line, with up to C$10 million more depending on 2027 results. Management puts the price near 5 times expected 2027 earnings.
What it did to the thesisNothing moved. The purchase was paid in cash and borrowing, not new shares, which is what our share-count assumption needed. It adds new lift types and about 10% of sales outside the US. Its size will first show in the 11 November results.
Bloomberg reported on 2 October that Blackstone and banks have gathered $60 billion for a Broadcom AI chip deal. In August, outlets said Broadcom was seeking more than $60 billion so investors can buy its chips and lease them to Anthropic. We read only the new headline, so the lenders, terms and Broadcom's share of the risk are unknown.
What it did to the thesisNothing moved. It looks like the financing we already track, and it does not say Broadcom has paid anything or been lent anything. It bears on our pending test of whether a second financing closes with an outside lead, which still needs the filing.
Applied Digital said another 75 megawatts of capacity at its Polaris Forge 1 campus in North Dakota is ready for customers, bringing the fully leased campus to 250 megawatts working. We could only read a news report quoting the announcement, not the announcement itself.
What it did to the thesisIt shows capacity being delivered on schedule, which our case needs, but it is one phase of a campus already leased. Nothing moved: the real test is next week's results, on whether recurring rent is overtaking construction pass-through revenue.
Amazon's cloud chief published a long post warning that freezes on new data centres would hurt the US for generations, saying over 100 are being considered locally. He announced more than $1 billion over five years for towns that host Amazon's data centres. Amazon withdrew a Maryland site in August.
What it did to the thesisNothing moved. Local resistance is one more sign that building capacity is getting harder, which we already track. The $1 billion is about 0.5% of the roughly $220 billion Amazon plans to spend this year. The 29 October results still decide the view.
A SpaceX rocket took off from California on 1 October carrying more than 100 small payloads. One was a Planet Labs satellite holding a Google AI chip, the first Google has sent to space, to test whether it works there. SpaceX only provided the ride; no price or contract was reported. Google calls its orbital-computing plan a long-term moonshot.
What it did to the thesisNothing moved. It is an outside customer on a launch business that mostly carries SpaceX's own satellites, and it adds no revenue figure. Our case rests on Starlink and the cloud contracts, so Google's orbit tests only matter if they later become a signed launch order.
Ouster announced that Seneca, a California company building self-flying firefighting drones, will use Ouster's Rev8 lidar sensor for navigation in smoke and rough terrain. The announcement gave no number of sensors, no order value and no start date. It also repeats that the sensor meets American-made sourcing rules.
What it did to the thesisNothing moved. It names one more user of the Rev8 sensor, but without an order size it adds nothing to revenue or margin. The November results, which test gross margin and Rev8 volume, remain the next real check on the case.
After winning a jury trial over how Facebook handled users' data, New Mexico asked a judge on 1 October to make Meta pay $35 billion to $40 billion. Meta argued for at most $3.45 billion and hinted it would appeal. The judge said he would decide by late October. Reuters's story could not be read, so local newspaper reports were used.
What it did to the thesisThe legal-risk part of our case was updated with both figures. Nothing moved in the view: this is a request, not a ruling, and the state's ask is below the $62.85 billion we already carried. The view stays Attractive, conviction Medium. A ruling is due before the 28 October results.
Meta's June 2026 quarter release warns that 'we continue to see scrutiny on youth-related issues in several markets and have a number of youth-relate…
First Solar sued JA Solar, a Chinese panel maker, and American Panel Solutions, a US panel seller, in a Delaware federal court. It says they use a method for making a type of silicon solar cell that First Solar owns a patent on. Only second-hand copies of the announcement could be read.
What it did to the thesisNothing moved. We said on 15 September that the company would pursue patent suits in court, and this is one. Our case rests on the import price floor and a US manufacturing tax credit, not on winning patent cases, so the view stays Attractive, conviction Medium.
Reports of Anthropic's confidential IPO document say Broadcom could lend it up to $42 billion, about a third of its $125.2 billion five-year chip-computing commitment, with the loan possibly convertible into Anthropic shares. Anthropic says it does not expect the notes to be sold before its listing, and warns that Broadcom being both supplier and lender could create conflicts.
What it did to the thesisNothing moved. Broadcom's own September filing already described this $42 billion facility, and nothing has been lent or paid. The new part is Anthropic's side, and it is a reminder of how much 2027 growth rests on one customer's ability to pay.
The Financial Times reports Amazon has asked investors about moving about $8 billion of Nvidia AI chips into a separate company. That company would borrow from outside investors and rent the chips back to Amazon, and Amazon would offer up to 10% of its ownership. Amazon has not confirmed it, and we could not read the FT itself.
What it did to the thesisNothing moved. Management said more financing was coming, and we had noted this kind of structure as a possibility. It is small against the roughly $220 billion Amazon plans to spend this year, and it would hide spending, not remove the bill. The 29 October results still decide the view.
Applied Materials and Besi, a Dutch maker of machines that join chips together, widened a partnership begun in 2020. Besi will work inside Applied's new research centre in California on ways to stack and connect AI chips. The release gives no orders, revenue, price or timetable for any product.
What it did to the thesisNothing moved. It adds another partner to a research programme our file already counts at 11, and it shows Applied pushing into chip packaging, which management says is growing fast. No sale, customer or money figure came with it, so it does not test our view.
Affirm's shares have fallen about 9% since we wrote the thesis, to $70.43, and more analysts now rate it a buy: 28, up from 24, with none saying sell. The company published nothing new, so we only brought our price and analyst figures up to date.
What it did to the thesisNothing moved. On normal earnings a buyer now pays about 69 times profit instead of 76, still a price that assumes Affirm's first profitable year keeps growing for years. The November results are still the real test.
Annualizing FY2026 pretax income ($492.7 million, from C04) at a normalized effective tax rate of about 27.5% (the midpoint of management's guided mi…
Analyst consensus as of 2026-08-30 was 24 buy, 10 hold and 1 sell - a strong net Buy, and markedly more bullish than the split this repo's SOFI thesi…
AFRM last traded at $77.76, implying a market capitalization of approximately $26.0 billion and a trailing-twelve-month GAAP price-to-earnings ratio…
Shareholders of Iridium, the satellite company Rocket Lab is buying, voted to approve the deal: 85.9 million votes for, 0.3 million against. Separately, Rocket Lab announced its biggest commercial order for its small Electron rocket, 20 launches for Synspective, but the announcement could not be opened, so we know no price or dates.
What it did to the thesisThe vote clears one of four hurdles for the Iridium deal; the US telecoms regulator's review, running to 9 November, is still open. The launch order's size is unknown, so it moves nothing yet. Our view stays unattractive on price.
The Iridium merger requires Iridium stockholder approval, HSR clearance, FCC consent to transfer Iridium's licenses and an effective Form S-4. The HS…
At its investor day on 29 September, Ooma said its copper-line replacement box, AirDial, is growing about 70% a year. A broker's report of the day puts its yearly subscription sales at about $20M, roughly 7% of Ooma's total. Canadian carrier TELUS will start reselling it in 2027 to a base of up to 300,000 lines, though it has not committed to any number.
What it did to the thesisNothing in our view moved. AirDial's size, our biggest unknown, came in about where we estimated: real and fast-growing, but small. TELUS is a promising sales channel without a committed order. Ooma's own growth and the price still decide the view.
Management says AirDial service revenue grew 75% in Q2 fiscal 2027 and 80% in Q1, but Ooma does not disclose AirDial revenue or lines.
Management's long-term goal is 300,000 AirDial lines earning $100M a year, about $28 a line a month; it gives no date.
AirDial is still small: its service revenue is probably no more than about $7M a quarter, under 10% of revenue.
At its 2026-09-29 Investor Day, management reported AirDial recurring revenue up 70%, a TELUS resale partnership in Canada targeting up to 300,000 li…
Nu told the SEC on 30 September that it is not pursuing a deal with Monzo, a British bank. A news report on 26 September had said talks were under way at about 10 billion pounds, and Nu's shares fell 10.0% the next trading day. Nu said its priorities and its rules for spending capital are unchanged.
What it did to the thesisNothing moved. The denial removes a possible large purchase that our case did not include. It leaves the US entry and the buyback in place, and the share price drop on the report was about a deal that is now denied.
The US Commerce Department and South Korea picked NextEra's power-development arm and Related Companies to build Project Star in Texas: 6.47 gigawatts of gas-fired power for a neighbouring 5-gigawatt data-center campus, costing $22 billion or more. Korea and the US would own it jointly. How much NextEra puts in, and when, was not stated.
What it did to the thesisNothing moved. It resembles the Japan-funded gas build already in our case, which NextEra has not yet turned into signed terms. The release gives no NextEra investment, return or start date, so it adds a project to watch and no figure to the argument.
Lilly reported two studies. Its weight-loss pill Foundayo was no worse for the heart than insulin in 2,749 people with type 2 diabetes, with a 16% lower risk that was not statistically clear. A trial of tirzepatide with a second medicine, eloralintide, found 23.3% weight loss in 48 weeks.
What it did to the thesisNothing moved. Both studies add to what could replace today's biggest product later, but neither changes a dated filing, a sales figure or the October results test. The view stays Neutral.
At an investor event, HPE said its networking business should grow 17% to 22% next year at a profit margin in the high 20s, up from earlier guidance. It raised its target for savings from the Juniper purchase to $800 million a year from $600 million, and said a cloud company, Vultr, ordered $1.2 billion of AI server racks.
What it did to the thesisThese are promises, not results. Networking grew only 10% last quarter, so the new outlook is a big step up still to be shown. The order has no delivery dates. Nothing in our view moved; the December results are the test.
Management reports Juniper cost savings on track for a $600M annual run rate by the end of fiscal 2028, and net leverage of 1.8 times, below its own…
Constellation announced a 20-year deal to sell Amazon 190 megawatts of power from its Calvert Cliffs nuclear plant in Maryland. Amazon is the second named buyer after Walmart. The announcement itself could not be opened, so the price, the start date and whether this is part of the 920 megawatts signed in August are not known.
What it did to the thesisNothing moved yet. Our case rests on named, sized power deals continuing to arrive, and this is one, but without terms we cannot say how much it adds. The next quarterly results, due 9 November, should show whether it is new.
ACM Research's Chinese subsidiary said its order backlog, the value of tools ordered but not yet counted as sales, was 17.1 billion yuan (about $2.5 billion) on 29 September. That is 88.2% more than a year earlier. The company warns that the measure is its own and may not match other firms'.
What it did to the thesisIt supports management's claim of fast order growth, but the figure does not say which products the orders are for. Our view rests on cleaning sales rebounding and two newer product lines winning orders, so nothing moved. The November results remain the test.
Tesla signed three bank credit lines worth $30 billion in total, according to a filing on 29 September: a $20 billion three-year loan it can draw in stages, an $8 billion five-year line and a $2 billion one-year line. The filing does not say any of it has been borrowed. Tesla may use it for general corporate purposes.
What it did to the thesisNothing moved. The lines show Tesla expects to keep spending heavily, which fits our note that cash flow turned negative, but they report no sales or profit. Our case turns on the 28 October results. We still find the shares unattractive, with medium confidence.
Talen picked its President, Terry Nutt, to be chief executive from 1 January 2027; the current CEO retires. It also agreed to buy back $1.5 billion of its own shares at once, paid for by selling about $1.5 billion of future power-capacity income to Citi. The company says debt will fall to its target in late 2027.
What it did to the thesisOur view held. Debt is a central worry, and this defers cash from later years to shareholders now, so the debt claim is noted, not changed. We still need a second signed customer and falling debt at a results report.
Talen targets net leverage below 3.5x net debt-to-Adjusted EBITDA; as of July 31, 2026, total available liquidity was approximately $1.9B ($525M unre…
Since the start of 2024, Talen has repurchased approximately 15 million shares of common stock for a total of approximately $2.3 billion (including 5…
Bitdeer's AI cloud arm said customers have committed to more than 70% of the capacity at its 21.7-megawatt A201 site in Malaysia. Only the headline could be read. A filing the same day shows it has sold about $8.4 million of new shares since 10 August.
What it did to the thesisNothing moved. A201 is small next to 1,752 megawatts, and the terms are unknown. Our case turns on whether the Tydal project is funded without new shares. The small share sales fit that view but do not settle it.
Soluna said Bitdeer, a bitcoin mining company, will place about 7 MW more of its own mining machines at the Kati 1 site, for about 35 MW in total, finishing in November 2026. Soluna supplies the site and power and shares the bitcoin mined. The copy filed with the SEC is stamped as a draft.
What it did to the thesisSmall change to one fact: Bitdeer's share of Kati 1 grew. It is bitcoin mining, not AI, so it does not touch what holds our view down: no AI tenant has signed and the company still pays for growth by selling shares.
Bitdeer agreed in August 2026 to place about 28 MW of its own mining machines at Kati 1 and share the bitcoin they produce with Soluna, which supplie…
NetApp said it plans to buy PEAK:AIO, a company selling storage software for AI. At its yearly conference it also announced a cloud storage service with Oracle, a wider deal with SAP, and a Supermicro collaboration. We could read only the headlines, so we know no prices, sizes or sales.
What it did to the thesisNothing moved. This is NetApp pushing further into AI storage, where newer rivals are strong, but with no numbers it cannot show that its growth is its own rather than higher memory prices. The view stays Unattractive and confidence Medium.
Meta hired CJ Desai, who ran the database company MongoDB, to lead a new push selling AI tools to businesses. MongoDB's shares fell about 16 to 18 percent on the news. Separately, Meta will rent AI computing capacity in Southeast Asia from Australia's Firmus. No revenue, price or spending amount was given for either.
What it did to the thesisNothing moved. We are waiting to see whether Meta puts a revenue number on its business AI products and how much it spends on computing. The hire shows intent and the Firmus deal shows demand for computing, but neither is a result. The October 28 report remains the test.
AT&T and Corning announced a multi-year agreement worth more than $3 billion. Corning will supply the fibre and cable AT&T needs to expand its network to more homes. The release gives no start date, length, volume or price, and Corning has not said how much of the value is new business.
What it did to the thesisIt fits our case: Corning says its capacity growth is backed by signed long-term buyers, and AT&T is another named one after Verizon, Meta and Amazon. It says nothing about profit margin or the share-issuing worry, so the view stays Unattractive, Medium conviction.
FTAI bought 27 Boeing 737-700 passenger jets from Canadian airline WestJet. Seventeen stay leased to WestJet through FTAI's new investor-funded vehicle; the other ten are empty and will be broken up for their CFM56-7B engines, which FTAI repairs and sells. No price was given. The release was read through a summary, not directly.
What it did to the thesisNothing moved. It fits the story that engines are scarce and FTAI is stocking up, but without a price we cannot say what it adds to profit. The real test is the 26 October results: the parts business's margin and its first new-turbine delivery.
Adeia named Dipti Vachani as its new chief executive, starting 12 October. She spent nearly 30 years in chips, most recently running a car-chip licensing unit at Arm. The outgoing chief executive, Paul Davis, who left for health reasons, stays on as a paid consultant until the end of December.
What it did to the thesisNothing moved in our view. The leadership question is now answered, but the case rests on royalties from two unsigned customers and a price that already assumes a recovery. The November results are the first real test, and she will not yet have run that quarter.
Chief executive Paul Davis announced on 4 May 2026 that he will step down by Q4 2026 for health reasons and remain until a successor is appointed; on…
The EU committee that could let Tesla sell its driver-supervised Full Self-Driving in every EU country will not vote on it at its 6 October meeting. Its published agenda gives the Dutch request 25 minutes of 'continuation of discussions'. The committee has no later meeting on the EU's register yet, and Reuters reports December as the earliest chance.
What it did to the thesisNothing moved. Our case waits on Tesla reporting what self-driving actually earns, and Tesla reports no such sales anywhere, so a delay in Europe changes nothing we can measure. We still find the shares unattractive, with medium confidence, and the next test is the 28 October results.
On September 25 a New Mexico jury found that Meta misled the state's residents about data privacy after the Cambridge Analytica scandal. No penalty is set; Meta's own filing says the state wants up to $62.85B. The same day, a researcher found a flaw in Meta's new Muse assistant that could expose personal data, and Meta added a warning; glasses owners can now keep camera requests out of AI training.
What it did to the thesisOur view holds: Attractive, medium conviction. We had assumed legal costs stay near today's size; a penalty near $62.85B would break that, but none is set. Separately, the shares rose 34.5% since we measured them, so we re-measured: still the cheapest rival on profit, now fairly priced, not cheap.
Meta's June 2026 quarter release warns that 'we continue to see scrutiny on youth-related issues in several markets and have a number of youth-relate…
Insider activity in Meta comprised 15 Form 4 filings with zero open-market purchases and 15 open-market sales. The chief financial officer sold on Au…
At a reference price of $559.02 Meta trades at 17.5 times trailing enterprise value to operating profit against a comparable-peer median of 32.25 - A…
Meta's trailing operating margin of 38.1% is the highest of the comparable cohort against a median of 28.2% - Alphabet 33.1%, Reddit 28.2%, Snap nega…
As of the research pack date Meta traded at $559.02, 29.31% below its 252-day high of $790.80 and 7.45% above its 252-day low of $520.26, at 14.3% of…
Meta's research pack raises no errors and its vendor-versus-filings cross-check reports a gap of exactly 0.0% on both annual revenue and annual opera…
Short interest in META was 28,807,174 shares at the August 31, 2026 settlement, up 2.71% from 28,048,106 a fortnight earlier - 1.31% of a float of 2,…
US regulators approved Lilly's Olumiant, a daily pill, for teenagers aged 12 and over with severe alopecia areata, a disease that makes hair fall out. In the trial, 42% of teenagers on the higher dose had at least 80% of their scalp covered with hair after 36 weeks, against 5% on a dummy pill. Lilly does not report Olumiant's sales on their own.
What it did to the thesisNothing moved. Olumiant sits in a group of immunology medicines that brought in $561 million last quarter, 2.4% of Lilly's $22,974 million, while one drug, tirzepatide, made 64.7%. A wider label for a small product cannot change that, so the view stays Neutral with Medium conviction.
GMF AeroAsia, Indonesia's largest aircraft-maintenance shop, agreed to keep repair capacity free for FTAI's CFM56 jet engines, and for the small extra power units planes carry, for five years. It already repairs engines for FTAI. No volume, price or value was given, and FTAI filed nothing with the US securities regulator. The shares fell 8.2% in the week with no stated cause.
What it did to the thesisFigures updated; the view held at Neutral, Medium conviction. More repair capacity helps FTAI deliver the engine parts it has promised, but says nothing about what each one earns. The real test is the 26 October results: the parts business's profit margin and its first new-module delivery.
At $190.74 on 18 September 2026 the enterprise value is about $22.7 billion: about 27 times the vendor's trailing operating profit - FTAI tags no ope…
The frozen pack's analyst panel shows 18 Buy, no Hold and no Sell, its monthly rating series ten analysts all positive for twelve readings to 1 Septe…
Over the six months to 18 September 2026 the shares fell 20.6% while trailing revenue per diluted share rose 23.9%, so the multiple paid for each dol…
The full filing for the Personalis purchase sets how many new shares Tempus issues: about 18.5 million at the 24 September share price, and up to 31.5 million if Tempus's price falls to $48.42, against the 26 million we had written. Paying up to half in cash instead would cost about $762 million, more than Tempus's $599.6 million of cash.
What it did to the thesisWe corrected the deal claims and added the new shares; the view held, and we still find the shares unattractive. More shares mean each holder owns less of the company without changing what it earns, and the price still needs profit margins Tempus has never earned.
Tempus agreed on 20 July 2026 to buy Personalis for $16.25 a share, about $1.5B of enterprise value, entirely in its own stock unless it elects up to…
A New York federal court gave final approval to SolarEdge's $55 million settlement of an old shareholder lawsuit and closed the case. The money came from the company's insurers, who had already paid it in. The June quarterly report already said so: $55.0 million of the money set aside for legal claims is this case, matched by $55.0 million owed by insurers.
What it did to the thesisFigures updated; the view held. The filing shows as fact, with corrected figures, what we had inferred. A lawsuit insurers paid does not touch why we find the shares unattractive: profit leans on a manufacturing credit the company has never sized, and its data-centre product has no named customer.
At June 30, 2026 SolarEdge's provision for legal claims was $68.7M against $13.2M at December 31, 2025, alongside a new insurance recovery receivable…
Six top officers, including the chief executive and the finance chief, sold 98,037 shares between them at about $33.96 each. Every filing says the shares were sold to pay tax on stock pay that had just become theirs. Over the past year, 95.0% of the shares company insiders sold went through selling plans set up months in advance.
What it did to the thesisFigures updated; the argument did not move. Selling to pay tax says nothing about the business, so only our record of insider selling was redone. The share price has risen 15.7% since we wrote the case, so it now assumes sales growing 40.7% a year for five years, not 38.4%.
Net of about $454M of cash and with no debt, buyers are paying about $2.12B for Ouster - roughly 9.7 times annualised Q2 revenue and about 24.9 times…
Ouster closed at $35.75 on 25 August 2026, 44.0% below its 252-day high of $63.79 and 118.0% above its low of $16.40. It has returned 20.3% over 252…
In the window to 19 August 2026 Ouster insiders filed eight open-market sales worth about $3.5M at prices between $44.65 and $47.09 and no purchases.…
At its Connect conference Meta launched Muse, an AI assistant app; AI glasses with no camera; and Muse Charm, a $1,299 AI pendant. Amazon blocked Muse from its shopping pages, while Shopify, PayPal and Instacart agreed to let it work on theirs. Meta gave no sales, unit or usage figures for any of it.
What it did to the thesisNothing changed. We already accept that Reality Labs, Meta's devices arm, keeps losing money and that its heavy spending may not pay off. These launches are that bet, with no sales figure attached. We test the core advertising business at the next quarterly report. Still Attractive, Medium conviction.
Vertiv agreed to buy King Environmental Services, a firm near Dublin that flushes, tests and sets up the liquid-cooling systems in data centres. It takes a similar business Vertiv bought in December 2025 into Europe, and is the seventh deal in that run. The price was not disclosed; Vertiv says it is too small to matter to its results.
What it did to the thesisNothing changed, because the deal is too small and too vague to test our case. Our view rests on the share price against profit and on growth Vertiv makes without buying it; a small bought-in business only adds to a count of deals our case already tracks.
Tesla started paid rides in Austin with the Cybercab, a robotaxi with no steering wheel, pedals or mirrors; the US road-safety regulator called it a small number of cars. The same day the regulator opened an audit of how Tesla certified an estimated 1,000 Cybercabs as meeting every federal safety standard, and ordered sworn answers by 30 September.
What it did to the thesisWe added the audit as a new claim and widened the risks it touches; the view held, and we still find the shares unattractive. The price pays for a self-driving software business that reports no sales. The launch brought no fleet count, and the audit adds a new question.
The regulator has two open investigations covering more than three million vehicles. EA26002, opened 18 March 2026, covers an estimated 3,203,754 veh…
Tenable borrowed $800 million through notes due 2031 paying 0.25% interest, which pay out partly in shares if the stock rises above about $44.84. It used the money to repay its $358.1 million bank loan and to buy back 5.3 million of its own shares for $170.5 million. Its debt minus cash rises from about $60 million to about $316 million.
What it did to the thesisWe corrected the claims about the balance sheet, which had described a loan now repaid; our Neutral view held. Our doubts are about paying staff in shares, keeping customers and growth, and the borrowing touches none of them. It keeps the buyback going, with $800 million due in 2031.
Tenable repurchased 11.4 million shares for about $230M in the first half of 2026 at an average of $20.23, and had $108M left on the authorisation at…
The balance sheet is close to neutral: a $353.0M term loan against $298.2M of cash and short-term investments, with a first lien net leverage ratio o…
Tempus called its Recursion deal an extension, but Recursion's own filing shows this data customer's yearly fee falling from $42 million to $14 million, and Tempus paying Recursion $12 million for one of its models. A filing for the Personalis purchase shows Tempus's own plan for that business losing money until 2030. The chief executive said Medicare pricing on one test adds $80 million to $100 million from January.
What it did to the thesisWe added three new claims; the view held, and we still find the shares unattractive. The price needs profit margins Tempus has never earned, and both filings sharpen that worry. The one hopeful figure is the chief executive's, found in no filing and not in the company's forecast.
To pay the cash part of its deal to buy Iridium, Rocket Lab sold about 29.3 million new shares for about $1.944 billion. Iridium's lenders agreed to keep its $1.775 billion of loans in place, so a $3.6 billion short-term loan was cancelled unused. The US telecoms regulator, the FCC, opened its review of the deal.
What it did to the thesisClaims on the funding and share count were corrected; we still find the shares unattractive. The deal is less likely to fail for lack of money but no cheaper per existing share, and the company is now valued at about 52 times a year's sales, up from 44.
Common shares outstanding rose from 543,574,552 (December 31, 2025) to 598,180,438 (June 30, 2026), and total shares outstanding (including preferred…
The Iridium merger requires Iridium shareholder approval (vote scheduled 2026-09-24), HSR clearance (lapsed as of 2026-08-13), FCC consent to transfe…
Over the trailing 365 days, officer Form 4 filings showed 252 open-market sales and zero open-market purchases; the COO and CFO both sold shares betw…
At the 2026-09-01 close, Rocket Lab's enterprise value is approximately 44 times trailing-twelve-month revenue.
Total funded debt today is minimal (about $13.1 million of convertible notes plus $1.7 million of other borrowings), but Rocket Lab has obtained fina…
On August 13, 2026, Rocket Lab replaced its equity distribution program with an ATM offering of up to $1,944,369,826 (the unsold amount under the pri…
DuPont, Chemours and Corteva settled North Carolina's claims over PFAS chemicals and other pollution from the Fayetteville Works plant. Qnity pays 44% of DuPont's after-tax cost in old cases like this, and its share stays at the $43 million it had already set aside in the second quarter, so there is no new charge.
What it did to the thesisNothing changed, because the case settled at the amount already set aside, inside the $253 million of old liabilities our case already counts. It closes one case of several; Qnity's open-ended 44% share of the rest, the real risk, is untouched.
Nielsen, which measures TV viewing, found Netflix had 7.8% of American TV time in July, against 8.8% a year earlier. June was also below a year earlier, so that is two falls in a row. YouTube hit a record 14.2%. Separately, the shares fell 12.9% from when we wrote our view, so they now cost about $24 for each dollar of profit the company forecasts for 2026.
What it did to the thesisWe updated price figures and one line: Netflix's TV share is now below a year earlier, not just off its peak. A third straight fall would trip one of our tests for being wrong. Still Neutral, Medium conviction: two falls is not three, and cheaper is not yet cheap.
Trailing diluted earnings per share of $3.18 include about $0.53 from the termination fee after tax, so at $81.89 the price is about $31 for each $1…
Nielsen measured YouTube at 13.8% of United States television watch-time in May 2026, the largest share of any distributor for a third consecutive mo…
Netflix's measured share of United States television time has not advanced since its December 2025 peak: Nielsen put it at 8.0% in May 2026 and repor…
At $81.89 the equity is about $349B and enterprise value about $354B, so Netflix's own 2026 guide of about $16.1B of operating profit and about $12.6…
Nielsen measured streaming at 48.6% of total United States television watch-time in May 2026, up 1.0 percentage point on the month, against broadcast…
The shares closed at $81.89 on 25 August 2026, down 32.0% over 252 sessions and 35.4% below the 252-day high of $126.71, with a trailing price of abo…
The analyst panel the research pack aggregates stands at 63 buy, 30 hold and 6 sell, with no strong sells, and its consensus label is Buy.
Shareholders of NextEra and Dominion both approved their merger by wide margins, with 99.47% of NextEra's votes in favour. To win over Virginia officials, the pair enlarged their offer, stretching a $10-a-month household bill credit from two years to four. Virginia's consumer lawyers want the state's 180-day review restarted. Separately, the US government agreed a loan of up to $1.9 billion to restart the Duane Arnold nuclear plant.
What it did to the thesisFacts were updated; nothing was re-judged. The vote is done and only regulators remain. Even a restarted Virginia review ends about March 2027, before the planned late-2027 completion. The view stays Neutral with Medium conviction, held there by shares valued above similar regulated utilities, which none of this touches.
The combined company proposes $2.25B in total bill credits for Dominion Energy's customers in Virginia (~79%), South Carolina (~17%) and North Caroli…
Closing requires both companies' shareholder approvals, HSR Act clearance, and regulatory clearances from FERC, the NRC, the Virginia SCC, the North…
NEER remains on track to bring the previously shut Duane Arnold nuclear plant in Iowa back online no later than Q1 2029; the Iowa Utilities Commissio…
Helios bought some assets of Radio Sound, which makes audio electronics for vehicles, mainly its technology and designs. With it came a contract lasting several years to supply electronics to Indian Motorcycle. Helios says the deal is too small to matter to its results and gave no price, contract value, volume or length. It filed no formal notice with the US securities regulator.
What it did to the thesisNothing changed. Our view turns on a data centre order arriving with a size attached, second-half profit reaching the company's forecast, and how much of its 2030 target relies on deals not found. A tiny purchase and an unsized contract answer none of those. Still Neutral, Medium conviction.
Corning signed a deal letting it sell up to $2.0 billion of new shares on the stock market whenever it chooses, through Goldman Sachs. At the 23 September price that is about 12.9 million shares, about 1.5% of the company, and none has been sold yet. It was signed on 11 September, the day we wrote our view, and the shares fell 13.7% the next day.
What it did to the thesisWe corrected our record: it said Corning needed no new shares and had signed nothing like this, both wrong the day we wrote them. New shares leave each share owning less, a worry we already held; this is too small to move a grade. Still Unattractive, Medium conviction.
First Solar is dropping its complaint asking a US trade body to block imports of one type of solar panel made by ten rivals, which it says uses its patents. It will keep suing them in federal court instead, and tied the change to a separate US tariff action on polysilicon. The trade body could not have ruled before September 2027. Only the announcement's first paragraph could be read.
What it did to the thesisThe argument held and one fact was updated. We never counted on an import ban. Our case rests on the price floor on rivals' imported cells and a US tax credit for making panels at home, so the view stays Attractive with Medium conviction.
First Solar is asking the trade commission to bar imports of competing panels made by ten named rivals.
Expand completed its purchase of Twin Eagle on 16 September, 54 days after signing and within the quarter it had promised. The next day it borrowed $500 million through bonds paying 5.65% a year, due 2031. The borrowing alone leaves debt minus cash unchanged, since the cash raised sits beside the new debt; the purchase lifts it to roughly $4.4 billion.
What it did to the thesisThe view stays Neutral, confidence Medium. We rewrote the deal claims as history and re-checked our debt warning line: debt minus cash is closer to $5 billion but about $574 million below it. The other thing we wait for, a permanent chief executive, is still missing.
The Twin Eagle Merger Agreement requires HSR Act clearance, approval under Canada's Competition Act and FERC approval under Section 203(a) of the Fed…
The executed Twin Eagle merger agreement, dated 2026-07-24, is more protective of Expand than the announcement disclosed. The Outside Date is January…
EQT won a Lithuanian tender to sell ten shiploads of liquefied natural gas to Ignitis, the country's state-controlled energy group, one a year from 2027 to 2036, priced on both US and European gas prices. It is the first named buyer on any EQT gas-export deal, but one shipload is about 0.14% of this year's expected sales volume. Lithuanian security and EQT approvals are still pending.
What it did to the thesisNothing moved. Our case rests on larger conditional gas sales deals becoming firm, on two projects, Southgate and Boost, staying on schedule, and on debt coming down. One shipload a year changes none of those, and EQT has not yet filed anything on the deal.
Chime agreed to buy Stride Bank for $590 million in cash. Stride is one of the two partner banks Chime relies on because it has no banking licence of its own. Regulators must approve, and closing is expected in the first half of 2027. Chime also raised this year's profit forecast, on its own adjusted measure, a fourth time, to $481 million to $489 million.
What it did to the thesisThe view stays Neutral, confidence Medium. The company, counting debt and cash, now costs about 18.5 times this year's forecast profit, down from 25, so we rate the price fair, not full. But becoming Attractive needs two reported quarters with profit above 17% of sales; none has topped 15%.
Chime raised FY2026 guidance to revenue of $2.725-$2.745 billion (25%-26% growth) and Adjusted EBITDA of $465-$475 million (about 17% margin, roughly…
CHYM's short interest was 18,952,244 shares, 8.4% of float, at the FINRA settlement of 2026-08-14, down 17.8% from the prior settlement, with 1.56 da…
CHYM last traded at $33.20, implying a market capitalization of approximately $12.65 billion and, against the $1.05 billion of cash and marketable se…
FY2026 Adjusted EBITDA guidance moved up in three steps across the company's first year public: $380-400 million (14%-15% margin) issued February 25,…
Constellation agreed to buy a gas-fired power plant in Johnston, Rhode Island, from a Shell company for $715 million. That is about 2.9% of Constellation's roughly $24.7 billion of debt. The announcement could be read only in part, so how the purchase will be paid for is not known. It names no data-centre customer or power contract.
What it did to the thesisNothing moved. The deal is too small to change Constellation's debt in any way that matters. Our view rests on signed data-centre power deals, the Crane plant restarting in 2027, and the regional grid not loading new costs onto existing plants. The next quarterly filing will show the funding.
Oracle says its Project Jupiter data centre in New Mexico will run on Bloom fuel cells, but the gas pipeline feeding it slipped from August 2026 to February 2027, and Oracle sent the developer a notice letting it delay payments. A July filing we had missed shows Bloom denies its scandium, a rare metal, depends on China, but names no source. Four executives sold shares; none bought.
What it did to the thesisThe view stays Unattractive, confidence Medium. We corrected our record, which wrongly said Bloom never answered the scandium charge; a denial naming no supplier leaves the question open. The shares rose 34.9% without new results, so the company, counting debt, costs $25.20 per $1 of yearly sales, up from $19.35.
A securities class action has been filed against Bloom Energy in respect of a class period running February 27, 2025 through July 8, 2026, alleging t…
Shares of common stock outstanding rose from 231,969,446 at March 31, 2025 to 233,661,168 at June 30, 2025 to 280,045,459 at December 31, 2025. Again…
On the research pack's market tier, Bloom's trailing-twelve-month multiples are: price-to-earnings 244.10 against a prior-fiscal-years median of -20.…
Insider activity in the research window comprised 15 Form 4 filings with 12 open-market sales and zero open-market purchases. Sellers include directo…
As of the research pack date Bloom traded at $204.02, 41.92% below its 252-day high of $351.28 and 51.98% up its 52-week range from a low of $44.64;…
An unnamed workforce housing company picked Aramark's Nexus unit to run dining, cleaning, fitness and leisure for up to 4,000 trade workers at a new AI data-centre site in Texas. No sales figure, contract length or start date was given. It may be a Texas site of the same size that Aramark already counted at about $160 million a year.
What it did to the thesisNothing moved. Our view turns on Nexus growing past the three sites Aramark has sized at $400 million to $500 million of yearly sales, with each new site signed, sized and dated. This one is signed but not sized or dated, so it cannot count yet.
Amazon borrowed £4.25 billion through its first bonds in British pounds, paying 5.2% to 6.65% a year. The Federal Trade Commission, a US regulator, and 22 states sued, saying Amazon secretly raised prices in its ad auctions since 2019, so advertisers paid their full bid about 80% of the time in 2024. Qualcomm said it will work with Amazon on custom AI chips; no terms were given.
What it did to the thesisNothing moved. More borrowing was expected, and the lawsuit names no amount and hits advertising, not the cloud business, AWS, where most profit is made. Our view rests on cloud growth, signed cloud contracts and whether spare cash stops falling, which only the 29 October results will show.
Muse, Meta's new standalone AI assistant app, reached number one on the US App Store within days of launch. Meta has given no figures for how many people use it, what it charges or what it earns. Separately, a German court ruled Meta liable for fake adverts on Instagram and Facebook; no damages figure was reported.
What it did to the thesisNothing changed. Our case turns on whether Meta's $130 to $145 billion of heavy investment pays off, and Meta still reports no sales from it; a chart ranking is not sales. The German ruling has no amount, so it cannot be weighed. Still Attractive, Medium conviction.
US regulators fully approved Inluriyo, a Lilly breast cancer drug, for use with another Lilly drug, Verzenio, in advanced cancer carrying a particular gene change. It is Inluriyo's second approval in under a year. In the trial, the pair held the disease back for a typical 11.1 months, against 5.5 months for Inluriyo alone. Inluriyo sold $75 million last quarter, 0.3% of Lilly's $22,974 million.
What it did to the thesisWe updated one line. We had said the fast growth of small new products like Inluriyo might not last; a second approval is a reason this one may. But one drug, tirzepatide, is still 64.7% of sales, so the view stays Neutral with Medium conviction.
St. Joe announced plans for 3,500 more homes at Latitude Margaritaville Watersound, a community it builds with a partner. Its filings put that community at about 3,700 homes, with 2,359 lived in at 30 June 2026. A week earlier it announced a new weddings and events business. Neither announcement could be read beyond its title, so nothing is known about timing or cost.
What it did to the thesisNo fact moved: a headline cannot replace a filed number. But one of our tests for changing our mind counted only a new venture, so it could never fire if this one simply grows; we rewrote it to count either. Still Unattractive, Medium conviction.
The Federal Trade Commission, a US regulator, accepted a deal under which Corpay and its chief executive, Ronald Clarke, pay $100 million back to business customers harmed by hidden fuel-card fees. The regulator's release, the only one we could read, adds that an appeals court upheld the 2023 ruling against the company on all counts, and that Clarke agreed not to fight a court order against him personally.
What it did to the thesisThe view stays Neutral, confidence Medium. We updated the record because the settlement is no longer preliminary, and the chief executive being a named party is a fact about how the company is run. The money was already counted as a cost; the fees involved are about 3% of sales.
Corpay recorded a $100M charge in Q2 2026 for a preliminary settlement with the FTC's Bureau of Consumer Protection, subject to commission approval,…
A second group of shareholders has sued AppLovin on behalf of anyone who bought its shares from 12 February to 5 August 2026. They claim the company overstated how steadily its AI models were improving and hid delays to a tool that makes video ads with AI. Nothing has been decided; a lawsuit is one side's account. An earlier, separate suit is about the accounting.
What it did to the thesisThe view stays Attractive and confidence Medium. We rewrote the record to name two lawsuits, because this one challenges the weakest part of our case: that the second-quarter slowdown came from the timing of AppLovin's model releases, not weak demand. The 4 November results test that; a complaint does not.
A securities class action alleging materially false statements about the advertising solutions and financial growth is live; the motion to dismiss wa…
Affirm says it now decides who gets a loan with a new kind of AI model. It gave no numbers - not how many people it approves, nor how many loans go bad - and the announcement itself could not be read beyond its headline. The first filing that must describe it is due on 5 November.
What it did to the thesisNothing moved. How Affirm decides who to lend to is the heart of our case, but without results there is nothing to judge the new model by. The November results, which report how many loans go bad, are the first real test.
The company selling DBM Global, a steel business IES is buying, published DBM's audited accounts. DBM earned $91.8 million of operating profit, profit from the business before interest and tax, over the year to 4 July 2026, not the $111 million we got by doubling one strong half-year. Its managers expect profit to fall in 2027. In an auction with 37 interested parties, IES raised its bid to $650 million.
What it did to the thesisWe corrected our most flattering number: IES pays about 7.5 times DBM's yearly profit, not 6. That is still far cheaper than IES's own shares at 26 times, so the deal still adds to profit per share, and the view stays Unattractive with Medium conviction.